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ABSTRACT

TOWARDS A “UNIVERSAL CHEMICAL BIOLOGY TOOLBOX” FOR TACKLING
HUMAN DISEASES

By
Christopher Swank
August 2021

Thesis supervised by Dr. David J. Lapinsky
A lack of new drug targets and drug mechanisms, coupled with drug-pipeline
attrition, represent significant problems in oncology drug discovery. Towards addressing
this challenge, “fully-functionalized small-molecule probes” (FFSMPs) have been
established, which are compounds that can be immediately used as “bait” to capture their
protein targets under the same assay conditions used for oncology-based phenotypic
screening. Specifically, each FFSMP library member contains one or more structuraldiversity elements to promote interactions of the probe with different protein targets in
living cells, an electrophile or photoreactive functional group for covalent attachment of
the probe to interacting proteins via affinity or photoaffinity labeling, and a terminal alkyne
click chemistry handle for visualization, enrichment, and identification of probeinteracting proteins. In particular, direct phenotypic screening of FFSMPs has been shown

iv

to facilitate the discovery of pharmacologically-active probes that are readily amenable to
mechanistic characterization and accelerated target identification using advanced
chemoproteomic techniques. However, there is an urgent/critical need for FFSMPs with
increased structural diversity in order to sample a larger amount of chemical space towards
discovering new drug candidates, drug targets, and drug mechanisms in the battle against
cancer.
The overall objective of my research is to synthesize structurally-diverse FFSMPs
via one-pot isocyanide based multicomponent reactions that are capable of sampling a large
amount of chemical space during integrated cancer-based phenotypic screening and target
identification studies. My research focuses on a clickable trifunctional monomer toolkit,
which allows for high chemical scaffold diversity. The rationale that underlies the research
is that studies involving FFSMPs are capable of producing ligands for proteins that have
yet to be described and can reveal a diverse array of traditional or non-traditional druggable
targets in cells, both of which have the exciting potential to shift research efforts in
completely new directions yet to be realized.
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CHAPTER ONE
1. Biochemical Review
1.1. Chemical Proteomic Techniques for Drug Target Identification
1.1.1. Introduction and Overview
When it comes to conventional drug discovery, bioactive small-molecules are
employed to modulate druggable proteins, which in turn control or compensate altered
protein signaling cascades for reversing a disease state (Schreiber, 2019). However, the
druggable proteins currently being targeted by clinically used drugs today make up a
minimal portion of the entire proteome (Oprea et al., 2018). As a result, the current
diversification of therapeutics is significantly limited, leading to the necessity for novel
approaches to drug target identification and drug discovery.
Phenotypic screening has recently grown more popular for drug discovery because
of its unbiased nature towards discovering bioactive compounds through their positive
effects on abnormal phenotypes (Berg, 2021). Because phenotypic screening does not rely
on knowledge of the mechanism of action(s) or protein targets of the compounds being
pharmacologically tested, phenotypic screening can increase the probability of discovering
bioactive molecules that currently target proteins considered “undruggable” (Wagner,
2016). However, the subsequent identification of the target protein of a phenotypic
screening “hit compound” tends to be very challenging and time-consuming, traditionally
on the order of months to years (Schenone et al., 2013).
Traditionally, drug target identification has typically relied on the pull-down of
proteins bound to bioactive small-molecules (Ha et al., 2020) conjugated to a solid support
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(i.e., affinity chromatography (Rodriguez et al., 2020); for a brief discussion of affinity
chromatography, see Section 1.1.2. and Figure 1.2.; Rodriguez et al., 2020). For affinity
chromatography as a biochemical experimental technique, the binding affinity between the
target protein and bioactive small-molecule must be strong enough to withstand multiple
washing steps and buffer exchanges in order to isolate the target protein(s) from the
proteome. However, most initial hit compounds resulting from phenotypic screening have
relatively moderate binding affinities and may not be acceptable to significant structural
modifications for subsequent attachment to an affinity chromatography solid matrix (Rix
and Superti-Furga, 2009).
To overcome setbacks resulting from relying on weaker, reversible, non-covalent
interactions between a small-molecule and its target protein(s), multiple approaches
utilizing small-molecule covalent capture of target proteins have been developed (Park et
al., 2013; Dalton and Campos, 2020). The most successful applications of these stronger,
irreversible, covalent ligand-binding strategies for drug target identification have typically
resulted from the incorporation of electrophilic or photoreactive functional groups into
bioactive small-molecules for affinity- or photoaffinity-labeling (Figure 1.1; for a brief
discussion of affinity labeling and photoaffinity labeling, see Section 1.1.4.). In particular,
the stronger, irreversible, covalent-binding approach can allow for successful drug target
identification for small-molecules with relatively low potency or drug target binding
affinities (Park et al., 2013).

2

Figure 1.1: Common non-covalent versus covalent drug target identification methods.
A.) Reversible, non-covalent affinity-based chromatography for drug target
identification. B.) Irreversible, covalent affinity labeling-based drug target identification
using chemo-reactive/electrophilic chemical probes. C.) Irreversible, covalent
photoaffinity labeling-based drug target identification using UV/photoreactive chemical
probes.

1.1.2. Drug Target Identification Using Affinity Chromatography
Affinity chromatography is an experimental technique for separating a specific
biological macromolecule from a complex mixture of biological macromolecules (Figure
1.2; Rodriguez et al., 2020). Specifically, affinity chromatography takes advantage of
highly specific, non-covalent, reversible binding interactions between a biological
macromolecule within a mobile phase and a ligand-binding partner covalently immobilized
to a stationary phase by means of a chemical linker. In a typical affinity chromatography
experiment, a bioactive ligand of interest is first chemically modified such that it retains its
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bioactivity and can form a stable covalent bond to a chemical linker attached to a solid,
insoluble support matrix. This stationary phase is then loaded into a column to which a
mobile phase containing a complex mixture of biological macromolecules is introduced.
Next, any biological macromolecule that binds tightly to the immobilized ligand will
remain bound to the stationary phase. A wash buffer is then applied to the column to
remove any non-specific binding biological macromolecules, namely by disrupting their
significantly weaker, reversible, non-covalent interactions with the stationary phase. Target
biological macromolecules with highly specific, non-covalent binding interactions to the
immobilized ligand can then be removed by applying an elution buffer that disrupts the
reversible non-covalent interactions between the bioactive ligand and its interacting
proteins. In turn, biological macromolecules with high specific binding to the immobilized
ligand are recovered from an eluting solution and can be identified via mass spectrometry
techniques (Loo et al., 1999).
One advantage for the use of affinity chromatography for biological macromolecule
mixture separation is the biologically active small-molecule of interest for protein tagging
requires little to no structural modification or functionalization for binding with the solid
support system. In general, agarose- or Sepharose-based polymers are functionalized with
N-hydroxysuccinimidyl (NHS) esters, which are easily coupled to amino or hydroxy
functional groups. The resin-bound biological small-molecule then undergoes affinity
chromatography as previously mentioned resulting in a relatively simple separation of the
protein targets of interest. However, this approach does not address the issue of nonspecific target binding so additional experimental techniques are required to elucidate
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which protein targets are specifically bound versus non-specifically bound (e.g.,
knockdown experiments as described in Yoon et al., 2019).

Figure 1.2: Schematic representation of affinity chromatography. A.) Sample
application/washing steps. B.) In general, three types of elution are used in affinity
chromatography: non-specific elution, isocratic elution, and bio-specific elution. Methods
for bio-specific elution can be further divided into normal-role elution, wherein a
competing agent binds to the target protein, and reversed-role elution, wherein a
competing agent binds to the immobilized affinity ligand. (Reprinted with permission
from Rodriguez et al., 2020)
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In 2019, Yoon et al., identified actin-related protein 2/3 complex subunit 2
(ARPC2) as a molecular target of benproperine (Benp) (identified through phenotypic
screening of 719 FDA-approved drugs or clinically tested compounds) (Figure 1.3) via
affinity chromatography. Specifically, colorectal adenocarcinoma cell line DLD-1 cells
were lysed, and the cell lysate was pre-cleared via incubation with Sepharose beads. The
lysate was then loaded on Benp-tagged Sepharose beads and subjected to affinity
chromatography with pH gradient buffer washes. The collected Benp-tagged proteins were
then visualized via SDS-PAGE and identified via mass spectrometry. Knockdown studies
of ARPC2 in cancer cells showed defective cell migration and decreased metastasis in an
animal model, suggesting that ARPC2 is a potential target for anti-metastatic therapy
(Yoon et al., 2019).

Me
O

N

Benproperine (Benp)

Figure 1.3: Structure of benproperine as a potent anti-migratory drug with anti-metastatic
activity for affinity-based target identification.

1.1.3. Drug Target Identification Using Biotinylated Chemical Probes
One common example of affinity chromatography utilizes bioactive smallmolecules functionalized with a biotin moiety towards capturing the protein targets of a
bioactive small-molecule (Figure 1.4.C). Specifically, biotin binds to the proteins avidin
and streptavidin with some of the strongest, yet reversible, noncovalent binding affinities
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known. As a result, this makes the highly specific interaction between biotin and
avidin/streptavidin chemically stable under all but the harshest conditions (Laitinen et al.
2006).

Figure 1.4: A.) Affinity-based drug target identification of bioactive small-molecules.
B.) General composition of an affinity chromatography column for affinity-based drug
target identification of bioactive small-molecules. An affinity chromatography column
features a bioactive compound of interest is attached to a solid support by means of a
chemical linker. C.) General representation of a biotinylated chemical probe of a
bioactive compound of interest for affinity-based drug target identification of bioactive
small-molecules using avidin-/streptavidin-coated beads. (Adapted and reprinted with
permission from Kawatani and Osada, 2014)

For drug target identification using a biotinylated chemical probe (Figure 1.4.C.),
cell lysates can be incubated with a biotinylated small-molecule, followed by the addition
of avidin-/streptavidin-coated beads. Alternatively, pre-incubation of a biotinylated
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chemical probe with avidin-coated beads prior to incubation with a cell lysate prevents the
risk of target protein degradation, and therefore, is more efficient in drug target protein
capture. Additionally, pre-incubation with excess of a biotinylated chemical probe ensures
full saturation of the avidin-/streptavidin-coated beads, which in turn, prevents any
unwanted binding of endogenous biotinylated proteins present in the cell lysate, thus
reducing the isolation of non-specific protein binders. Drug target proteins are then
subsequently enriched on a solid support, wherein non-specific binding proteins are
removed through washing steps. In turn, the remaining binding proteins or beads are eluted
under acidic conditions or by boiling with SDS, followed by mass spectrometry
identification of the eluted proteins (Hermanson, 2008).
Of note, biotin and a number of biotin derivates are commercially available and can
be easily conjugated to most functional groups within a bioactive small-molecule (Trippier,
2013). However, biotin can significantly reduce the aqueous solubility of the parent
bioactive compound. Additionally, non-specific protein binders during biotinylated affinity
chromatography can be difficult to remove in the washing steps, which can make
successful drug target protein identification practically challenging. However, one strategy
that can be used to overcome these obstacles is to synthesize a variety of biotinylated
probes based on the bioactive parent compound, wherein “positive biotin chemical probes”
retain the original biological activity of the parent compound and “negative biotin chemical
probes” do not retain the original biological activity of the parent compound. In brief,
proteins that are enriched by both the “positive” and “negative biotin chemical probes” can
be used to determine non-specific protein binders of the parent bioactive compound of
interest.
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Specifically, in 2013, the Hung group developed 7DG-Biotin (Figure 1.5), a
biotinylated variant of the parent compound 7DG, a small molecule that prevents
macrophages from anthrax lethal toxin (LT) induced death, as an affinity-based covalent
probe. 7DG-Biotin was developed through structure activity relationship (SAR) studies
and was found to retain similar cellular potency in protecting cells from LT-induced cell
death when compared to the parent compound 7DG. J774 macrophages were incubated
with DMSO, 7DG, 7DG-Biotin, or 7DG-Biotin with an excess of free 7DG. The cells
were then lysed, the lysates were incubated with streptavidin-labeled beads, and subjected
to affinity chromatography. The remaining proteins retained on the beads were then
analyzed by SDS-PAGE and proteins singularly labeled by 7DG-Biotin were identified
via mass spectrometry. The authors identified eleven proteins that were enriched with
7DG-Biotin. Knockdown studies of the eleven identified proteins showed that inhibition
of protein kinase R (PKR) was instrumental in protection from LT-induced cell death (Hett
et al., 2013).
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Figure 1.5: 7DG and its biotinylated electrophile-based probe for affinity
chromatography and covalent target identification.

1.1.4. Drug Target Identification Using Covalent Chemical Probes – Photoaffinity
Labeling and Affinity Labeling
Photoaffinity labeling is a well-established biochemical experimental technique
involving the use of photoreactive (i.e., “UV light-reactive”) chemical probes that can
covalently bind to their biomolecular target(s) in response to activation by UV light (Figure
1.6) (Lapinsky, 2012; Lapinsky and Johnson, 2015; Smith and Collins, 2015).
Photoaffinity labeling experimentally creates an irreversible and covalent ligandbiomolecule complex (4) made possible by the incorporation of a photoreactive functional
group within the structure of a compound of interest. Initially, a photoaffinity labeling
probe/photoaffinity ligand/photoprobe (1) initially interacts non-covalently and reversibly
with its target protein(s) (2) in biological sample of varying complexity. However, upon
irradiation of reversible probe•protein complex 3 with UV light of a specific wavelength,
the photoreactive functional group within the chemical probe undergoes photolysis to form
a highly reactive chemical intermediate that reacts rapidly, irreversibly, and covalently with
the nearest molecule, which ideally will be amino acid residues of the target protein in the
vicinity of the chemical probe-binding site. In contrast to affinity labeling (see below),
photoaffinity labeling does not require the presence of a nucleophilic amino acid residue
within the chemical probe-binding site to facilitate covalent bond formation between the
chemical probe and its interacting protein(s). However, covalent bond formation via
photoaffinity labeling can be unpredictable and non-specific, which can limit certain

10

applications of this biochemical experimental approach. Of note, photoaffinity labeling
probes can also be known as Affinity-Based Protein-Profiling probes (AfBPPs) (Conway
et al., 2021).

Figure 1.6: Schematic representation and main applications of photoaffinity labeling in
medicinal chemistry and chemical biology. PRG = PhotoReactive functional Group.
(Reprinted with permission from Lapinsky and Johnson, 2015)

The most common photoreactive functional groups traditionally employed in
photoaffinity labeling chemical probes are benzophenones, diazirines, and aryl azides,
which are either incorporated directly within a small-molecule as a structural replacement,
or attached to a bioactive compound of interest by means of a chemical linker (Smith and
Collins, 2015). UV-irradiation of these photoreactive functional groups facilitates the
formation of a highly reactive diradical, carbene, or nitrene intermediate, respectively (see
Scheme 2.10 and Section 2.1.3.1. for a brief chemical discussion of these photoreactive
11

functional groups). However, these common photoreactive functional groups are not
without their advantages and disadvantages.
Azides (-N3), for example, are relatively small photoreactive functional groups that
can be easily incorporated into a ligand of choice; however, azides are not necessarily
stable under certain harsh chemical conditions (e.g., strong acidic, strong basic, oxidizing
or reducing conditions, etc.) and have a maximum wavelength absorption at <300 nm. Of
note, proteins have a wavelength absorption around 280 nm due to their aromatic amino
acid side chain residues, and as a result, this similarity in wavelength absorption can
potentially result in significant damage to the biological system when photoactivating an
aryl azide-based photoaffinity labeling probe (Murale et al., 2016).
In contrast to aryl azides, the photoreactive benzophenone functional group has a
wavelength absorption of 350-360 nm, which typically results in less biological damage
during photoaffinity labeling when compared to aryl azides (Hassan and Olaoye, 2020).
However, the photoreactive benzophenone functional group is rather bulky and can
experience significant steric issues when the photoprobe is trying to properly interact with
its biological targets. As a result, it is not uncommon for researchers to synthesize and
compare several versions of photoaffinity-based probes that ideally retain biological
activity comparable to the parent compound and achieve optimal protein labeling
efficiency (e.g., see Bush et al., 2013 and Xu et al., 2015). Alternatively, the diazirine
photoreactive functional group, though complicated to synthesize, has a similar wavelength
absorption to the benzophenone photoreactive functional group (350-380 nm), and unlike
aryl azides, are rather stable in many chemical environments. In general, aliphatic and aryl
diazirines as photoreactive functional groups are preferred over benzophenones due to their
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smaller size and relatively better protein labeling efficiency (Hill and Robertson, 2018; Li
et al., 2013; West et al., 2021).
Additionally, a fluorescence in two-dimensional (2D) gel electrophoresis (FITGE)
experimental approach can be used to overcome the issue of non-specific protein labeling
by photoreactive small-molecule probes during drug target identification (Figure 1.7) (Park
et al., 2012, 2016, and 2017). In brief, the FITGE approach involves photoaffinity labeling
a proteome with “positive photoaffinity labeling probes” and “negative photoaffinity
labeling probes” that are derived from an initial hit compound. Once again, “positive
photoaffinity labeling probes” retain the biological activity of the parent compound and
“negative photoaffinity labeling probes” do not retain the biological activity of the parent
compound. Specifically, each photoaffinity labeling probe consists of a photoreactive
functional group for photoaffinity-based ligand-protein covalent complex formation and a
terminal alkyne click chemistry handle for target protein visualization, enrichment, and
identification (Parker and Pratt, 2020). First, live cells are incubated with each photoprobe
separately to ensure independent binding events with biological targets. Next, the separate
cell lysates are then visualized in a side-by-side manner to compare which biological
targets are bound to the “positive photoaffinity labeling probe”, the “negative photoaffinity
labeling probe”, or both probes. However, due to inconsistencies in gel-to-gel comparisons,
this comparison between the cell lysates can prove difficult. To address this issue, the
proteome labeled with the “positive photoaffinity labeling probe” is conjugated via click
chemistry to a red Cy5 dye, while the proteome labeled with the “negative photoaffinity
labeling probe” is conjugated with a green Cy3 dye. In-gel fluorescent visualization of the
labeled proteins then shows the specific target proteins bound to the “positive photoaffinity
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labeling probe” in red, non-specific non-target proteins bound to the “negative
photoaffinity labeling probe” in green, and proteins bound to both probes in yellow. In
particular, use of a higher resolution 2D gel can allow for clearer protein separation for
subsequent gel excision and identification of specific drug target proteins via mass
spectrometry techniques (Park et al., 2012).

Figure 1.7: Schematic representation of the fluorescence in two-dimensional (2D) gel
electrophoresis (FITGE) method for drug target identification. See the text above for a
description of this experimental technique. (Reprinted with permission from Park et al.,
2012)

Alternative to photoaffinity labeling, affinity labeling can be used to create
irreversible, covalent ligand-protein complexes (Figure 1.8) (Givol and Wilchek, 1998).
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Specifically, affinity labeling is a biochemical experimental technique for covalently and
irreversibly labeling the ligand-binding site of a protein via the use of a ligand that contains
a chemically reactive electrophilic functional group. This electrophilic functional group is
capable of forming an irreversible covalent bond with a suitably oriented nucleophilic
amino acid within the ligand-binding site of a protein. Such an affinity label/affinity
labeling chemical probe is traditionally composed of: 1.) a biologically active compound
that is capable of forming a reversible complex with its given target protein(s), and 2.) a
properly positioned, chemically reactive electrophilic functional group to facilitate
covalent bond formation between the probe and a nucleophilic amino acid within the
ligand-binding site of the protein (Figure 1.8). Upon incubation with a biological sample
of varying complexity, an affinity labeling chemical probe initially interacts reversibly and
non-covalently with its target protein counterpart(s) to form a reversible affinity labeling
chemical probe•protein complex. The formation of this complex increases the local
concentration of the affinity labeling chemical probe at the ligand-binding site within the
interacting protein relative to its concentration in solution. As a result, this ensures that a
subsequent irreversible and covalent chemical labeling reaction between the electrophilic
functional group of the affinity labeling chemical probe and the proximal nucleophilic
functional group of a protein amino acid will take place at the ligand-binding site within
the interacting target protein and not elsewhere.
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Figure 1.8: The formation of irreversible and covalent ligand-protein complexes via
affinity labeling. A.) Affinity labeling of a target protein surface. B.) Affinity labeling of
the interior of a ligand-binding pocket within a target protein. (Reprinted with
permission from Takaoka et al. 2017)

Closely related to traditional affinity labeling chemical probes, Activity-Based
Protein-Profiling probes (ABPPs) are bioactive small-molecule probes that contain an
electrophilic functional group that can react covalently and mechanistically with related
classes of enzymes (Figure 1.9) (Cravatt et al., 2008). Importantly, ABPP can reveal the
activity of enzymes because ABPP probes are mechanistically and covalently bound to the
active site of an enzyme (Niphakis and Cravatt, 2014; Sanman and Bogyo, 2014). Rather
than being limited to protein or mRNA abundance, one major advantage of ABPP is the
ability to monitor the availability of an enzyme active site directly. For example,
metalloproteases and serine hydrolases are classes of enzymes that often exist as inactive
zymogens or interact with endogenous inhibitors (Liu et al., 1999; Saghatelian et al., 2004).
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As a result, ABPP as an experimental technique offers a valuable advantage over traditional
techniques that rely on protein abundance rather than enzymatic activity.
Much like small-molecule photoaffinity labeling/AfBPP chemical probes that
contain photoreactive functional groups, electrophilic/affinity labeling and ABPP probes
frequently contain a terminal alkyne tag for biotinylation via CuACC click chemistry
(Parker and Pratt, 2020; for a brief discussion of CuACC click chemistry, see Section
2.1.4.). Once a given probe is covalently and irreversibly bound to its target protein(s), the
isolation and target identification of the protein is essentially identical for clickable affinity
and photoaffinity labeling probes, wherein the protein-bound probes are biotinylated,
enriched, eluted, and identified via mass spectrometry (Ha et al., 2020).
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Figure 1.9: General workflows of activity-based protein profiling (ABPP) and affinitybased protein profiling (AfBPP) as biochemical experimental strategies. (a) For covalent
and irreversible enzyme inhibitors, direct activity-based probes (ABPs) can be designed
to covalently label the active site of a given class of enzymes using the mechanism of the
enzyme. Subsequently, a typical ABPP experiment is performed for probe-protein
visualization, identification of probe-labeled proteins, and/or quantification of target
proteins. (b) For non-covalent and reversible protein inhibitors, photoreactive functional
groups can be incorporated to enable formation of a covalent bond with a target protein
upon UV-irradiation. Subsequent bio-orthogonal ligation chemistry can then enable
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photoprobe-labeled proteins for protein identification, enrichment, and/or visualization.
(Reprinted with permission from Deng et al., 2020)

1.2. Recent Successful Applications of Fully-Functionalized Small Molecule Probes
(FFSMPs) in Drug Target Identification
One of the main goals in the field of chemoproteomics/chemical proteomics is to
map proteome-wide small-molecule interactions in complex, native systems, and identify
the protein targets of pharmacological modulators. This has led to development of several
modern chemoproteomic methods towards identifying the protein targets of phenotypic
screening hits, as well as investigating their mechanisms of action (Conway et al., 2021).
In this regard, chemical probes classified as Fully-Functionalized Small Molecule Probes
(FFSMPs) can be used in label-based enrichment methods for drug target identification
(Figure 1.10, lower left- and right-hand corners) (Drewes and Knapp, 2018; Conway et al.,
2021).

Figure 1.10: Schematic of screening chemical libraries and corresponding drug target
identification chemical probes. (Reprinted with permission from Conway et al., 2021)
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In general, FFSMPs (Figure 1.10, lower left- and right-hand corners) are composed
of three structural entities: 1.) a protein-recognition group in light blue that promotes
interactions of the FFSMP with a subset of proteins, 2.) a protein-reactive functional group
in purple (e.g., an electrophilic or photoreactive functional group for affinity labeling or
photoaffinity labeling, respectively) for the covalent capture of FFSMP-interacting
proteins, and 3.) a reporter tag in green (e.g., fluorophores, biotin, or click-chemistryenabled handles) for the detection, enrichment, and identification or visualization of
FFSMP interacting proteins. Additionally, bioactive hits from traditional chemical
screening libraries typically can be retrofitted with chemical linkers and proteinenrichment functionalities (e.g., biotin, click chemistry handles, photoreactive groups, etc.)
for drug target identification (Figure 1.10., upper right-hand corner). Furthermore,
chemoproteomic-enabled screening libraries can be created to include: 1.) electrophilic
compounds that covalently label protein targets via affinity labeling, wherein drug target
engagement is determined through the use of broad-spectrum electrophilic probes; and (2)
Fully-Functionalized Small Molecule Probes (FFSMPs) as screening compounds, wherein
each probe contains a protein-reactive functional group and a reporter functional group
(Conway et al., 2021).
Select recent examples of successfully using Fully-Functionalized Small Molecule
Probes (FFSMPs) in chemoproteomic drug target identification studies will now be briefly
highlighted.
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1.2.1. Retrofitting Biologically Active Compounds as Fully-Functionalized Small
Molecule Probes (FFSMPs) for Chemoproteomic Drug Target Identification
1.2.1.1. Select Recent Examples of Affinity Labeling/Electrophile-Based FullyFunctionalized Small Molecule Probes (FFSMPs) for Successful Drug Target
Identification
The α,ß-unsaturated ketone natural product Zerumbone (Figure 1.11) is known to
display significant anticancer and anti-inflammatory properties (Prasannan et al., 2012). In
2015, Kalesh et al. converted Zerumbone into a cell-permeable clickable FFSMP (1.1,
Figure 1.11) via the addition of a terminal alkyne click chemistry handle (Figure 1.11)
(Kalesh et al., 2015). The clickable and electrophilic affinity-labeling probe 1.1 was
incubated with HeLa whole cells, the cells were lysed, and then probe-protein complexes
were subsequently tagged with azido-TAMRA-biotin via CuAAC Click chemistry. Initial
proteome labeling, determined by in-gel fluorescent scanning following SDS-PAGE of
1.1in comparison with Zerumbone, showed significantly different protein-labeling
patterns. The most statistically significant labeled proteins were then determined via mass
spectrometry. Of the top 20 targets determined for Zerumbone (based on cell-permeable
clickable FFSMP 1.1), DFNA5, CDA, UVRAG, and LCMT1 are known to play critical
roles in regulating apoptosis and cell survival.
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Figure 1.11: Zerumbone and its clickable FFSMP variant (1.1) for electrophile/affinity
labeling-based drug target identification.

As another example of retrofitting a biologically active compound into a FullyFunctionalized Small Molecule Probe (FFSMP) for chemoproteomic drug target
identification, Yoo et al. was able to determine the previously unknown mechanism of
action of Salinipostin A (Sal A, Figure 1.2) as a serine hydrolase-targeting antimalarial
compound (Yoo et al., 2020). The authors of this reported study performed a competition
experiment between the parent compound Sal A and its FFSMP variant 1.2 in Plasmodium
falciparum cells. The 1.2-labeled proteins were tagged with biotin-azide via CuAAC Click
chemistry, subjected to avidin-affinity chromatography, and identified via mass
spectrometry. The most notable enzymes that were identified as direct protein targets for
Salinipostin A (via its FFSMP 1.2) were Plasmodium falciparum prodrug activation and
resistance esterase (PfPARE), which is responsible for activating antimalarial prodrug
compounds, and Plasmodium falciparum exported lipase 2 (PfXL2) and Plasmodium
BEM46-like protein (PBLP), which are essential for parasite growth.
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Figure 1.12: Salinipostin A and its clickable FFSMP variant (1.2) for
electrophile/affinity labeling-based drug target identification.
1.2.1.2. Select Recent Examples of Photoaffinity Labeling/Photoreactive-Based FullyFunctionalized Small Molecule Probes (FFSMPs) for Successful Drug Target
Identification
As a recent example of retrofitting a biologically active compound into a
photoreactive Fully-Functionalized Small Molecule Probe (FFSMP) for chemoproteomic
drug target identification, Ross et al. subjected JTE-607 (Figure 1.13) to phenotypic
screening using a defined subset of the Cancer Cell Line Encyclopedia consisting of 92
human cancer cell lines of different lineages (Ross et al., 2020). In particular, JTE-607
was previously known to cause cell death in acute myeloid leukemia (AML) cells lines in
vitro (Tajima et al., 2010) . Of the cell lines tested, AML and Ewing’s sarcoma cell lines
showed sensitivity to JTE-607 (Ross et al., 2020). The FFSMP variant 1.3 (Figure 1.13)
was developed to include a photoreactive diazirine moiety for covalent binding of JTE607 to its target proteins via UV irradiation and an alkyne tag for CuAAC conjugation with
biotin-azide. Via a competition study performed between JTE-607 and FFSMP 1.3,
followed by affinity-based chromatography methods, a single target protein was identified
as pre-messenger RNA endonuclease cleavage and polyadenylation specificity factor 3
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(CPSF3), which upregulates apoptosis and causes tumor-selective stasis in mouse
xenografts.
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Figure 1.13: JTE-607 and its clickable FFSMP variant (1.3) for
photoreactive/photoaffinity labeling-based drug target identification.

In another study, Madhusudhan et al. developed FFSMP 1.4 (Figure 1.14) as a
benzophenone-containing photoaffinity-based probe for target identification of lead
compound QDC (Figure 1.14) (Madhusudhan et al., 2020). In particular, QDC showed
noteworthy anti-proliferative effects and was identified as a promising lead compound via
phenotypic screening of 202,103 small-molecules using 12 non-small-cell lung cancer
(NSCLC) cell lines. Specifically, a benzophenone was added to QDC as a photoreactive
functional group for covalent binding to its target proteins via photoaffinity labeling, and
an alkyne tag was added for diazo-biotin-azide immobilization via CuAAC Click
chemistry. During this work, K-562 cells were treated with QDC-based FFSMP 1.4 and
subjected to photoaffinity-labeling. The resulting FFSMP-labeled proteins were then eluted
off and identified via mass spectrometry, wherein an active target of QDC-based FFSMP
1.4 was determined to be mitochondrial complex I, which provides the electrochemical
potential for ATP production and thus stymies NSCLC cell growth.
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Figure 1.14: QDC and its clickable FFSMP variant (1.4) for photoreactive/photoaffinity
labeling-based drug target identification.

1.2.2. Fully-Functionalized Small Molecule Probes (FFSMPs) for Integrated
Phenotypic Screening and Drug Target Identification Studies
1.2.2.1. Select Recent Examples of Affinity Labeling/Electrophile-Based FullyFunctionalized Small Molecule Probes (FFSMPs) for Integrated Phenotypic
Screening and Drug Target Identification Studies
One of the earliest examples of using affinity labeling/electrophile-based FullyFunctionalized Small Molecule Probes (FFSMPs) for integrated phenotypic screening and
drug target identification was reported by Evans et al. in 2005 (Evans et al., 2005). This
particular study involved screening a library of approximately 50 small-molecule
electrophilic probes for antiproliferation activity against the MDA-MB-231 breast cancer
line. Subsequently, MJE3 (Figure 1.15), a clickable spiroepoxide-containing FFSMP for
activity-based drug target identification, was identified as a hit compound with excellent
antiproliferation activity. In turn, MDA-MB-231 cells were subjected to MJE3 and probelabeled proteins were tagged with a rhodamine-azide tag via CuAAC Click chemistry.
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Subsequent separation and visualization of the MJE3-labeled proteins via SDS-PAGE and
in-gel fluorescence showed MJE3 specifically targets a protein that was not targeted by
similar probes in the screening library. The target protein of MJE3 was ultimately
identified via mass spectrometry to be brain-type phosphoglycerate mutase 1 (PGAM1),
which is an enzyme that is crucial for executing glycolysis.
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Figure 1.15: Clickable FFSMP anticancer compound MJE3 was identified via an
integrated phenotypic screening and electrophile/affinity labeling-based drug target
identification campaign.

More recently, Liu et al. screened a library of 37 FFSMPs against the pancreatic
cell line BxPC-3 as part of an integrated phenotypic screening and electrophile/affinity
labeling-based drug target identification campaign (Liu et al., 2019). Specifically, FFSMP
1.5 (Figure 1.16), an acrylamide-containing affinity labeling probe synthesized via an Ugi
four-component reaction, was identified as having high antiproliferation activity in the
noted pancreatic cell line. In order to identify the protein targets of FFSMP 1.5, BxPC-3
cells were first subjected to affinity labeling with FFSMP 1.5, then probe-labeled proteins
26

were subsequently tagged with biotin-azide via CuAAC Click chemistry, separated via
SDS-PAGE, and visualized via in-gel fluorescence scanning. After mass spectrometry
studies, glutathione S-transferase omega 1 (GSTO1) was identified as the major protein
target of electrophilic FFSMP 1.5, thus suggesting this enzyme as a potential therapeutic
drug target for treating pancreatic cancer.
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Figure 1.16: Clickable FFSMP anti-pancreatic cancer compound 1.5 was identified via
an integrated phenotypic screening and electrophile/affinity labeling-based drug target
identification campaign.

1.2.2.2. Select Recent Examples of Photoaffinity Labeling/Photoreactive-Based FullyFunctionalized Small Molecule Probes (FFSMPs) for Integrated Phenotypic
Screening and Drug Target Identification Studies
In 2012, Cisar and Cravatt reported a pioneering study that involved phenotypic
screening of a library of approximately 30 photoreactive-based FFSMPs of varying
structural diversity against the breast cancer cell line, MDA-MB-231 (Cisar and Cravatt,
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2012). As a result of this effort, FFSMP 2.7 (Figure 1.17), which contains a photoreactive
benzophenone as part of an indole privileged structure, was identified as a selective hit
compound with antiproliferation activity under low-glucose conditions that phenotypically
represent hypoxic breast cancer cells. To determine the protein targets of
pharmacologically active meta-substituted FFSMP 2.7, a photoaffinity labeling
competition experiment was performed using a para-substituted derivative of FFSMP 2.7
as a negative control compound that lacked antiproliferation activity against MDA-MB231 cells under the same low-glucose conditions. In turn, FFSMP 2.7-labeled proteins were
subjected to click chemistry conjugation using biotin-azide, SDS-PAGE and in-gel
fluorescent scanning, followed by target protein identification using mass spectrometry.
Ultimately it was confirmed that clickable photoreactive FFSMP 2.7 targets mitochondrial
complex 1, whose inhibition is detrimental to mitochondrial respiration and leads to MDAMB-231 breast cancer cell death under nutrient-poor conditions.
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Figure 1.17: Clickable FFSMP anti-breast cancer compound 2.7 was identified via an
integrated phenotypic screening and photoreactive/photoaffinity labeling-based drug
target identification campaign.
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More recently, Parker et al. screened a library of fully functionalized fragments
(FFF) with molecular weights <300 Da for their phenotypic effects on adipogenesis in 3T3L1 mouse preadipocytes (Parker et al., 2017). During this work, FFF 1.6 (Figure 1.18), a
diazirine-containing FFF that could be used in photoaffinity-based drug target
identification experiments, was identified as a primary hit compound for its relatively high
promotion of lipid accumulation in the noted preadipocytes. In turn, photoaffinity labeling
competition

experiments

involving

pharmacologically

active

FFF

1.6

and

pharmacologically active and inactive control compounds were performed to identify any
specific drug target proteins for FFF 1.6 pharmacological action. Subsequently, FFSMP
1.6-labeled proteins were tagged with TAMRA-azide via CuAAC Click chemistry,
separated by SDS-PAGE, and visualized via and in-gel fluorescent scanning. As a result
of these experiments, progesterone receptor membrane component 2 (PGRMC2) was
identified via mass spectrometry as the primary target of FFF 1.6, wherein this compound
promotes adipocyte function through a gain-of-function mechanism.
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Figure 1.18: Clickable FFF 1.6 was identified via an integrated phenotypic screening and
photoreactive/photoaffinity labeling-based drug target identification campaign involving
adipogenesis in 3T3-L1 mouse preadipocytes.
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1.3. Conclusion
Phenotypic screening can offer key advantages over target-based drug screening,
namely because phenotypic screening offers the potential to discover a broader range of
potential drug targets, as well as compounds with novel mechanisms of action. Historically,
practical experimental difficulties in identifying the mechanisms of action of hit
compounds from phenotypic screening campaigns has hindered their development into
lead compounds and clinical candidates. However, numerous recent advances in chemical
biology methods and analytical technologies has made the process of drug target
identification of compounds with desired pharmacology much more manageable. As seen
via the select examples above, label-based chemoproteomic experiments are often pursued
first towards providing direct evidence of target engagement for a chemical probe.
Additionally, the development and integration of chemoproteomic-enabled chemical probe
libraries directly into phenotypic screens represents a powerful strategy to agnostically
discover new druggable proteins. As a result, continued integration of chemoproteomics
alongside phenotypic screening is expected to catalyze increased new knowledge of human
disease and cell biology in the future.
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CHAPTER TWO
2. Chemical Review
2.1. Chemical Review Associated with Compounds in This Thesis
2.1.1. General Approaches to Designing and Synthesizing Fully Functionalized SmallMolecule Probes (FFSMPs) for Chemical Biology and Medicinal Chemistry
Applications
In general, Fully Functionalized Small-Molecule Probes (FFSMPs) for integrated
phenotypic screening and target identification campaigns contain at least three structural
features (Figure 2.1.A): 1.) one or more structural diversity elements (e.g., privileged
structures (Kim et al., 2014) and Topliss optimization moieties (Topliss, 1972)) to promote
interactions of the FFSMP/ligand/recognition element with its target protein(s), 2.) a
protein-reactive functional group/warhead, typically a photoreactive group for UV lightinduced photoaffinity labeling (Smith and Collins, 2015) or an electrophilic functional
group for affinity labeling (Givol and Wilchek, 1998), and 3.) a bioorthogonal chemistry
handle, most commonly a terminal alkyne, as an indirect reporter group for FFSMP-protein
enrichment, visualization, and identification through click chemistry techniques (Parker
and Pratt, 2020).
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Figure 2.1: A.) Schematic representation of the individual components of fully
functionalized small-molecule probes (FFSMPs). B.) Schematic representation of
designing activity-based protein profiling (ABPP) probes. Here, a protein-reactive
electrophilic functional group typically leads the design of the compounds by exploiting
the mechanism of the target enzyme as a starting point. C.) Schematic representation of
designing affinity-based protein profiling (AfBPP) probes. Here, a bioactive compound
of interest typically leads the design of these probes by serving as a starting point. D.)
Schematic representation of fully functionalized fragments (FFFs). Here, small chemical
fragments are equipped with identical protein-reactive and reporter functional groups for
screening against complex protein mixtures via chemoproteomic approaches. (Reprinted
with permission from van der Zouwen and Witte, 2021)

Towards designing FFSMPs for activity-based protein profiling (ABPP; Cravatt et
al., 2008), most often the electrophilic functional group as the protein-reactive functional
group serves as the starting point for developing these compounds. This is because
traditional ABPP probes for enzymes typically function to exploit the mechanism of the
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target enzyme to form an irreversible and covalent probe-enzyme complex. As a result,
ABPP probes are often obtained by derivatizing an appropriate mechanism-based proteinreactive electrophilic functional group (e.g., a fluorophosphonate for serine hydrolases;
Figure 2.1.B) with a tag as a reporter group and a ligand as a protein-recognition element.
In this way it is possible that the activity of an entire enzyme family (e.g., serine hydrolases)
can be profiled with select ABPP probes, wherein the electrophilic protein-reactive
functional group will confer selectivity of the probe toward the enzyme family. If the goal
is to use an ABPP probe to target a single enzyme within an enzyme family, selectivity
toward the specific target enzyme can be achieve by tuning the ligand/recognition element
part of the probe.
Towards designing FFSMPs for affinity-based protein profiling (AfBPP), most
often a bioactive compound of interest, or a known protein-binding compound, typically
serves as the starting point for developing these probes. In turn, these starting point
compounds are derivatized with a protein-reactive functional group (either a photoreactive
functional group for photoaffinity labeling or an electrophile for affinity labeling) and a
reporter group (Figure 2.1.C). In cases where the target proteins of the starting point
compounds are unknown, or in the absence of structural information of how a starting point
compound specifically interacts with its target protein(s), several FFSMP derivatives are
typically pursued featuring different protein-reactive groups and different positioning of
these protein-reactive group on the parent ligand scaffold. Using this FFSMP library
strategy, a AfBPP probe can be obtained with the desired target selectivity profile and
efficient protein target engagement (e.g., Xu et al., 2015; Wright et al., 2017).
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Most recently, researchers have been starting to investigate either electrophilic
(e.g., Backus et al., 2016; Crowley et al., 2021) or photoreactive (e.g., Parker et al., 2017;
Wang et al., 2019) Fully Functionalized Fragments (FFFs) in the context of an entire
proteome. The easiest way to design FFFs is to introduce a protein-reactive functional
group into chemical fragments that already contain a bioorthogonal reporter tag (Figure
2.1.D). Alternatively, identical protein-reactive functional groups and bioorthogonal
reporter tags can be appended to chemical fragments to produce FFFs. In turn, FFFs
libraries can then be screened directly, the bioorthogonal tag can be functionalized for the
purpose of affinity enrichment or visualization, followed by analysis of the FFF-modified
proteins by mass spectrometry. From an innovation perspective, chemoproteomic
applications of FFFs can reveal a pattern of target protein selectivity for different chemical
fragments and uncover covalent fragments for proteins that have yet to be targeted.
Finally, regardless of pursuing FFSMPs, ABPP probes, AfBPP probes, or FFFs,
combining the three elements of

fully

functionalized compounds (i.e., the

ligand/recognition element, the protein-reactive functional group, and the reporter group)
into a single probe can be a synthetic challenge. This is particularly true when a number of
variants of a probe are desired towards identifying the most efficient compound. Given this
practical synthesis challenge, a number of different modular approaches have been pursued
in which FFSMPs, ABPP probes, AfBPP probes, and FFFs can be prepared from different
chemical fragments (reviewed in van der Zouwen and Witte, 2021). In particular,
utilization of a modular synthetic approach to make fully functionalized compounds
generally results in a simpler and less time-consuming synthesis, as different versions of
the compounds can be readily prepared by simply exchanging one or more of the modalities
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with one that has different chemical or pharmacodynamic properties. In this way, modular
synthetic approaches to fully functionalized compounds allow researchers to
systematically and powerfully screen different ligand-protein-reactive group combinations
within the context of an entire proteome.
Select examples of synthesizing FFSMP libraries for integrated phenotypic
screening and target identification studies will now be highlighted.

2.1.1.1. Select Examples of Synthesizing Photoreactive-Based FFSMP Libraries for
Integrated Phenotypic Screening and Target Identification Studies
Towards obtaining compounds for integrated phenotypic screening and target
identification studies, several FFSMP library syntheses have been described in the
chemical literature since 2012. Specifically, the concept of pursuing photoreactive-based
FFSMP libraries for integrated phenotypic screening and target identification originated
via the work of Cisar and Cravatt (Cisar and Cravatt, 2012). This pioneering study involved
an approximately 30-member library of 5-benzoyl indoles (BzIndoles) and 7-benzoylbenzo-1,4-diazepin-2,5-diones (BzBDs) as privileged chemical scaffolds (i.e., a fixed
central core) with multiple sites to introduce structurally diverse chemical appendages.
The synthesis of the 5-benzoyl indoles (BzIndoles) FFSMPs as part of the Cisar
and Cravatt study is depicted in Scheme 2.1 (Cisar and Cravatt, 2012). The synthesis began
with a Suzuki coupling of boronic acid 2.1 with regioisomeric aryl iodides 2.a-b in the
presence of carbon monoxide to give 5-benzoyl indoles 2.3a-b in 58% and 57% yield,
respectively. Specifically, this Suzuki coupling strategy was used to fuse a photoreactive
benzophenone group directly into a privileged indole structure. Subsequent indole N-
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propargylation using propargyl bromide then gave propargyl indoles 2.4a-b, wherein the
methyl ester within these compounds was then hydrolyzed with lithium hydroxide to give
carboxylic acids 2.6a-b in 70% and 72% yields, respectively. In turn, the carboxylic acid
functional group was then EDC coupled with a series of primary and secondary amines (2.
to provide FFSMPs 2.7-2.25 in respectable yields (i.e., meta-regioisomers in 43-89% yield
and para-regioisomers in 46-76% yield). Overall, the total synthesis of these clickable
photoreactive BzIndoles FFSMPs involved four synthetic steps to provide for the metaand para-regioisomeric FFSMPs in 14-29% yield and 16-27% yield, respectively.
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Scheme 2.1. Synthesis of clickable and photoreactive 5-benzoyl indoles (BzIndoles) as
FFSMPs for integrated phenotypic screening and target identification studies (Cisar and
Cravatt, 2012).

43

Alternatively, the synthesis of the 7-benzoyl-benzo-1,4-diazepin-2,5-diones
(BzBDs) FFSMPs as part of the Cisar and Cravatt study is depicted in Scheme 2.2 (Cisar
and Cravatt, 2012). Analogous to the BzIndoles, which feature a privileged indole
structure, these BzBDs FFSMPs feature fusion of a photoreactive benzophenone group
directly into a privileged benzodiazepine structure. The synthesis of this series of clickable
photoreactive BzBDs began by combining carboxylic acid 2.26, primary amine 2.27,
aldehyde 2.28, and convertible isocyanide 2.29 in a one-pot Ugi four-component reaction
(U-4CR) to give multicomponent adducts 2.30a-c in moderate yields. Concomitant Boc
deprotection and intramolecular cyclization under acidic conditions was then used to create
the privileged benzodiazepine chemical scaffold within compounds 2.31a-c. Finally, and
analogous to preparing the BzIndoles, a Suzuki coupling strategy using a varying boronic
acids under carbon monoxide conditions provided the clickable and photoreactive 7benzoyl-benzo-1,4-diazepin-2,5-diones 2.32-2.41 in yields of 20-55%.
In short, analysis of the biological activity of the library of BzBD and BzIndole
FFMSPs by Cisar and Cravatt using gel-based protein profiling and chemoproteomic
techniques revealed that different FFSMP library members covalently labeled different
subsets of proteins within a complex proteome (Cisar and Cravatt, 2012). As a result, and
as the first reported effort toward developing of a combinatorial FFSMP synthesis strategy,
the Cisar and Cravatt study illustrates the power of the approach. However, the broad
applicability of this particular FFSMP library is still somewhat impaired by the relatively
complicated multistep synthesis of the FFSMPs.
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Synthesis of 7-benzoyl-benzo-1,4-diazepin-2,5-dione (BzBD)
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Scheme 2.2: Synthesis of clickable and photoreactive 7-benzoyl-benzo-1,4-diazepin-2,5diones (BzBDs) as FFSMPs for integrated phenotypic screening and target identification
studies (Cisar and Cravatt, 2012).
As a follow-up to the original report from Cisar and Cravatt, Kambe et al. realized
that FFSMP libraries could potentially be prepared in a single step by appropriately
manipulating the inputs of multicomponent reactions (Kambe et al., 2014). Specifically,
Kambe et al. hypothesized that different multicomponent reaction building blocks, each
containing one of the structural elements of a FFSMP (i.e., a protein-reactive group, a
bioorthogonal handle, or a ligand/protein-recognition element), could be combined in
multicomponent reactions. By using this approach, each combination of the different
multicomponent reaction building blocks should then theoretically yield a unique FFSMP
with a distinct protein-labeling pattern.
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To test the noted hypothesis, Kambe et al. used aldehydes or ketones, 1˚ or 2˚
amines, isocyanides, and trimethylsilyl azide in an Ugi-tetrazole four-component reaction
(UT-4CR) to prepare a 60-member library of 1,5-substituted tetrazole FFSMPs (Figure 2.2)
(Kambe et al., 2014). In brief, each UT-4CR utilized a building block containing a diazirine
photoreactive functional group and a building block containing a terminal alkyne reporter
group, thereby allowing clickable photoreactive FFSMPs would be obtained via the
multicomponent reaction. Select examples of individual tetrazole FFSMPs from this effort
are pictured in Figure 2.2C. In turn, affinity-based protein profiling (AfBPP) with the
resulting clickable photoreactive tetrazole FFMPs showed that many of the library
members labeled distinct and unique subsets of a whole proteome. In particular, the large
diversity in proteins targets observed during this study, as well as the appendage
differences between the FFSMPs, further illustrates the effectiveness of using a
multicomponent reaction approach to synthesize FFSMPs.
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Synthesis of FFSMPs via Ugi-Tetrazole 4 Component Reaction
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Figure 2.2: A.) The Ugi-tetrazole four-component reaction (UT-4CR) is a
multicomponent reaction that combines 1˚ or 2˚ amines, aldehydes or ketones,
isocyanides, and trimethylsilyl azide in a single reaction step. B.) Isocyanide, aldehyde or
ketone, and 1˚ or 2˚ amine inputs used by Kambe et al., 2014 to synthesize a library of
appendage diverse FFSMPs via the UT-4CR. C) Select examples from Kambe et al.,
2014 of clickable diazirine-based FFSMPs for integrated phenotypic screening and target
identification.
For the FFSMP libraries highlighted in Scheme 2.1., Scheme 2.2., and Figure 2.2.,
the terminal alkyne click chemistry reporter group and the photoreactive functional group
for protein capture were positioned on different building blocks that were utilized in the
synthesis. In turn, this approach can restrict the diversity of the building blocks that can
be used in the library preparation of FFSMPs, since at least one component should contain
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the photoreactive functional group and another the click chemistry reporter group.
Additionally, the FFSMP libraries highlighted in Scheme 2.1., Scheme 2.2., and Figure
2.2., all feature a single core chemical scaffold and only explore chemical diversity of the
surrounding appendages. Although these libraries have proven successful in select
phenotypic screening and target identification studies, the chemical scaffolds of these
clickable photoreactive FFSMPs are only moderately diverse and, therefore, are only
capable of sampling a relatively small portion of chemical space. In particular, this limited
sampling of chemical space is sub-optimal for FFSMP libraries if the primary goal is to
“move the needle” on discovering new druggable proteins and compounds with novel
mechanisms of action. Alternatively, FFSMP libraries that sample a larger amount of
chemical space would be expected to improve the likelihood of achieving that lofty primary
goal towards innovative therapeutics.
Towards addressing these limitations, Jackson and Lapinsky hypothesized that a
multicomponent reaction building block that contains both the photoreactive functional
group and the click chemistry reporter group in a single entity would enable the synthesis
of a large number of not only appendage-diverse FFSMPs using multicomponent reactions,
but chemical scaffold-diverse FFSMPs as well (Jackson and Lapinsky, 2018). To test this
hypothesis, Jackson and Lapinsky designed and prepared a minimalist isocyanide building
block (2.52) containing an aliphatic diazirine as a photoreactive functional group for
protein capture and a terminal alkyne as a reporter group (Figure 2.3). In particular,
minimalist isocyanide building block 2.52 was rationally pursued by Jackson and Lapinsky
because: 1.) there are a host of known multicomponent reactions that use isocyanides as
one of the building blocks (Akritopoulou-Zanze, 2008), and 2.) the chemical diversity and
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commercial availability of isocyanides are significantly limited compared to carboxylic
acids, amines, ketones, and aldehydes as inputs for multicomponent reactions.
The synthesis of minimalist isocyanide building block 2.52, as depicted in Figure
2.3, began by refluxing Yao’s known minimalist 1˚ amine-aliphatic diazirine-terminal
alkyne building block 2.50 (Li et al., 2013) in ethyl formate and triethylamine to afford
formamide 2.51 in excellent yield (97%). Formamide 2.51 was then dehydrated with
phosphoryl chloride to provide the desired isocyanide (2.52) in 85% yield. Isocyanide 2.52
was then subsequently applied in the Passerini 3-component reaction (P-3CR), the Ugi 4component reaction (U-4CR), the Ugi tetrazole 4-component reaction (UT-4CR), the Ugi
5-center-4-component reaction (U-5C-4CR), and the Ugi beta-lactam-3-component
reaction (UBL-3CR). Additionally, select multicomponent reaction products were readily
derivatized as part of this work. As a result, employment of bifunctional building blocks
like isocyanide 2.52 in multicomponent reactions are expected to simplify FFSMP
synthesis even further.
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Synthesis of a Minimalist Aliphatic Diazirine-Terminal Alkyne-Isocyanide
Yao's Minimalist Linker
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Figure 2.3: A.) Synthesis of an isocyanide-aliphatic diazirine-terminal alkyne building
block (2.52) for producing appendage- and scaffold-diverse, clickable FFSMPs via
isocyanide-based multicomponent reaction technology (Jackson and Lapinsky, 2018). B.)
Passerini 3-component reaction-based (P-3CR) ((±)-2.61a), Ugi 4-component reactionbased (U-4CR) ((±)-2.61b), Ugi tetrazole 4-component reaction-based (UT-4CR) ((±)2.61c), Ugi 5-center-4-component reaction- based (U-5C-4CR) ((±)-2.61d), and Ugi
beta-lactam-3-component reaction-based (UBL-3CR) ((±)-2.61e) FFSMPs derived from
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isocyanide-aliphatic diazirine-terminal alkyne building block 2.52 (Jackson and
Lapinsky, 2018).

2.1.1.2. A Select Example of Synthesizing an Electrophile-Based FFSMP Library for
an Integrated Phenotypic Screening and Target Identification Study
In 2019, Liu et al. synthesized a 37-member library of clickable acrylamide- and
alpha-chloroamide-containing electrophilic FFSMPs for integrated phenotypic screening
and target identification studies in pancreatic cancer cells (Liu et al., 2019). Analogous to
that previously described, the clickable affinity labeling-based FFSMPs in this report were
synthesized via the Ugi four-component reaction (U-4CR) (Scheme 2.3A), wherein the
carboxylic acid input for each FFSMP library member was either acrylamide-containing
building block 2.47 (synthesized by N-acylation of aniline 2.46) or chloroacetic acid
(Scheme 2.3B). In short, acrylamide-benzoic acid 2.47 or chloroacetic acid were condensed
in a combinatorial manner with four different isocyanide inputs (none of which contained
a terminal alkyne), eleven different aldehyde/ketone inputs (two of which contained a
terminal alkyne), and eleven different amine inputs (one of which contained a terminal
alkyne) to quickly afford an appendage diverse library of U-4CR adducts. Specifically, of
the 61 library members reported in this study, 37 compounds contained a terminal alkyne
as a bioorthogonal/click chemistry handle. For example, FFSMPs 2.48 and 2.49 were
produced in 49% and 26% yield, respectively, using the U-4CR. In turn, several of the
FFSMPs displayed anti-proliferative activity in the pancreatic cancer cell line BxPC3 as
interesting chemical probe leads (Liu et al., 2019).
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Synthesis of Acrylamide and Alpha-Chloramide FFSMPs via Ugi 4 Component Reaction
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Scheme 2.3: A) The Ugi four-component reaction (U-4CR) is a multicomponent reaction
that combines carboxylic acids, 1˚ amines, aldehydes or ketones, and in a single reaction
step. B) Synthesis of an acrylamide-based carboxylic acid input (2.47) used in FFSMP
synthesis via the U-4CR (Liu et al., 2019). C.) Select examples of clickable acrylamideand alpha-chloro amide-based FFSMPs for integrated phenotypic screening and target
identification via affinity labeling in pancreatic cancer cells (Liu et al., 2019).

2.1.1.3. Select Examples of Popular Trifunctional Toolbox Monomers for
Synthesizing FFSMPs
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FFSMPs are often prepared by arming a bioactive small-molecule of interest with
a reporter group and a protein-reactive functional group (Figure 2.4.B). As a result, a
number of trifunctional reagents have been developed to aid in FFSMP synthesis that
include: 1.) a protein-reactive functional group/warhead for protein capture, 2.) a
bioorthogonal tag to enable click chemistry-based proteomics, and 3.) a functional group
that allows the bioactive small-molecule of interest to be conjugated with the trifunctional
reagent (Figure 2.4.C-E).

Figure 2.4: A.) The general composition of a trifunctional reagent for synthesizing a
FFSMP. B.) General synthesis of a FFSMP using a trifunctional reagent. C.) An example
of an amino acid-based trifunctional reagent for FFSMP synthesis. D.) Examples of
minimalistic trifunctional photoreactive-based reagents for FFSMP synthesis. E.)
Examples of minimalistic trifunctional electrophile-based reagents for FFSMP synthesis.
(Adapted with permission from van der Zouwen and Witte, 2021) trifunctional
photoreactive-based reagents for FFSMP synthesis. E.)
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The first reported trifunctional reagents for FFSMP synthesis used photoreactive
functional groups and were derivatives of natural amino acids. For example, Compound
2.62 (Figure 2.4.C) is a derivative of photo-methionine whose: 1.) side chain features
replacement of the sulfur atom within the methionine side chain with an aliphatic diazirine
as a photoreactive functional group for protein capture, 2.) carboxylic acid was converted
into a propargyl amide for click chemistry-based proteomics, and 3.) primary amine was
unaltered to allow a bioactive small-molecule of interest to be conjugated (e.g., via Nacylation) with this trifunctional reagent (Shi et al., 2011).
However, given their relatively large size, amino acid-based trifunctional reagents
for synthesizing FFSMPs could significantly alter the biological activity or protein-binding
profile of a parent ligand by increasing binding affinity to off-target proteins. As a result,
Li and co-workers subsequently introduced a very popular set of “minimalist” trifunctional
reagents (2.63, 2.50, and 2.64, Figure 2.4.D) where the distance between the aliphatic
diazirine protein-reactive functional group, the terminal alkyne reporter group, and the
functionalization handle for conjugation to a parent bioactive compound was kept as short
as possible (Li et al., 2013). For example, carboxylic acid 2.63 and primary amine 2.50 can
be used to create an amide link to a bioactive parent compound that contains an amine and
carboxylic acid functional group, respectively. Alternatively, primary alkyl iodide
derivative 2.64 can be employed in alkylation reactions (e.g., Williamson ether synthesis)
as a means of arming a parent bioactive ligand with a minimalist photoreactive diazirine
and a terminal alkyne click chemistry handle.
Finally,

as

an

example

of

recently

commercially

available

(https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/chemistry-

54

and-synthesis/peptide-synthesis/trifunctional-probe-building-blocks)

minimalistic

trifunctional electrophile-based reagents for FFSMP synthesis, a toolbox of clickable aryl
sulfonyl fluoride monomers (2.56a-b, 2.59a-b, 2.58a, 2.60a-b, and 2.65, Figure 2.4.E) that
can be used to covalently modify tyrosine and lysine residues within ligand-binding pocket
of a target product has been reported (Fadeyi et al., 2016). Specifically, monomers
containing a carboxylic acid, aldehyde, 1˚ aniline, alcohol, or alkyl halide functional group
were prepared as part of this report. These trifunctional reagents could then be attached to
a bioactive ligand of interest using a variety of well-established chemical reactions. For
example, carboxylic acids 2.56a and 2.56b, as well as aldehydes 2.60a and 2.60b, were
conjugated to amines within bioactive ligands via amide formation and reductive
amination, respectively. Additionally, benzyl bromides 2.59a and 2.59b were
demonstrated in a Williamson ether synthesis strategy to O-alkylate a phenolic bioactive
ligand, whereas aryl halide 2.65 was used as an electrophile in a palladium-catalyzed
Buchwald-Hartwig N-arylation (Fadeyi et al., 2016).
Given this toolbox of clickable aryl sulfonyl fluoride monomers (2.56a-b, 2.59a-b,
2.58a, 2.60a-b, and 2.65, Figure 2.4.E) served as inspiration for some of the building
blocks in this thesis, their preparation will now be briefly highlighted (Scheme 2.4). The
synthesis of the toolbox of target monomers began with fluorine exchange of aryl
sulfonylchloride 2.53a, or bromination of aryl sulfonylfuoride 2.53b, to afford aryl
sulfonylfluoride-aryl bromides 2.54a and 2.54b in 82% and 99% yield, respectively. These
aryl bromides were then Sonogashira coupled with trimethylsilyl (TMS) acetylene to give
the TMS-protected-ethynyl ester 2.55a and 2.55b in 82% and 90% yield, respectively. In
order to avoid concomitant hydrolysis of the aryl sulfonyl fluoride functional group, the
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esters within 2.55a-b were uniquely reacted with Me3SnOH to give the benzoic acids
2.56a-b, which were then subjected to a Curtius rearrangement to give the anilines 2.58a
in 41% yield and 2.b in 64% yield. Alternatively, esters 2.55a-b could be reduced with
diisobutylaluminum hydride (DIBAL) to give the benzyl alcohols 2.57a in 89% yield and
2.57b in 65% yield. These benzyl alcohols were then brominated via the Appel reaction to
give the corresponding benzyl bromides 2.59a-b. Additionally, benzyl alcohols 2.57a-b
could be treated with Dess-Martin periodinane to give benzaldehydes 2.60a-b in 81% yield
each.
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Synthesis of a Toolbox of Aryl Sulfonylfluoride Monomers
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Scheme 2.4: Synthesis of a toolbox of clickable aryl sulfonylfluoride monomers for
preparing electrophile-based FFSMPs.

2.1.2. Mechanisms of Select Examples of Isocyanide-Based Multicomponent
Reactions (IMCRs) Relevant To This Thesis
2.1.2.1. An Overview of IMCRs

57

Multicomponent reactions (MCRs) are generally described as any chemical
reaction with three or more starting materials being combined in one-pot to form a product
with essentially total conservation of the atoms (i.e., high atom economy). There have been
hundreds of MCRs reported over the years, with Isocyanide-Based Multicomponent
Reactions (IMCRs) being one specific subclass of MCRs that is highly versatile and
diverse. In general, isocyanides (R-NC) are chemically tolerant of other functional groups
and have high levels of chemo-, regio-, and stereoselectivity. In turn, the high variability
of starting materials for IMCRs can generate large libraries of structurally-diverse adducts
in one synthetic step, making them particularly valuable for FFSMP synthesis (partially
reviewed in van der Zouwen and Witte, 2021). Of the known IMCRs, the Ugi and Passerini
variations are most widely used in drug candidate synthesis (Domling, 2006; Alvim et al.,
2014).

2.1.2.2. The Mechanisms of the Ugi Four-Component Reaction (U-4CR), the Ugi
Tetrazole Four-Component Reaction (UT-4CR), the Ugi Five-Center FourComponent Reaction (U5C-4CR), and the Ugi Beta-Lactam Three-Component
Reaction (UBL-3CR).
The Ugi four-component reaction (U-4CR) mechanism is depicted in Scheme 2.5
and is proposed to begin with condensation of the primary amine component with the
aldehyde/ketone component to form an imine intermediate upon loss of water. The
relatively basic imine nitrogen is then protonated via the carboxylic acid input to form a
corresponding iminium ion, which is then subjected to nucleophilic attack by the carbanion
portion of isocyanide input to give an alkylated nitrile intermediate. This alkylated nitrile
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intermediate then undergoes nucleophilic attack by the previously deprotonated carboxylic
acid intermediate, followed by a Mumm rearrangement, to give the final U-4CR adduct as
an alpha-acylamino amide (Rocha et al., 2020).
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Scheme 2.5. The Ugi four-component reaction (U-4CR) mechanism.

As a common variant to the Ugi four-component reaction (U-4CR), the Ugitetrazole four-component reaction (UT-4CR) mechanism is highlighted in Scheme 2.6.
This particular MCR is proposed to begin with TMS-azide, as a U-4CR carboxylic acid
surrogate, reacting with methanol to give hydrazoic acid and methoxy trimethylsilane. The
reaction then occurs similarly to the U-4CR mechanism via condensation of the 1˚ or 2˚
amine input with the aldehyde/ketone input to form an imine intermediate after subsequent
loss of water. The imine is then protonated via the previously generated hydrazoic acid to
the corresponding iminium ion, which is then subjected to nucleophilic attack by the
carbanion portion of isocyanide input to give an alkylated nitrile intermediate. This
alkylated nitrile intermediate then undergoes nucleophilic attack by azide ion, followed by
an intramolecular cyclization, to give the final tetrazole-based UT-4CR adduct (Medda et
al., 2015).
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Scheme 2.6: The Ugi-tetrazole four-component reaction (UT-4CR) mechanism.

As a slightly more complex variant to the Ugi four-component reaction (U-4CR),
the Ugi five-center four-component reaction (U-5C-4CR) mechanism is presented in
Scheme 2.7. In contrast to the U-4CR, which involves a separate carboxylic acid input and
a separate 1˚ amine input, the U-5C-4CR uses an amino acid as way of tethering these two
functional groups. Additionally, a primary difference between the U-4CR reaction
mechanism and the U-5C-4CR reaction mechanism is that the former features an
intermolecular reaction between the alkylated nitrile electrophile intermediate and the
deprotonated carboxylic acid nucleophile, whereas the latter uses an intramolecular version
to provide an imine-lactone six-membered ring intermediate. This lactone can then undergo
methanolysis (i.e., MeOH is both the reaction solvent and a nucleophilic alcohol input in
the reaction) to give final U-5C-4CR product as a methyl ester (Moni et al., 2018).
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Additionally, proline can be used successfully in U-5C-4CRs as a carboxylic acid-2˚ amine
input, whereas U-4CRs generally only prove successful with 1˚ amine inputs. Furthermore,
it is also possible to intercept the imine-lactone six-membered ring intermediate of an U5C-4CR with a 1˚ amine as a nucleophile, instead of methanol as a nucleophile, to produce
iminodicarboxamides (Khoury et al., 2012)
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Scheme 2.7. The Ugi five-center four-component reaction (U5C-4CR) mechanism.

Similar to the Ugi five-center four-component reaction (U-5C-4CR), the Ugi betalactam three-component reaction (UBL-3CR) uses an amino acid that tethers the traditional
carboxylic acid and 1˚ amine inputs of an U-4CR into a single input. The proposed
mechanism of the UBL-3CR is given in Scheme 2.8. Although both the U-5C-4CR and
UBL-3CR reaction mechanisms feature an intramolecular reaction between the alkylated
nitrile electrophile intermediate and the deprotonated carboxylic acid nucleophile, the U5C-4CR gives an imine-lactone six-membered ring intermediate, whereas as the UBL-3CR
proceeds through an imine-lactone seven-membered ring intermediate. Much like the U4CR, the imine-lactone seven-membered ring intermediate of an UBL-3CR can undergo a
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second intramolecular cyclization to produce the final beta-lactam product (Domling,
2006).
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2.1.2.3. The Mechanism of the Passerini Three-Component Reaction (P-3CR)
The Passerini three-component reaction (P-3CR) mechanism is depicted in Scheme
2.9 and begins with nucleophilic attack of the isocyanide carbanion with the
aldehyde/ketone component. The carboxylic acid input is then deprotonated to give a
hydroxy-containing alkylated nitrile intermediate, which undergoes nucleophilic attack by
the previously generated carboxylate ion to give an alpha-hydroxy imino-ester
intermediate. Subsequent intramolecular transesterification of this intermediate then gives
the final P-3CR adduct as an alpha-acylxo amide (Alvim et al., 2014).
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2.1.3. Mechanisms of Select Protein-Reactive Functional Groups for Covalent
Labeling of a Protein Target by an FFSMP That Are Relevant to This Thesis
2.1.3.1. Mechanisms of Select Photoreactive Groups as Protein-Reactive Functional
Groups Relevant to This Thesis
The proposed mechanism by which a photoreactive benzophenone covalent reacts
with a target protein is highlighted in Scheme 2.10.A. Upon irradiation with UV light of
wavelength ~350-365 nm, a benzophenone is proposed to form a diradical intermediate
that can react by proton abstraction and carbon-heteroatom bond formation to form a
covalent bond with a nearby amino acid (X) within a target protein (Dorman and Prestwich,
1994). In contrast, irradiation of an aryl azide with UV light of wavelength ~254-400 nm
proceeds with loss of nitrogen gas to give a nitrene intermediate (Scheme 2.10.B). This
nitrene can potentially undergo a ring expansion reaction to give a 7-membered ring
electrophilic ketenimine intermediate, wherein a nucleophilic amino acid residue within
the target protein FFSMP-binding site can react covalently with the ketenimine to give an
irreversible FFSMP-protein adduct (Ge et al., 2018). Finally, analogous to an aryl azide,
irradiation of an aliphatic diazirine with UV light of ~350 nm proceeds with loss of nitrogen
gas to give the singlet carbene intermediate (Scheme 2.10.C). The singlet carbene
intermediate can then form a covalent bond with a nearby amino acid within the target
protein through proton abstraction or through nucleophile insertion into an empty p-orbital
(Das, 2011; Ge et al., 2018).

63

H

Photoreative Probe Protein Labeling Reaction Mechanisms
A

FFSMP

X

O

O
H
N

UV Light
FFSMP

HO

H
N

FFSMP
O

O

X

H
N
O

= Target Protein

B

H
N2

N3

X

X

N

UV Light

N

FFSMP

N

FFMSP

FFSMP

FFMSP

= Target Protein

C

FFSMP

N N

H
N

H

N2
UV Light

O

FFSMP

H
N

X
FFSMP

O

H

H
N

X

O

= Target Protein

Scheme 2.10. Reaction mechanisms for FFSMP protein labeling relevant to this thesis
using: A.) a benzophenone, B.) an aryl azide, or C) an aliphatic diazirine as traditional
photoreactive functional groups.

2.1.3.2 Mechanisms of Select Electrophiles as Protein Reactive Functional Groups
Relevant to This Thesis
For acrylamide-based electrophiles, the mechanism for covalent labeling of a target
protein proceeds via Michael addition of a nearby nucleophilic amino acid residue within
the target protein FFSMP-binding site with the electrophilic acrylamide α,β-unsaturated
system of the FFSMP (Scheme 2.11A) (Giraldo et al., 2016). In contrast, ring-strained
beta-lactams as electrophiles can react with a well-positioned nucleophilic amino acid

64

within the FFSMP-binding site of a protein (Scheme 2.11B). Subsequent collapse of the
tetrahedral intermediate and ring-opening releases the inherent ring strain associated with
a beta-lactam ring, thus resulting in acylation of the nucleophilic amino acid within the
FFSMP-binding site of the target protein (Bush and Bradford, 2016). Finally, appropriately
substituted arylchloro nitro compounds (e.g., 2-chloro-5-nitrobenzoic acid derivatives;
Scheme 2.11C) can react by a nucleophilic aromatic substitution (SN Ar) mechanism with
an appropriately placed nucleophilic amino acid within the FFSMP-binding site of a target
protein. Specifically for the pictured electrophilic 2-chloro-5-nitrobenzoic acid derivative
in Scheme 2.11C, nucleophilic attack by the nucleophilic amino acid protein residue occurs
at the aromatic carbon bonded to the chlorine atom, resulting in a loss of aromaticity of the
originally aromatic ring and formation of a tetrahedral intermediate also known as a
Meisenheimer complex (Terrier, 1982). In turn, subsequent collapse of the tetrahedral
intermediate/Meisenheimer complex results in the ring regaining aromaticity, loss of HCl,
and a covalently bound FFSMP-protein complex featuring substitution of the original
chlorine atom within the FFSMP with a nucleophilic amino acid within the FFSMPbinding site of the target protein (Rohrback et al., 2019).
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Scheme 2.11. Reaction mechanisms of FFSMP protein-labeling by electrophilic FFSMPs
(relevant to this thesis) via A.) Michael addition to an acrylamide, B.) beta-lactam ring
opening, and C.) nucleophilic aromatic substitution (SN Ar).

Finally, given the FFSMPs synthesized as part of this thesis contain a terminal
alkyne for a click chemistry based proteomic applications (Parker and Pratt 2020), a brief
description of this chemistry will now be highlighted.
2.1.4. The Copper-Catalyzed 1,3-Cycloaddition of Azides with Terminal Alkynes
(CuAAC) /Click Chemistry Reaction for Proteomic Applications
In 2001, the term “click chemistry” was put forth by K. Barry Sharpless and
coworkers to describe certain chemical reactions that are highly chemo- and regioselective,
modular in nature, wide in scope, and generally high-yielding (Kolb et al., 2001).
Specifically, the Cu(I)-catalyzed reaction between an aryl or aliphatic azide and a terminal

66

alkyne to form a 1,2,3-triazole (CuAAC; Scheme 2.12) is traditionally regarded as the
prototype “click chemistry reaction” and one of the most widely utilized bioorthogonal
reactions in chemical proteomics. In particular during 2003, Speers and coworkers
optimized CuAAC conditions for bioorthogonal chemistry reactions in complex native
environments (e.g., mouse tissue homogenates and human cell lysates) in order to profile
endogenous enzymatic activity via activity-based protein profiling (ABPP) (Speers et al.,
2003). Specifically, it was this latter report that laid the groundwork for using the CuAAC
reaction in complex biological systems as a bioorthogonal reaction during proteomic
investigations.
The mechanism of the CuAAC has been the subject of much debate. The most
recently accepted mechanism of the CuAAC reaction stems from the work of Bertrand and
colleagues and is pictured in Scheme 2.12 (Jin et al., 2015). Prior to this report, it was
proposed that mono mononuclear catalytic species underpinned the CuAAC reaction.
However, the isolation of a previously postulated p,s-bis(copper) acetylide and a
bis(metallated) triazole complex by Bertrand and colleagues, coupled with kinetic
experiments, points to bis-copper complexes being involved in the promotion of the
CuAAC reaction.
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Scheme 2.12. The reaction mechanism of the copper-catalyzed azide-alkyne Huisgen
1,3-cycloaddition to produce 1,2,3-triazoles, the most common “click-chemistry” reaction
used in bioorthogonal chemoproteomic applications.
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CHAPTER THREE
3. Statement of Problem
3.1 Statement of the Problem – A Lack of New Drug Targets and Drug Mechanisms
of Action
Within commercial and academic drug research settings, drug target prioritization
and selection are common goals that are crucial towards eventually reaching an approved
drug. However, it is known that current researchers tend to focus their work only on a small
subset of well-known genes and proteins as currently validated or potential drug targets
(Edwards et al., 2011). As a result, the U.S. National Institutes of Health (NIH) launched
the Illuminating the Druggable Genome (IDG; https://commonfund.nih.gov/idg)) initiative
in 2014 as a strategic and deliberate attempt to identify knowledge gaps around potential
protein drug targets. This initiative also encourages researchers to change the current “play
it safe” culture and instead investigate potentially druggable proteins that are currently
understudied. As a result, the primary goal of IDG is to support drug target hypothesis
generation with subsequent creation of new knowledge, particularly for proteins and genes
that are not well studied.
Currently, there is a sizeable knowledge deficit concerning a large portion of the
human proteome as potential drug targets (i.e., one out of three human proteins have been
largely understudied; Opera et al., 2018). Towards trying to classify and quantify this
knowledge deficit, Opera et al. put forth the following four categories to reflect the degree
to which a target protein is comparatively unstudied or well-studied (please see Opera et
al., 2018 for specific criteria of how an given protein is assigned to one of the four
categories):
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1.) Tclin (clinic) proteins = these are proteins that have been linked to at least one clinically
approved drug by a mechanism of action; additionally, drug target proteins interpreted as
“mechanism of action-related proteins” are also classified as Tclin (clinic) proteins (i.e.,
these are proteins that are essentially clinically validated with a known drug as a known
therapeutic drug target protein)
2.) Tchem (chemistry) proteins = these are proteins that lack a mechanism of action-based
link to a clinically approved drug, but these proteins are known to bind to a small-molecule
with pharmacologically high potency (i.e., these are proteins that tend to have at least one
experimentally validated specific molecular probe associated with them)
3.) Tbio (biology) proteins = these are proteins that have a confirmed disease phenotype and
have been annotated genetically, but they are not “mechanism of action-related protein
drug targets” as defined by Tclin (clinic) proteins (i.e., these are proteins that are linked to a
disease but currently lack at least one experimentally validated specific molecular probe
associated with them)
4.) Tdark (dark genome) proteins = these are “the remaining proteins” that do not meet any
of criteria defined by Opera et al. for classification as a Tclin, Tchem, or Tbio protein; that is,
these are proteins for which there is the least current knowledge and a low number of
specific molecular probes available; some of these proteins represent unexplored
opportunities within the druggable human genome
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Figure 3.1: Target development level categories applied to the human proteome. The
percentages of the whole proteome are shown via the depicted ring with the Tclin category
expanded. The ring colors are as follows: Tdark, black; Tbio, red; Tchem, green; and Tclin,
blue. (Adapted with permission from Opera et al., 2018)

As highlighted via Opera et al., 2018 in Figure 3.1, proteins currently in the Tclin
category represent only a small fraction (3%) of the human proteome. However, 90% of
proteins in the human proteome (Tdark = 35% + Tbio = 55%) are currently classified as being
understudied and in more need of explication. Additionally, Opera et al., 2018 recommends
that to move proteins from Tdark and Tbio to Tclin over time, researchers should return to drug
discovery via a phenotypic screening approach (i.e., “It is possible that induced binding
sites in proteins in which a druggable pocket is not initially found may enable them to be
targeted with drug-like small-molecules, but identifying these binding sites with structural
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approaches is likely to be challenging, and phenotypic screens may be more useful.”).
Finally, the absence of high-quality, well-characterized molecular probes has been put forth
by Opera et al., 2018 as a root cause for why 90% of proteins in the human proteome are
currently classified as being understudied (i.e., “Lack of tools leads to lack of interest, and
lack of interest diminishes the probability of such tools being developed.”)
In short, the analysis performed by Opera et al., 2018 indicates that the process of
selecting druggable target proteins is incremental and conservative, wherein limited
progress has been observed concerning our understanding of newly discovered proteins.
As a result, while much is known regarding the human proteome, there is a large portion
of the human proteome that is significantly understudied.

3.1.1 The Historical Problem/Practical Challenges of Coupling Phenotypic Screening
“Hits” With Drug Target Identification
As highlighted above, a lack of new drug targets and drug mechanisms, coupled
with drug pipeline attrition, represent significant challenges in drug discovery (Earm and
Earm, 2014). Phenotypic screening is well known to accelerate the discovery of efficacious
compounds for treating numerous disease states (e.g., cancer; Moffatt et al., 2014);
however, determining the biologically relevant protein targets of small-molecule “hits”
from phenotypic screens is a major hurdle and significantly hinders the downstream drugdevelopment process. As a result, there is an urgent/critical need for research strategies that
can accelerate identification of the biologically relevant protein targets of small-molecule
“hits” originating from disease-based phenotypic screening campaigns.
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A review of drug discovery efforts in cancer (Moffatt et al., 2014) and other
therapeutic areas (Swinney and Anthony, 2011) revealed that phenotypic screening
strategies were more successful than target-based approaches for first-in-class smallmolecule drugs over the years 1999-2008, despite the fact that target-based strategies were
more popular during that time. While highly successful in identifying therapeutic
compounds, phenotypic screening has the disadvantage that optimization of “hit”
compounds is more difficult without knowledge of the protein target(s) of the compound.
In particular, the status quo for identifying the protein targets of “hit” compounds from
phenotypic screens involves prolonged downstream structure-activity relationship (SAR)
studies, derivatization of “hit compounds” into suitable chemical probes for target capture,
and/or genetic approaches (Ursu and Waldmann, 2015). As a result, drug target
identification is the primary obstacle in translation of phenotypic screening results into
drug candidates. However, as highlighted in Chapters 1 and 2, fully functionalized smallmolecule probes (FFSMPs) are innovative in that the compounds for phenotypic screening
are pre-engineered to facilitate rapid, streamlined drug target identification (Oeljeklaus et
al., 2013).
In general, determining the mechanism(s) of action, biochemical pathways, and
biologically relevant protein targets of small-molecule “hits” from phenotypic screens
remains a major bottleneck and technical/practical challenge for multiple reasons (Ursu
and Waldmann, 2015). In particular, small-molecules can interact with multiple protein
targets, often with moderate to weak binding affinities, and in general, there is a lack of
straightforward, robust technologies for target identification and characterizing compound
interactions in living systems to define the mechanistic basis of pharmacology.
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However, and as introduced in Chapters 1 and 2, the innovative chemoproteomic
strategy involving fully functionalized small-molecule probes (FFSMPs) pioneered by the
Cravatt group (Cisar and Cravatt, 2012; Kambe et al., 2014) enables the quantitative
assessment of reversible small-molecule-protein interactions directly in living systems
(Scheme 3.1). Once again, FFSMPs are compounds that can form covalent bonds with their
protein targets under the same assay conditions used for phenotypic screening, and their
chemical design allows for direct progression from cell-based phenotypic screening to
target protein identification without requiring lengthy synthetic modification of
biologically active "hit" compounds.

Scheme 3.1: The traditional experimental workflow of streamlined phenotypic screening
and target protein identification using fully functionalized small-molecule probes
(FFSMPs; e.g., “1”). (Adapted with permission from Oeljeklaus et al., 2013)

Prior to the Cisar and Cravatt study in 2012 and historically, analog creation and
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subsequent follow-up target identification studies of “hits” from phenotypic screening
campaigns traditionally spanned many years due to the technical challenges that
accompany incorporation of photoreactive or electrophilic functional groups and reporter
groups (usually radioisotopes, biotin, or fluorophores (Sadaghiani et al., 2007) prior to the
advent of click chemistry proteomics (Parker and Pratt, 2020; ) into pharmacologically
active compounds, as well as the difficulties inherent to biochemical purification and
analysis of probe-protein complexes. In sharp contrast, the proof-of-concept studies from
the Cravatt group (Cisar and Cravatt, 2012; Kambe et al., 2014) show that direct
phenotypic screening of a library of FFSMPs can unite and dramatically accelerate the
steps of phenotypic screening and target protein identification. Additionally, these studies
demonstrated that generation and integration of FFSMP compound libraries directly into
phenotypic screening campaigns can facilitate the discovery of pharmacologically active
probes, which are readily amenable to accelerated target identification and mechanistic
characterization using advanced chemoproteomic techniques. In turn, this is expected to
significantly reduce experimental effort and timelines for drug development.
Additionally, it is known that studies involving FFSMPs are capable of producing
ligands for proteins that have yet to be described, and can reveal a diverse array of
traditional or non-traditional druggable targets in cells (Cisar and Cravatt, 2012; Kambe et
al., 2014). Continued proteomic studies involving FFSMPs can then further define the
target profile required to produce a desired pharmacological or phenotypic effect, as well
as establish SAR for such activities, thus setting the stage for future medicinal chemistry
efforts to convert “tool-compound” FFSMPs into more “drug-like” clinical candidates.
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3.1.2 The Current Limitations and Drawbacks of FFSMP Libraries for Integrated
Phenotypic Screening and Drug Target Identification Studies
Currently, there is an urgent/critical need to create FFSMP libraries of much greater
size, structural complexity, and chemical diversity for use in phenotypic screening
campaigns (Oeljeklaus et al., 2013). For example, the development of synthetic strategies
that would allow for efficient incorporation of different photoreactive or electrophilic
functional groups (i.e., as protein-reactive functional groups for target protein capture)
would be expected to not only expand the structural complexity and chemical diversity of
FFSMP libraries, but also simultaneously address the confounding feature of variable
protein capture efficiency/yields associated with these protein-reactive functional groups,
which may seriously impact interpretation of the actual target protein. Concerning the
latter and once again, for affinity labeling proximity-induced covalent chemistry to be
successful between an electrophilic FFSMP and its target protein(s) (see Scheme 2.11), an
appropriately positioned nucleophilic amino acid reaction center must be present within
the target protein FFSMP-binding site and in close proximity to the electrophilic reaction
center within the electrophilic FFSMP. However, this need for an appropriately positioned
nucleophilic amino acid to be present within the FFSMP-binding site of a target protein is
not a requirement for photoreactive FFSMPs (Dalton and Campos, 2020). This is because
an external factor like UV light can be employed to induce “on demand” formation of a
highly reactive chemical functionality within a photoreactive FFSMP that covalently reacts
with its bound protein. That is, use of a photoaffinity labeling experimental approach
provides a snapshot of a photoreactive FFSMP’s interactions with a protein at a particular
moment in time, with covalent protein labeling enhanced by strong reversible FFSMP-
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protein binding interactions. As a result, photoreactive FFSMPs can function as tool
compounds to probe binding pockets in proteins that do not necessarily possess
nucleophilic amino acids within their ligand-binding site(s) (Smith and Collins, 2015).
Additionally, photoaffinity labeling identifies FFSMP-protein interactions at equilibrium,
whereas affinity labeling to produce a covalent FFSMP-protein complex is time-dependent
(Geurink et al., 2011).
More importantly, however, it is well known that the overall structural, and thus
functional diversity of a compound library (i.e., the range of biological activities displayed
by the compounds), is known to be highly dependent upon the variety of chemical scaffolds
present (Galloway et al., 2010; Sauer and Schwarz, 2003a and 2003b). As highlighted in
Chapter 2, while there are known examples of synthetic strategies to produce collections
of structurally similar FFSMPs (i.e., compounds with varying appendages around a single
core scaffold; summarized in Figure 3.2), synthesis strategies for the efficient generation
of more structurally diverse FFSMP collections, particularly in which there is a greater
variation in the nature of the chemical scaffolds present, have yet to be pursued other than
that by Jackson and Lapinsky (Jackson and Lapinsky, 2018). For the most part, the only
type of structural complexity/chemical diversity examined to date with FFSMPs has been
appendage diversity (i.e., different peripheral structural entities at multiple sites around a
single core scaffold), and only four chemical scaffolds have been reported with respect to
FFSMPs (summarized in Figure 3.2). However, each of these scaffolds has only modest
structural complexity, biased chemical diversity, examines a small number of proteinreactive functional groups, and is capable of sampling only a very small portion of chemical
space (Reymond and Awale, 2012). Once again, the chemical scaffold diversity of any
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compound set has a pivotal role in defining its overall 3-D molecular shape, with peripheral
substituents (i.e., appendage diversity) being of considerably less importance (Galloway et
al., 2010; Sauer and Schwarz, 2003a; O’Connell et al., 2013). As a result of these specific
limitations, the recent focus of the Lapinsky group is on generating an FFSMP collection
with higher core structural diversity that will provide a higher “hit” rate against a broader
range of biological targets, particularly where the nature of the biological target is unknown
as in phenotypic screening (Galloway et al., 2010).
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Figure 3.2: Apart from Jackson and Lapinsky, 2018, previously reported FFSMP
libraries for integrated phenotypic screening and target identification studies have
focused on appendage diversity and not chemical scaffold diversity.

3.2. The Main Objective and Hypotheses of the Work Described in This Thesis
3.2.1. Towards a “Universal Chemical Biology Toolbox” for Tackling Human
Diseases
Chemical biology is a scientific discipline involving applying chemical techniques,
analysis, and chemical matter to the study and manipulation of biological systems (“Voices
of chemical biology.” Nat Chem Biol. 2015, 11, 378-379). Chemical biology studies are
dependent on chemical probes, which are used to study and manipulate a biological system
by binding to and altering the function of a natural drug target (most commonly a protein)
within that system. As a result, chemical probes are precious chemicals in biomedical
research (Schreiber et al., 2015).
The main objective of the work described in this thesis was to begin populating a
“universal chemical biology toolbox”, composed of synthetically valuable chemical
building blocks, that researchers worldwide could use to make chemical probes.
Additionally, this thesis also begins to demonstrate several synthetic applications of select
members of this “universal chemical biology toolbox”, principally via the generation of
FFSMPs towards accelerating the discovery new drug targets and drugs to treat human
disease in an unbiased manner.
Because chemical biology studies play increasingly critical roles in modern drug
discovery in academic and industrial pharmaceutical research, quickly accessible chemical
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probes are vital for decision making and rapid research project progression. Specifically,
the work described in this thesis aimed to: 1.) start creating a toolbox of clickable
trifunctional aryl nitro monomers for FFSMP synthesis analogous to that previously
described for aryl sulfonyl fluoride monomers (see Scheme 2.4.; Fadeyi et al., 2016), and
2.) exploit the relative chemical stability of aryl nitro functional groups (i.e., Ar-NO2,
Figure 3.3) within this proposed toolbox of clickable trifunctional aryl nitro monomers (see
proposed structures 3.1 – 3.5, 4.4 – 4.5, 4.10 – 4.12, 4.17, and 5.3, Figure 3.3 as a “universal
chemical biology toolbox”) to survive several NO2 -sparing functional group chemical
manipulations and ultimately serve as a masked aniline for N-acylation with either
photoreactive or electrophilic functional groups as protein-reactive functional groups (thus
meeting the desire stated at the beginning of Section 3.1.2.). In turn, this toolbox would be
expected to find broad general utility by biomedical researchers across the globe to quickly
prepare FFSMPs for numerous drug discovery projects (e.g., analogous and in addition to
known

trifunctional

reagents

already

offered

commercially

https://www.sigmaaldrich.com/technical-documents/articles/technologyspotlights/trifunctional-probe-building-blocks.html).
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A.) clickable carboxylic acid, aldehyde, and benzyl alcohol monomers
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Figure 3.3: Proposed members of a clickable trifunctional aryl nitro monomer toolbox
(3.1 – 6.3) to quickly prepare FFSMPs in support of drug discovery projects (i.e., a
“universal chemical biology toolbox”). The aryl nitro functional group will ultimately
serve as a masked aniline for N-acylation with either photoreactive or electrophilic
functional groups as protein-reactive functional groups (vide infra).

As shown in Scheme 3.2.A, clickable aryl nitro monomers 2, 3, 5, and 6 could
potentially serve as chemical building blocks to prepare structurally diverse FFSMPs
bearing an aryl ring via isocyanide-based multicomponent reactions (IMCRs). Once again,
IMCRs are an instrumental and large group of reactions in organic chemistry that can
provide smooth and rapid access to compounds with a diversity of chemical structures
(Zarganes-Tzitzikas et al., 2015). As a result, it is no surprise IMCRs are a preferred
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method toward discovering new drugs (Domling et al., 2012). Additionally, and analogous
to that reported in Jackson and Lapinsky, 2018, as an essential strategy to augment the
collection of FFSMP chemical scaffolds, we propose to employ bifunctional isocyanides
(R-NC; Giustiniano et al., 2017) (e.g., 3.3 and 4.17, Figure 3.3) that contain the two
additional functionalities needed towards generating a FFSMP (namely a protein-reactive
functional group and click chemistry handle).
In turn, after performing a desired IMCR, we hypothesized that structurally diverse
FFSMPs bearing an aryl ring could be made by a simple synthetic sequence depicted in
Scheme 3.2.A. First, -SiMe3 removal (if necessary) could unmask the terminal alkyne click
chemistry handle. Second, the nitro group could be reduced to the corresponding aniline
derivative potentially by any number of methods except hydrogenation, and finally, the
requisite aniline could be armed with a protein-reactive functional group (PRG) of choice
using any number of readily available carboxylic acids or acid chlorides that contain a
photoreactive or electrophilic functional group for protein capture (Scheme 3.2.A,
middlebox).
Additionally, as depicted in Scheme 3.2.B, we propose monomers 2 – 5 and 7 could
alternatively be attached to a compound of interest with known activity in a model of
human disease. In brief, the range of functional groups in the toolbox could allow several
chemical options for coupling specific chemical entities, principally depending on the
chemical functionality present within the bioactive chemical of interest. In turn, after
derivatizing the bioactive compound of interest, we expect FFSMPs could be produced
using the same three-step synthetic sequence previously described for the end of Scheme
3.2.A.

86

Scheme 3.2: A.) Proposed use of a trifunctional aryl nitro monomer as an aryl fragment
in combination with other chemical fragments to produce FFSMPs bearing an aryl side
chain. B.) Proposed use of a trifunctional aryl nitro monomer for attachment to a
bioactive compound of interest that bears a functional group suitable for derivatization.
Protein-reactive group (PRG) for protein capture highlighted in red; terminal alkyne click
chemistry handle for proteomic applications highlighted in blue.
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According to a review by Domling et al., 2012, most bioactive compounds stem
from a relatively small number of multicomponent reactions (MCRs). Of these MCRs,
seventeen of them require an aldehyde component, seven require an isocyanide component,
and two require a carboxylic acid component (Domling et al., 2012). With each of these
MCRs requiring at least three independent parts/inputs, the possible modular combinations
of these components are essentially endless. However, using either the aldehyde (4.15),
isocyanide (4.17), or carboxylic acid (4.5) aryl nitro monomer as a direct input in a MCR,
each of which contains a masked aniline for arming the FFSMP with a protein-reactive
functional group and a terminal alkyne for click chemistry-based proteomics, allows for
the selection of the remaining MCR inputs to be from a larger, commercially available pool
of compounds/fragments that would function to increase the structural diversity of the
resulting FFSMPs. Once again, as previously mentioned in Section 2.1.1.1. of Chapter 2,
for the FFSMP libraries highlighted in Figure 3.2. (other than that from Jackson and
Lapinsky, 2018), the terminal alkyne click chemistry reporter group and the photoreactive
functional group for protein capture were positioned on different building blocks utilized
in the synthesis of these FFSMPs. In turn, this approach can restrict the diversity of the
building blocks that can be used in the library preparation of FFSMPs, since at least one
component should contain the protein-reactive functional group and another the click
chemistry reporter group. Additionally, as medicinal chemists tapping into chemical
biology, we will not necessarily choose MCR inputs for FFSMP synthesis randomly.
Rather, the FFSMPs synthesized as part of this thesis were rationally designed to include
logical incorporation of: 1.) a privileged structure (Welsch et al., 2010; Kim et al., 2014)
to pilot the FFSMP to sample biologically-relevant chemical space, and 2.) a Topliss
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optimization moiety (Topliss, 1972) for subsequent rational medicinal chemistry
optimization of “hit” FFSMPs identified by phenotypic screening.
As a final hypothesis to test as part of this thesis, we hypothesized that replacement
of the aryl nitro functional group in monomers 3.1 – 3.5, 4.4 – 4.5, 4.10 – 4.12, 4.17, and
5.3 (Figure 3.3) with an azide moiety could potentially be used to facilitate a “library from
library” approach (Ostresh et al., 1994; more specifically a “FFSMP library from FFSMP
library” approach) to not only increase the number of FFSMP candidates, but also their
chemical diversity (Scheme 3.3). In particular, the rationale for pursuing this research
approach/strategy stemmed from the following two observations: 1.) aryl azides are
traditional photoreactive groups for photoaffinity labeling (Smith and Collins, 2015), and
2.) Jewett and coworkers previously demonstrated chemoselective one-step conversion of
a photoreactive aliphatic azide (Szymanski et al., 2018) to a photoreactive aliphatic
diazirine (Smith and Collins, 2015) by means of an amide link using 2(diphenylphosphaneyl)phenyl 3-(3-methyl-3H-diazirin-3-yl)propanoate (PhosDAz, 4.59)
as a traceless Staudinger reagent (Ahad et al., 2013).
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Scheme 3.3: A proposed “FFSMP library from FFSMP library” approach using an aryl
azide as a traditional photoreactive functional group, but also as a masked aniline for Nacylation via a traceless Staudinger reaction.
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CHAPTER FOUR
4. Chemical Discussion
4.1. Chemical Discussion of the Main Compounds Designed and Synthesized During
This Thesis
4.1.1. Design and Synthesis of a “Universal Chemical Biology Toolbox” of Clickable
Trifunctional Reagents/Building Blocks for Fully Functionalized Small-Molecule
Probe (FFSMP) Synthesis
As mentioned in Section 2.1.1.3., a number of trifunctional reagents/building
blocks have been developed to aid in FFSMP synthesis that include the following three
entities: 1.) a protein-reactive functional group/warhead for protein capture (i.e., either a
photoreactive or electrophilic functional group for formation of an irreversible, covalent
FFSMP-protein complex by either photoaffinity labeling or affinity labeling, respectively),
2.) a bioorthogonal tag (most commonly a terminal alkyne) to enable click chemistry-based
proteomics of irreversibly-formed, covalent FFSMP-protein complexes (Parker and Pratt,
2020), and 3.) a functional group that allows a compound or chemical fragment of interest
to be conjugated with the trifunctional reagent/building block (e.g., conjugating functional
groups such as carboxylic acids and amines for N-acylation, aldehydes for reductive
amination, aryl halides for Pd-mediated coupling reactions, etc.; e.g., see Fadeyi et al.,
2016). Additionally, and analogous to that reported by Fadeyi et al., 2016 for a known
toolbox of clickable aryl sulfonyl fluoride monomers (Figure 4.1, left panel) as
trifunctional reagents/building blocks for electrophilic FFSMP synthesis, trifunctional
reagents/building blocks, in general, can be: 1.) used as chemical fragments to prepare
clickable FFSMPs containing an aryl ring (Figure 4.1.A., right panel), or 2.) attached to a
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bioactive compound of interest as a clickable FFSMP aryl substituent (Figure 4.1.B., right
panel).

A.) Clickable aldehhyde and carboxylic acid SF monomers
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Figure 4.1. Left panel = a known toolbox of clickable aryl sulfonyl fluoride monomers
for electrophilic FFSMP synthesis (Fadeyi et al., 2016). Right panel = A.) clickable aryl
sulfonyl fluoride monomers can be used as a chemical fragment and combined with other
chemical fragments to produce electrophilic FFSMPs. Right panel = B.) clickable aryl
sulfonyl fluoride monomers can be conjugated to a fragment or compound of interest that
bears a functionality suitable for derivatization, thus generating electrophilic FFSMPs.
(Adapted with permission from Fadeyi et al., 2016)

With these thoughts in mind and as discussed within Section 3.2.1., we desired a
toolbox of highly functionalized nitro- or azide-based intermediates for FFSMP synthesis
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(Figure 4.2) analogous to that described by Fadeyi et al., 2016. Specifically, we
hypothesized that the aryl sulfonyl fluoride functional group within Fadeyi et al., 2016’s
toolbox of known clickable aryl sulfonyl fluoride 1,3,5-trisubstituted monomers could be
replaced with either a nitro or azide functional group. In turn, this nitro or azide functional
group would serve as a “masked aniline” for final FFSMP creation via a two-step sequence
of aniline formation and N-acylation with a photoreactive or electrophilic functional group
of choice (vide infra).
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Figure 4.2. Proposed members of a clickable trifunctional aryl nitro or azide monomer
“universal chemical biology toolbox” to quickly prepare FFSMPs in support of drug
discovery projects. The clickable aryl sulfonyl fluoride monomers are known compounds
for electrophilic FFSMP synthesis via Fadeyi et al., 2016. The aryl nitro or azide
functional group within the proposed toolbox members will ultimately serve as a masked
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aniline for N-acylation with either a photoreactive or electrophilic functional group as a
protein-reactive functional group.

The remainder of this chapter describes: 1.) my work towards generating certain
individual members of this “universal chemical biology toolbox”, and 2.) initial synthetic
applications of these toolbox members as inputs in several isocyanide-based
multicomponent reactions (IMCRs), followed by subsequent transformation into
clickable FFSMPs for integrated phenotypic screening and target identification studies.

4.1.1.1. Design and Synthesis of Trifunctional Carboxylic Acid “Universal Chemical
Biology Toolbox” Member 4.5 By Replacing the Aryl Sulfonyl Fluoride Within
Known Toolbox Compound 2.56b with a Nitro Functional Group
To begin, proposed trifunctional carboxylic acid “universal chemical biology
toolbox” member 4.5 was rationally designed by replacing the aryl sulfonyl fluoride
group within known toolbox compound 2.56b (Fadeyi et al., 2016) with a nitro functional
group (Scheme 4.1). The reason for this functional group replacement stemmed from the
hypothesis that the nitro functional group could serve as a masked aniline for subsequent
FFSMP synthesis, namely by nitro group reduction and aniline N-acylation with a
protein-reactive functional group of choice. In turn, we hypothesized target carboxylic
acid 4.5 could be obtained beginning with Fischer esterification of commercially
available (albeit relatively expensive; $384 for 25 g from Alfa Aesar) carboxylic acid 4.1,
followed by diazonium salt formation and iodide displacement (Scheme 4.1).
Sonogashira coupling with TMS acetylene followed by concomitant ester hydrolysis and
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TMS deprotection under basic hydrolysis conditions could then potentially provide target
carboxylic acid 4.5. With this retrosynthesis in mind, an efficient, relatively large-scale
synthesis of target carboxylic acid 4.5 was pursued and is described in Scheme 4.1.
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ChemBioChem 2016, 17, 1925
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Scheme 4.1. Rational design and proposed retrosynthesis of trifunctional carboxylic acid
“universal chemical biology toolbox” member 4.5 by replacing the aryl sulfonyl fluoride
within known toolbox compound 2.56b (Fadeyi et al., 2016).

Specifically, target carboxylic acid 4.5 is a known compound and I executed its
synthesis (see Scheme 4.2) somewhat analogous to that previously described by Posta et
al., 2016. Using a procedure described in Charrier et al., 2008, the synthesis of target
carboxylic acid 4.5 began by refluxing a methanolic solution of commercially available
carboxylic acid 4.1 and thionyl chloride to give known methyl ester 4.2 in quantitative
yield. Subsequent diazotization of known aniline 4.2 and iodide displacement with KI
(according to Posta et al., 2016) then gave known aryl iodide 4.3 in good yield (76%).
Finally, Sonogashira coupling of known aryl iodide 4.3 with TMS acetylene, followed by
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tandem ester hydrolysis and TMS deprotection using aqueous and methanolic LiOH, gave
target carboxylic acid 4.5 in excellent yield (82% over two steps from aryl iodide 4.3).
Concerning the synthesis of target carboxylic acid 4.5 depicted in Scheme 4.2,
diazonium salt formation proved practically challenging to scale up, wherein aniline 4.2
was poorly soluble in water and required significantly harsh acidic conditions to ensure
acceptable solubility for a chemical reaction to occur. However, the total synthesis of target
carboxylic acid 4.5 according to Scheme 4.2 was relatively high yielding on an appreciable
scale (62% over four steps) and purification of each synthetic intermediate by flash silica
gel chromatography proved relatively simple and straightforward.
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Scheme 4.2. Synthesis of trifunctional carboxylic acid “universal chemical biology
toolbox” member 4.5 analogous to that previously described by Posta et al., 2016.
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4.1.1.2. Design and Synthesis of Trifunctional Nitro-Benzaldehyde “Universal
Chemical Biology Toolbox” Member 4.12 By Replacing the Aryl Sulfonyl Fluoride
Within Known Toolbox Compound 2.60b with a Nitro Functional Group
As previously mentioned in Section 3.2.1. and reviewed by Domling et al., 2012,
there are seventeen known multicomponent reactions (MCRs) that use an aldehyde as an
oxo component/input towards producing structurally diverse bioactive compounds in an
atom-economical manner. Therefore, in theory, successful employment of an aldehydecontaining trifunctional reagent/building block as an oxo component/input within those
seventeen MCRs could potentially represent a powerful way to produce scaffold- and
appendage-diverse FFSMPs in a modular manner. With this in mind, and analogous to
carboxylic acid 4.5 described in Section 4.1.1.1., trifunctional nitro-benzaldehyde
“universal chemical biology toolbox” member 4.12 was proposed and rationally designed
by replacing the aryl sulfonyl fluoride group within known toolbox compound 2.60b
(Fadeyi et al., 2016) with a nitro functional group (Scheme 4.3). Once again, the reason for
this functional group replacement stemmed from the hypothesis that the nitro functional
group could serve as a masked aniline for subsequent FFSMP synthesis, namely by nitro
group reduction and aniline N-acylation with a protein-reactive functional group of choice.
Next, we envisioned the preparation of nitro-benzaldehyde “universal chemical
biology toolbox” member 4.12 via the proposed retrosyntheses given in Scheme 4.3.
Specifically, we hypothesized that novel clickable nitro-benzaldehyde 4.12 could come
from either: 1.) known iodo-benzyl alcohol 4.9 (Zhang et al., 2011) via a three-step
sequence of Sonogashira coupling with ethynyltrimethylsilane, silyl deprotection, then
final oxidation of the 1˚ alcohol to the aldehyde, or 2.) regioselective electrophilic aromatic
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Scheme 4.3. Rational design and proposed retrosynthesis of trifunctional nitrobenzaldehyde “universal chemical biology toolbox” member 4.12 by replacing the aryl
sulfonyl fluoride within known toolbox compound 2.60b (Fadeyi et al., 2016) with a
nitro functional group.

The synthesis of trifunctional nitro-benzaldehyde “universal chemical biology
toolbox” member 4.12 was ultimately achieved in the lab through known iodo-benzyl
alcohol 4.9 (Zhang et al., 2011) (Scheme 4.4). The synthesis began with regioselective
SEAr iodination (analogous to that previously described by Dillon et al., 2015) of 3nitrobenzaldehyde or 3-nitrobenzoic acid using strong acidic and heating conditions, as
well as excess iodine. In particular, we were surprised to see that SEAr iodination of 3nitrobenzaldehyde under these conditions, with the reaction flask open to air, proceeded
with concurrent oxidation of the aldehyde to the carboxylic acid, thus resulting in an
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inseparable crude mixture of iodinated and non-iodinated benzoic acids (4.8). Specifically,
the 1H NMR spectrum of the crude reaction mixture from this experiment indicated that 3iodo-5-nitrobenzoic acid (Vaidyanathan et al., 2001) was the major product within the
inseparable mixture. Likewise, electrophilic aromatic iodination of 3-nitrobenzoic acid
under the given conditions also provided an inseparable mixture of iodinated and noniodinated benzoic acids, albeit in lower crude yield (76%) compared to using 3nitrobenzaldehyde as the starting material. It was also discovered that these iodination
reactions must be run in a vessel with a relatively small opening to air (e.g., a 14/20 neck
round-bottom flask). This is because during attempted scale-up of the iodination of 3nitrobenzaldehyde using a 250 mL beaker as the reaction vessel, the iodine sublimed under
the heating conditions and vacated the reaction vessel, thus resulting only in the recovery
of non-iodinated 3-nitrobenzoic acid.
In turn, the crude mixture of iodinated and non-iodinated benzoic acids (4.8),
specifically obtained from the electrophilic iodination of 3-nitrobenzaldehyde, was reduced
using borane (BH3) generated in situ from sodium borohydride and BF3 •OEt2 (procedure
adapted from Velagaleti, 2014). It was at this stage that non-iodinated 3-nitrobenzyl
alcohol could be separated from iodo benzyl alcohol 4.9 (Zhang et al., 2011) by silica gel
chromatography to give the latter target compound in excellent yield (91%). Next,
Sonogashira coupling of TMS acetylene to iodo-benzyl alcohol 4.9, followed by TMS
deprotection under basic conditions (analogous to that described by Posta et al., 2016),
gave terminal alkyne-nitrobenzyl alcohol 4.11 in good yield. As a final step, benzyl alcohol
4.11 was oxidized with pyridinium chlorochromate (PCC) (analogous to that described by
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Klyatskaya et al., 2002) to give target nitro-benzaldehyde toolbox member 4.12 in 81%
yield.
Overall, the total synthesis of nitro-benzaldehyde toolbox member 4.12 depicted in
Scheme 4.4 was relatively efficient on an appreciable scale (47% yield over five steps from
3-nitrobenzaldehyde). This synthesis also proved practically easy with little complication
from the previously noted inseparable crude mixture of iodinated and non-iodinated
benzoic acids obtained after the electrophilic aromatic iodination step.
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Scheme 4.4. Synthesis of trifunctional nitro-benzaldehyde “universal chemical biology
toolbox” member 4.12 through known iodo benzyl alcohol 4.9 (Zhang et al., 2011).

4.1.1.3. Design and Synthesis of Azide-Based Trifunctional Benzaldehyde “Universal
Chemical Biology Toolbox” Member 4.15 By Replacing the Nitro Group in Toolbox

104

Compound 4.12 or the Aryl Sulfonyl Fluoride Group Within Known Toolbox
Compound 2.60b
Once again, we envisioned the aryl nitro functional group within the individual
trifunctional toolbox members to principally serve as a masked aniline, wherein nitro group
reduction followed by aniline N-acylation with a protein-reactive functional group would
produce a FFSMP. With this in mind, we also hypothesized that an aryl azide could
alternatively serve as a more efficient “masked aniline” equivalent compared to the aryl
nitro functional group. This hypothesis was generated based on: 1.) aryl azides already
represent traditional photoreactive groups for photoaffinity labeling that are relatively
small and can be somewhat easily incorporated into compounds of choice (Smith and
Collins, 2015), and 2.) an azide can function as a masked amine for chemoselective and
immediate N-acylation via traceless Staudinger ligation chemistry (e.g., PhosDAz is a
traceless Staudinger reagent that can chemoselectively deliver an aliphatic diazirine to an
azide without isolation of the amine intermediate (see Scheme 3.3; Ahad et al., 2013).
Particularly concerning the latter point, using an aryl azide as a masked aniline group would
be more synthetically efficient via the removal of one synthetic step compared to FFSMP
synthesis from aryl nitro compounds. The latter of which require isolation of the aniline
intermediate for subsequent N-acylation. Additionally, if a suite of traceless Staudinger
reagents could be developed analogous to PhosDAz that could chemoselectively deliver a
protein-reactive group of choice to an aryl azide FFSMP, this would allow FFSMP
synthesis to be pursued via a “library from library” approach (previously mentioned in
Section 3.2.1.).

105

To begin testing these ideas, azide-based trifunctional benzaldehyde toolbox
member 4.15 was first designed by: 1.) replacing the nitro functional group within toolbox
compound 4.12, or 2.) replacing the aryl sulfonyl fluoride functional group within known
toolbox compound 2.60b (Fadeyi et al., 2016). Next, we envisioned azide-based
benzaldehyde toolbox member 4.15 could be made using nitro-ethynylbenzyl alcohol 4.11
as a starting material (see Scheme 4.4 for the synthesis of nitro-ethynylbenzyl alcohol
4.11). As depicted in Scheme 4.5, we hypothesized that the nitro functional group within
nitro-ethynylbenzyl alcohol 4.11 could be reduced then converted to the corresponding aryl
azide derivative (4.14). Subsequent, 1˚ alcohol oxidation of aryl azide derivative 4.14 could
then provide the desired azido-ethynyl-benzaldehyde toolbox member (4.15).
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Scheme 4.5. Rational design and proposed retrosynthesis of trifunctional azide-based
benzaldehyde toolbox member 4.15 by: 1.) replacing the nitro functional group within
toolbox compound 4.12, or 2.) replacing the aryl sulfonyl fluoride functional group
within known toolbox compound 2.60b (Fadeyi et al., 2016).
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The synthesis of azido benzaldehyde toolkit member 4.15 is given Scheme 4.6 and
began with nitro reduction of ethynyl-nitrobenzyl alcohol 4.11 to the corresponding aniline
using refluxing stannous chloride conditions (procedure adapted from Posta et al., 2016).
Aniline 4.13 was then subjected to diazotization and azide displacement using t-BuONO
and TMSN3 (procedure adapted from Barral et al., 2007) to give aryl azide 4.14 in excellent
yield (95%). Specifically, these milder diazotization and azide displacement reaction
conditions proved more effective than using NaNO2 and NaN3 . Finally, ethynyl-azidebenzyl alcohol 4.14 was oxidized with pyridinium dichromate (PDC) (procedure adapted
from Umezawa et al., 2010) to give target azido benzaldehyde toolkit member 4.15 in high
yield (84%). Specifically, IR spectroscopy was used to confirm the presence of the azide
functional group within 4.14 and 4.15.
Similar to the synthesis of ethynyl-nitro-benzaldehyde 4.12 in Scheme 4.4, the
overall synthesis of ethynyl-azido-benzaldehyde 4.15 described in Scheme 4.6 was rather
high yielding (37% overall yield, seven total steps from 3-nitrobenzaldehyde). In
particular, the final three steps from ethynyl-nitro-benzyl alcohol 4.11 to target azido
benzaldehyde toolkit member 4.15 were high-yielding and practically simple to execute in
the lab on an appreciable scale.
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Scheme 4.6. Synthesis of trifunctional azide-based benzaldehyde “universal chemical
biology toolbox” member 4.15 through ethynyl-nitrobenzyl alcohol 4.11.

107

4.1.1.4. Design and Synthesis of Trifunctional Benzyl Isocyanide “Universal Chemical
Biology Toolbox” Member 4.17 Based on Known Nitro- and Ethynyl-Containing
Benzyl Isocyanides or Formamides
As a final “universal chemical biology toolbox” member for this thesis towards
scaffold- and appendage-diverse FFSMPs, we desired a trifunctional isocyanide that could
potentially be employed as an isocyanide input in several isocyanide-based
multicomponent reactions (IMCRs). With the 1,3,5-trisubstituted benzene pattern of the
other toolbox members in mind, trifunctional benzyl isocyanide 4.17 was designed with
support from known benzyl isocyanides 4.78 and 4.79, or formamide precursors thereof
(4.77) (Scheme 4.7) (Neochoritis et al., 2015b; Bon et al., 2005; Li et al., 2013).
Specifically, these latter known compounds provided literature support that an aryl nitro
functional group and an ethynyl functional group can tolerate a Leuckart-Wallach
formamide synthesis and dehydration strategy to generate the isocyanide functional group.
Therefore, the synthesis of trifunctional benzyl isocyanide 4.17 was envisioned from nitroethynyl-benzaldehyde 4.12 via a Leuckart-Wallach formamide synthesis and dehydration
strategy (Scheme 4.7).
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Scheme 4.7. Design and retrosynthesis of trifunctional benzyl isocyanide toolbox
member 4.17 based on known nitro- and ethynyl-containing benzyl isocyanides or
formamides.

In turn, the synthesis of trifunctional benzyl isocyanide toolbox member 4.17 was
achieved by applying the known Leuckart-Wallach formamide synthesis and dehydration
strategy (Scheme 4.8). First, previously synthesized ethynyl nitrobenzaldehyde 4.12 (see
Scheme 4.4 for synthesis of 4.12) was refluxed in formic acid and formamide to give the
corresponding benzyl formamide (4.16) in moderate yield (43%). Subsequent formamide
dehydration according to Neochoritis et al., 2015a using triphosgene and triethylamine then
provided target benzyl isocyanide toolkit member 4.17, albeit in rather low yield (20%).
More specifically, target benzyl isocyanide toolkit member 4.17 was isolated as a side
product during application of formamide 4.16 in a known “isocyanide-less P-3CR” strategy
(Neochoritis et al., 2015a) (vide infra; see Scheme 4.21).
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Scheme 4.8. Synthesis of trifunctional benzyl isocyanide toolbox member 4.17 by
applying a known Leuckart-Wallach formamide synthesis and dehydration strategy
(Neochoritis et al., 2015a).

4.1.2. Synthesis of Clickable FFMSPs By Applying Select Trifunctional “Universal
Chemical Biology” Toolbox Members as Inputs in Several Isocyanide-Based
Multicomponent Reactions (IMCRs)
With carboxylic acid 4.5, aldehydes 4.12 and 4.15, and formamide 4.16 in hand,
attention was now turned to the other main goal of this thesis, which was to start
demonstrating successful application of these toolbox members in the synthesis of
appendage- and scaffold-diverse FFSMPs for integrated phenotypic screening and target
identification studies. Specifically, the following sections describe examples of how
FFSMPs can be prepared using select trifunctional toolbox members as inputs in several
isocyanide-based multicomponent reactions (IMCRs).

4.1.2.1. Synthesis of Clickable FFMSPs By Applying Carboxylic Acid Trifunctional
“Universal Chemical Biology” Toolbox Member 4.5 as a Carboxylic Acid Input in the
Passerini Three-Component Reaction (P-3CR) and the Ugi Four-Component
Reaction (U-4CR)
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As reviewed in Domling et al., 2012, the Passerini three-component reaction (P3CR) and the Ugi four-component reaction (U 4-CR) are the only two isocyanide-based
multicomponent reactions (IMCRs) that use a carboxylic acid as an input towards
generating potentially bioactive compounds. As a result, we used carboxylic acid toolbox
member 4.5 as a carboxylic acid input in these two specific IMCRs as means of
demonstrating FFSMP synthesis via this building block (Schemes 4.9 and 4.10).
An example of FFSMP synthesis using carboxylic acid toolbox member 4.5 as a
carboxylic acid input in a Passerini three-component reaction (P-3CR) is given in Scheme
4.9. Specifically, the synthesis of target FFSMP (±)-4.24 began by refluxing tryptamine in
ethyl formate (according to Mirabal-Gallardo et al., 2012) to give the corresponding
formamide (4.19) in a nearly quantitative yield (98%) (Scheme 4.9A). Formamide 4.19
was then dehydrated with phosphoryl chloride and triethylamine (according to Matsuo et
al., 2009)to give isocyanide 4.20 as an indole-containing privileged structure isocyanide
input. Isocyanide 4.20 was then condensed with carboxylic acid toolkit member 4.5 and
isobutyraldehyde as an aliphatic Topliss optimization moiety aldehyde input in a P-3CR
(procedure adapted from Neochoritis et al., 2015a). This gave nitro adduct (±)-4.22 in
moderate yield (57%). The nitro functional group within P-3CR adduct (±)-4.22 was then
reduced using zinc under acidic conditions to provide the corresponding aniline ((±)-4.23)
(procedure adapted from Zhao et al., 2015). Finally, aniline (±)-4.23 was converted to
electrophilic acrylamide-based FFSMP (±)-4.24 via N-acylation with acryloyl chloride
(procedure adapted from Kathman, et al., 2014) (Scheme 4.9B).
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Scheme 4.9. A.) Synthesis of an indole-containing privileged structure isocyanide input
(Matsuo et al., 2009). B.) Synthesis of a clickable acrylamide-based FFSMP for
integrated phenotypic screening and target identification studies using toolbox member
4.5 as a carboxylic acid input in a P-3CR.
An example of FFSMP synthesis using carboxylic acid toolbox member 4.5 as a
carboxylic acid input in an Ugi four-component reaction (U-4CR) is given in Scheme 4.10.
The synthesis of target FFSMP (±)-4.36 was achieved by first condensing (procedure
adapted from Henze et al., 2010) carboxylic acid toolbox member 4.5, isopropylamine as
an aliphatic Topliss optimization moiety 1˚ amine input, methyl isocyanoacetate as an
isocyanide input containing a methyl ester as a future synthetic handle, and 4chlorobenzaldehyde as an aromatic Topliss optimization moiety aldehyde input. The nitro
functional group within U-4-CR adduct (±)-4.34 was then reduced to the corresponding
crude aniline using zinc under acidic conditions (procedure adapted from Zhao et al.,
2015). Specifically, the purification of aniline (±)-4.35 proved difficult, so it was taken on
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crude to electrophilic acrylamide-based FFSMP (±)-4.36 by reaction with acryloyl chloride
(procedure adapted from Kathman et al., 2014) and purified at this stage.
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Scheme 4.10. Synthesis of an electrophilic acrylamide-based FFSMP for integrated
phenotypic screening and target identification studies using toolbox member 4.5 as a
carboxylic acid input in a U-4CR.

4.1.2.2. Synthesis of Clickable FFSMPs Using Nitro-Benzaldehyde Trifunctional
“Universal Chemical Biology” Toolbox Member 4.12 as an Aldehyde Input in Several
Isocyanide-Based Multicomponent Reactions (IMCRs)
This section demonstrates successful application of nitrobenzaldehyde chemical
biology toolbox member 4.12 as an aldehyde input in a P-3CR, a Ugi tetrazole fourcomponent reaction (UT-4CR), a Ugi five-center four-component reaction (U-5C-4CR),
and a Ugi beta-lactam three-component reaction (UBL-3CR). In turn, each of these IMCR
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adducts was reduced to their corresponding aniline and armed with a protein-reactive
functional group of choice to provide scaffold- and appendage-diverse FFSMPs.
An example of FFSMP synthesis using nitro-benzaldehyde toolbox member 4.12
as an aldehyde input in a Passerini three-component reaction (P-3CR) is given in Scheme
4.11. The synthesis of target photoreactive aliphatic diazirine-based FFSMP (±)-4.40 began
with condensation of isobutyric acid as an aliphatic Topliss optimization moiety carboxylic
acid input, nitro-benzaldehyde toolbox member 4.12 as an aldehyde input, and methyl
isocyanoacetate as an isocyanide input. Using a procedure adapted from Neochoritis et al.,
2015a, this P-3CR gave nitro adduct (±)-4.38 in nearly quantitative yield (98%). In turn,
nitro adduct (±)-4.38 was reduced to the corresponding aniline then EDC coupled with
aliphatic diazirine-containing carboxylic acid 4.59 (Angelone et al., 2021) to provide
FFSMP (±)-4.40, albeit in relatively low yield (18%).
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Scheme 4.11. Synthesis of a clickable photoreactive diazirine-based FFSMP for
integrated phenotypic screening and target identification studies using toolkit member
4.12 as an aldehyde input in a P-3CR.

An example of FFSMP synthesis using nitro-benzaldehyde toolbox member 4.12
as an aldehyde input in an Ugi tetrazole four-component reaction (UT-4CR) is given in
Scheme 4.12. Specifically, using a procedure adapted from Kroon et al., 2016, the synthesis
of electrophilic acrylamide-based target FFSMP (±)-4.44 began by condensing
azidotrimethylsilane, tetrahydroisoquinoline as a 2˚ amine privileged structure input, nitro
benzaldehyde toolbox member 4.12, and methyl isocyanoacetate as an isocyanide input in
a UT-4CR. This provided nitro adduct (±)-4.42 in relatively good yield (74%). Per our
established methodology, nitro adduct (±)-4.42 was then reduced to the corresponding
aniline and subsequently converted to acrylamide-based FFSMP (±)-4.44 via N-acylation
of the requisite aniline with acryloyl chloride.

115

N N
N
N

O
NH

H
+

O

+

CN

TMSN3
OMe

NO2
4.41
Acros

MeOH/DCM
(UT-4CR)

O
OMe

N
NO2

4.12

4.29

(±)-4.42, 74%

Privileged Structure (Tetrahydroisoquinoline)
Electrophile (Acrylamide)

Zn(s)
AcOH/H2O

Click Chemistry Handle (Alkyne)

Topliss Structure (Methyl ester)
N N
N
N

O
OMe

Acrylic Acid
EDC•HCl, HOBT, DIPEA

N

DCM

N N
N
N

O
OMe

N
NH2

HN

(±)-4.43, 72%

O
(±)-4.44, 24%

Scheme 4.12. Synthesis of an electrophilic acrylamide-based FFSMP for integrated
phenotypic screening and target identification studies using nitro-benzaldehyde toolbox
member 4.12 in a UT-4CR.

An example of attempted FFSMP synthesis using nitro-benzaldehyde toolbox
member 4.12 as an aldehyde input in a Ugi five-center four-component reaction (U-5C4CR) is given in Scheme 4.13. The attempted synthesis of electrophilic alpha-chloro
amide-based FFSMP (±)-4.50 began with the reaction (procedure adapted from Neochoritis
et al., 2015a) of sarcosine as a dual aliphatic Topliss optimization moiety amino acid input,
nitro-benzaldehyde toolbox member 4.12 as an aldehyde input, tert-butyl isocyanide as a
1H NMR-distinctive isocyanide input, and methanol as both the reaction solvent and a U5C-4CR input. Nitro adduct (±)-4.47 was then reduced to the corresponding aniline and
EDC coupled with chloroacetic acid. However, the structure of alpha-chloro amide-based
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FFSMP (±)-4.50 proved inconclusive by 1H NMR due to decomposition. Currently, it is
our belief that electrophilic FFSMP (±)-4.50 may be unstable as the free base, but
potentially more stable in a salt form. Additionally, the reaction conditions for arming
aniline (±)-4.48 with a protein-reactive functional group may need to be optimized towards
readily producing electrophilic or photoreactive FFSMPs from this aniline.
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Scheme 4.13. Attempted synthesis of an electrophilic alpha-chloro amide-based FFSMP
for integrated phenotypic screening and target identification studies using nitro
benzaldehyde toolbox member 4.12 in a U-5C-4CR.

Finally, an example of FFSMP synthesis using nitro-benzaldehyde toolbox member
4.12 in an Ugi beta-lactam three-component reaction (UBL-3CR) is given in Scheme 4.14.
The synthesis of a benzophenone- and beta-lactam-based FFSMP (±)-4.55 began with the
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condensation (procedure adapted from Gedey et al., 2002) of ß-alanine as an amino acid
input, nitro benzaldehyde toolbox member 4.12 as an aldehyde input, and methyl
isocyanoacetate as an aliphatic Topliss optimization moiety isocyanide input. This gave
nitro adduct (±)-4.52 in moderate yield (33%). Per usual, nitro adduct (±)-4.52 was then
reduced to the corresponding aniline ((±)-4.53) (23%) then converted to benzophenoneand beta-lactam-based FFSMP (±)-4.55 via EDC coupling (procedure adapted from
Farooqui et al., 2009) using commercially available 4-benzoylbenzoic acid as a
photoreactive carboxylic acid.
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Scheme 4.14. Synthesis of a clickable benzophenone- and beta-lactam-based FFSMP for
integrated phenotypic screening and target identification studies using nitro-benzaldehyde
toolbox member 4.12 in a UBL-3CR.
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4.1.2.3. Synthesis of Clickable FFMSPs Using Azido-Benzaldehyde Trifunctional
“Universal Chemical Biology” Toolbox Member 4.15 as an Aldehyde Input in Several
Isocyanide-Based Multicomponent Reactions (IMCRs)
An example of FFSMP synthesis using azido-benzaldehyde toolbox member 4.15
as an aldehyde input in a Ugi tetrazole four-component reaction (UT-4CR) is given in
Scheme 4.15. Specifically, photoreactive aryl azide-based FFSMP (±)-4.65 was
synthesized (procedure adapted from Kroon et al., 2016) in 38% yield via condensation of
azidotrimethylsilane, tetrahydroisoquinoline as a 2˚ amine privileged structure input,
azido-benzaldehyde toolbox member 4.15, and methyl isocyanoacetate as an isocyanide
input.
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Scheme 4.15. Synthesis of a photoreactive aryl azide-based FFSMP for integrated
phenotypic screening and target identification studies using trifunctional
azidobenzaldehyde toolbox member 4.15 in a UT-4CR.

Azido-benzaldehyde toolbox member 4.15 also proved successful as an aldehyde
input in a Ugi five-center four-component reaction (U-5C-4CR) (Scheme 4.16).
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Specifically, photoreactive aryl azide-based FFMP (±)-4.66 was synthesized (procedure
adapted from Neochoritis et al., 2015a) in 22% yield by reacting glycine as an amino acid
input, azido-benzaldehyde toolbox member 4.15 as an aldehyde input, and tert-butyl
isocyanide in methanol, the latter of which serves as both the reaction solvent and an U5C-4CR input.
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Photoreactive Group (Aryl Azide)

Topliss Structure (Methyl ester, and t-Butyl)

Scheme 4.16. Synthesis of a photoreactive aryl azide-based FFSMP for integrated
phenotypic screening and target identification studies using trifunctional azidobenzaldehyde toolbox member 4.15 as an aldehyde input in a U-5C-4CR.

Additionally, azido-benzaldehyde toolbox member 4.15 also proved useful as an
aldehyde input in a Ugi beta-lactam three-component reaction (UBL-3CR) (Scheme 4.17).
Specifically, aryl azide- and beta-lactam-based FFSMP (±)-4.71 was generated (procedure
adapted from Gedey et al., 2002) in moderate yield (40%) by condensing ß-alanine as an
amino acid input, azido-benzaldehyde toolbox member 4.15, and methyl isocyanoacetate
as an aliphatic Topliss optimization moiety isocyanide input.
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Scheme 4.17. Synthesis of a (photoreactive) aryl azide- and (electrophilic) beta-lactambased FFSMP for integrated phenotypic screening and target identification studies using
trifunctional azido-benzaldehyde toolbox member 4.15 in a UBL-3CR.
4.1.2.4. Synthesis of Clickable FFMSPs Using Azido-Benzaldehyde Trifunctional
“Universal Chemical Biology” Toolbox Member 4.15 in a “Library from Library”
Approach
As mentioned in Section 3.2.1., FFSMPs synthesized using trifunctional azidebased benzaldehyde 4.15 as an aldehyde input in an IMCR could potentially allow
researchers to pursue a “library from library” approach (Ostresh et al., 1994), wherein the
photoreactive aryl azide functional group within the initial MCR adduct could potentially
be used as a synthetic handle to chemoselectively introduce other protein-reactive
functional groups by traceless Staudinger ligation chemistry (e.g., see Ahad et al., 2013).
With this thought in mind, PhosBP and PhosChloroNitro (Scheme 4.18) were designed and
synthesized as photoreactive and electrophilic traceless Staudinger reagents, respectively,
analogous to PhosDAz, which can chemoselectively deliver a photoreactive aliphatic
diazirine to a photoreactive azide by means of an amide linkage (Ahad et al., 2013).
Specifically, the syntheses of PhosDAz (4.59), PhosBP (4.61), and PhosChloroNitro (4.62)
are given in Scheme 4.18 and were achieved by EDC coupling (procedure adapted from
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Ahad et al., 2013) commercially available (2-hydroxyphenyl)diphenylphosphine (4.58)
with carboxylic acid 4.57 (Angelone et al., 2021), 4-benzoylbenzoic acid, and 2-chloro-5nitrobenzoic acid, respectively.
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Aldrich
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N N

Ph2P

4.60
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NO2

O

Cl

O
Ph2P
NO2
4.62, 62%
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Scheme 4.18. Synthesis of “PhosDAz”, “PhosBP”, and “PhosChloroNitro”. The latter
two compounds were designed as photoreactive and electrophilic analogs of PhosDAz,
respectively. Specifically, PhosDAz is a known traceless Staudinger reagent that can
chemoselectively deliver a photoreactive aliphatic diazirine to a photoreactive azide by
means of an amide linkage (Ahad et al., 2013).
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An example of FFSMP “library from library” synthesis via initial application of
azide-benzaldehyde toolbox member 4.15 as an aldehyde input in a Passerini threecomponent reaction (P-3CR) is given in Scheme 4.19. First, target aryl azide-based FFSMP
(±)-4.63 was produced in near quantitative yield (98%) by reacting (procedure adapted
from Neochoritis et al., 2015a) isobutyric acid and methyl isocyanoacate as aliphatic
Topliss optimization moiety carboxylic acid and isocyanide inputs, respectively, alongside
azido-benzaldehyde toolbox member 4.15 as an aldehyde input in a P-3CR. Aryl azidebased FFSMP (±)-4.63 was then converted (procedure adapted from Ahad et al., 2013) to
2-chloro-5-nitro benzamide-based FFSMP (±)-4.64 via traceless Staudinger ligation with
PhosChloroNitro (4.62) in good yield (60%). Specifically, the latter reaction demonstrates
chemoselective one-step conversion of a photoreactive aryl-azide based FFSMP ((±)-4.63)
to a SN Ar-electrophilic 2-chloro-5-nitro benzamide-based FFSMP ((±)-4.64) as an
alternative FFSMP synthesis strategy to the previously demonstrated two-step nitro
reduction/aniline N-acylation sequence.
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Scheme 4.19. Synthesis of a photoreactive aryl azide-based FFSMP using trifunctional
azido-benzaldehyde toolbox member 4.15 as an aldehyde input in a P-3CR, followed by
chemoselective conversion to an electrophilic 2-chloro-5-nitro benzamide-based FFSMP
via a traceless Staudinger ligation.

Another example of FFSMP “library from library” synthesis is given in Scheme
4.20, this time featuring initial application of azide-benzaldehyde toolbox member 4.15 as
an aldehyde input in an Ugi four-component reaction (U-4CR). To begin, photoreactive
aryl azide-based FFSMP (±)-4.69 was produced in 68% yield via an U-4CR featuring
reaction of N-Boc glycine as a carboxylic acid input, 4-methoxybenzylamine as a 1˚ amine
input, azido-benzaldehyde toolbox member 4.15 as an aldehyde, and methyl
isocyanoacetate as an isocyanide input. Specifically, apart from azido-benzaldehyde
toolbox member 4.15, the other U-4CR inputs were rationally chosen as being 1H NMRdistinctive (i.e., the t-Bu group in N-Boc glycine, the methoxy ether in 4124

methoxybenzylamine, and the methyl ester in methyl isocyanoacetate) to aid in detection
of successful target U-4CR FFSMP formation. In turn, photoreactive aryl azide-based
FFSMP (±)-4.69 was then converted to photoreactive aliphatic diazirine-based FFSMP (±)4.70 via using PhosDAz in a traceless Staudinger ligation (procedure according to Ahad et
al., 2013).
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Scheme 4.20. Synthesis of a photoreactive aryl azide-based FFSMP using azidobenzaldehyde toolbox member 4.15 as an aldehyde input in a U-4CR, followed by
conversion to a photoreactive aliphatic diazirine-based FFSMP using PhosDAz (Ahad et
al., 2013) in a traceless Staudinger ligation.

4.1.2.5. Towards a Clickable FFSMP Using Trifunctional Benzyl Isocyanide
“Universal Chemical Biology” Toolbox Member 4.17 in a Passerini ThreeComponent Reaction (P-3CR)
As a final example of employing a select toolbox member as an input in an IMCR,
it was previously mentioned in Section 4.1.1.4. that isocyanide chemical biology toolbox
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member 4.17 was isolated as a side product during the synthesis of a P-3CR adduct
(Scheme 4.21). Specifically, P-3CR adduct (±)-4.74 was synthesized in moderate yield
(42%) by applying a known “isocyanide-less P-3CR” strategy (Neochoritis et al., 2015a).
First, isocyanide toolbox member 4.17 was formed in situ via dehydration of benzyl
formamide 4.16 using triphosgene. 4-Chlorophenylacetic acid and isovaleraldehyde were
then added to the reaction flask as aromatic and aliphatic Topliss optimization moiety
carboxylic acid and aldehyde inputs, respectively. P-3CR adduct (±)-4.74 is currently in a
position to undergo nitro reduction and aniline N-acylation using a protein-reactive
functional group towards producing FFSMPs.

H

Cl

Triphosgene, NEt3

H
N

NO2

O

DCM, 0 °C

O

+

CN

OH

NO2
4.17

4.16

+

4.72
Aldrich

O

H

4.73
Alfa Aesar

Click Chemistry Handle (Alkyne)
Topliss Structure (i-Pr and 4-Chlorobenzene)

Cl

O

H
N

O
O

DCM
NO2

(P-3CR)

(±)-4.74, 42%

Scheme 4.21. Synthesis of a clickable FFSMP precursor using trifunctional isocyanide
chemical biology toolbox member 4.17 formed during a known “isocyanide-less” P-3CR
strategy (Neochoritis et al., 2015a).

4.2. Summary of Final Compounds Synthesized in This Thesis Work
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Final "Universal Chemical Biology Toolbox" Members Syntesized in This Thesis
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Figure 4.3: Final “universal chemical biology toolbox” monomers synthesized in this
thesis work.
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Figure 4.4. Summary of final acrylamide-, beta-lactam-, and 2-chloro-5-nitro benzamidebased FFSMPs synthesized in this thesis work using the “universal chemical biology
toolbox” monomers as MCR inputs.
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Figure 4.5. Summary of final aliphatic diazirine-, benzophenone-, and aryl azide-based
FFSMPs synthesized in this thesis work using the “universal chemical biology toolbox”
monomers as MCR inputs.
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4.3. Future Directions for the “Universal Chemical Biology Toolbox” Presented
Within This Thesis
It should be evident that the utility of a “universal chemical biology toolbox” is
practically endless. To this point, our current focus for this work is the continued
implementation of our “universal chemical biology toolbox” members (Figure 4.3.) within
the remaining biologically relevant IMCRs described by Domiling et. al. (Domling et al.,
2012). Additionally, we plan on synthesizing the remaining toolbox members proposed in
Section 4.1.1 (see compounds 3.2a-d and 3.4a-c, Figure 4.2) with the intention of either
utilizing these toolbox members directly in IMCRs (i.e., compounds 3.2b and 3.2d as
amine inputs) or further functionalizing chemical fragments with our toolbox members for
FFSMP synthesis (e.g., N-alkylation using compounds 3.4b and 3.4c). Finally, it is our
goal to optimize the “library within library” approach for FFSMP synthesis described in
Section 3.2.1 and implemented in Section 4.1.2.4 (Scheme 4.19 and 4.20) to
chemoselectively deliver a wide array of protein reactive groups to an aryl azide group.

4.4. References
- Ahad, A.M.; Jensen, S.M.; Jewett, J.C. A traceless Staudinger reagent to deliver
diazirines. Org. Lett. 2013, 15, 5060-5063.
- Angelone, D.; Hammer, A.J.S.; Rohrbach, S.; Krambeck, S.; Granda, J.M.; Wolf, J.;
Zalesskiy, S.; Chisholm, G.; Cronin, L. Convergence of multiple synthetic paradigms in a
universally programmable chemical synthesis machine. Nat Chem. 2021, 13, 63-69.
- Barral, K.; Moorhouse, A.D.; Moses, J.E. Efficient conversion of aromatic amines into
azides: a one-pot synthesis of triazole linkages. Org. Lett. 2007, 9, 1809-1811.

129

- Bon, R.S.; van Vliet, B.; Sprenkels, N.E.; Schmitz, R.F.; de Kanter, F.J.J.; Stevens, C.V.;
Swart, M.; Bickelhaupt, F.M.; Groen, M.B.; Orru, R.V.A. Multicomponent synthesis of 2imidazolines. J. Org. Chem. 2005, 70, 3542-3553.
- Charrier, N.; Clarke, B.; Cutler, L.; Demont, E.; Dingwall, C.; Dunsdon, R.; East, P.;
Hawkings, J.; Howes, C.; Hussain, I.; Jeffrey, P.; Maile, G.; Matico, R.; Mosley, J.; Naylor,
A.; O’Brien, A.; Redshaw, S.; Rowland, P.; Soleil, V.; Smith, K.J.; Sweitzer, S.; Theobald,
P.; Vesey, D.; Walter, D.S.; Wayne, G. Second generation of hydroxyethylamine BACE1 inhibitors: optimizing potency and oral bioavailability. J. Med. Chem. 2008, 51, 33133317.
- Dillon, M.P.; Hawley, R.C.; Chen, L.; Feng, L.; Yang, M. Preparation of tetrazolesubstituted arylamides as P2X3 and P2X2/3 antagonists. U.S. Pat. Appl. Publ. 2015,
20150191487.
- Domling, A.; Wang, W.; Wang, K. Chemistry and biology of multicomponent reactions.
Chem. Rev. 2012, 112, 3083-3135.
- Fadeyi, O.; Parikh, M.D.; Chen, M.Z.; Kyne, Jr., R.E.; Taylor, A.P.; O’Doherty, I.;
Kaiser, S.E.; Barbas, S.; Niessen, S.; Shi, M.; Weinrich, S.L.; Kath, J.C.; Jones, L.H.;
Robinson, R.P. Chemoselective preparation of clickable aryl sulfonyl fluoride monomers:
a toolbox of highly functionalized intermediates for chemical biology probe synthesis.
ChemBioChem 2016, 17, 1925-1930.
- Farooqui, M.; Bora, R.; Patil, C.R. Synthesis, analgesic and anti-inflammatory activities
of novel 3-(4-acetamido-benzyl)-5-substituted-1,2,4-oxadiazoles. Eur. J. Med. Chem.
2009, 44, 794-799.

130

- Gedey, S.; Van der Eycken, J.; Fulop, F. Liquid-phase combinatorial synthesis of alicyclic
ß-lactams via Ugi four-component reaction. Org. Lett. 2002, 4, 1967-1969.
- Henze, M.; Kreye, O.; Brauch, S.; Nitsche, C.; Naumann, K.; Wessjohann, L.A.;
Westermann, B. Photoaffinity-labeled peptoids and depsipeptides by multicomponent
reactions. Synthesis 2010, 17, 2997-3003.
- Kathman, S.G.; Xu, Z.; Statsyuk, A.V. A fragment-based method to discover irreversible
covalent inhibitors of cysteine proteases. J. Med. Chem. 2014, 57, 4969-4974.
- Klyatskaya, S.V.; Tretyakov, E.V.; Vasilevsky, S.F. Cross-coupling of aryl iodides with
paramagnetic terminal acetylenes derived from 4,4,5,5-tetramethyl-2-imidazoline-1-oxyl3-oxide. Russ. Chem. Bull. 2002, 51, 128-134.
- Kroon, E.; Kurpiewska, K.; Kalinowska-Tluscik, J.; and Domling, A. Cleavable ßcyanoethyl isocyanide in the Ugi tetrazole reaction. Org. Lett. 2016, 18, 4762-4765.
- Li, Z.; Hao, P.; Li, L.; Tan, C.Y.J.; Cheng, X.; Chen, G.Y.J.; Sze, S.K.; Shen, H.M.; Shao,
Q.Y. Design and synthesis of minimalist terminal alkyne-containing diazirine photocrosslinkers and their incorporation into kinase inhibitors for cell- and tissue-based
proteome profiling. Angew. Chem. Int. Ed. 2013, 52, 8551-8556.
- Matsuo, T.; Hayashi, A.; Abe, M.; Matsuda, T.; Hisaeda, Y.; Hayashi, T. Mesounsubstituted iron corrole in hemoproteins: remarkable differences in effects on peroxidase
activities between myoglobin and horseradish peroxidase. J. Am. Chem. Soc. 2009, 131,
15124-15125.
- Mirabal-Gallardo, Y.; Soriano, M.D.P.C.; Caballero, J.; Alzate-Morales, J.; Simirgiotis,
M.J.; Santos, L.S. Synthesis of the indolo[2,3-a]quinolizidine ring through the addition of

131

2-siloxyfurans to imines and intrinsic reaction coordinate calculations. Synthesis 2012, 44,
144-150.
- Neochoritis, C.G.; Stotani, S.; Mishra, B.; Domling, A. Efficient isocyanide-less
isocyanide-based multicomponent reactions. Org. Lett. 2015a, 17, 2002-2005.
- Neochoritis, C.G.; Zarganes-Tzitzikas, T.; Stotani, S.; Domling, A.; Herdtweck, E.;
Khoury, K.; Domling, A. Leuckart-Wallach route toward isocyanides and some
applications. ACS Comb. Sci. 2015b, 17, 493-499.
- Ostresh, J.M.; Husar, G.M.; Blondelle, S.E.; Dörner, B.; Weber, P.A.; Houghten, R.A.
"Libraries from libraries": chemical transformation of combinatorial libraries to extend the
range and repertoire of chemical diversity. Proc Natl Acad Sci USA. 1994, 91, 1113811142.
- Parker, C.G.; Pratt, M.R. Click chemistry in proteomic investigations. Cell 2020, 180,
605-632.
- Posta, M.; Soos, V.; Beier, P. Design of photoaffinity labeling probes derived from 3,4,5trimethylfuran-2(5H)-one for mode of action elucidation. Tetrahedron 2016, 72, 38093817.
- Smith, E.; Collins, I. Photoaffinity labeling in target- and binding-site identification.
Future Med. Chem. 2015, 7, 159-183.
- Umezawa, N.; Matsumoto, N.; Iwama, S.; Kato, N.; Higuchi, T. Facile synthesis of
peptide-porphyrin conjugates: towards artificial catalase. Bioorg. Med. Chem. 2010, 18,
6340-6350.
- Vaidyanathan, G.; Shankar, S.; Zalutsky, M.R. Synthesis of ring- and side-chainsubstituted m-iodobenzylguanidine analogues. Bioconjug Chem. 2001, 12, 786-797.

132

- Velagaleti, R. Dopamine transporter (DAT) and metabotropic glutamate receptor 5
(mGlu5) irreversible probes for identifying anti-psychostimulant therapeutics. Duquesne
University Ph.D. Dissertation, 2014, page 178.
- Zhang, Z.; Peng, Z.W.; Fan, K.Z. Synthesis of polynorbornene with pendant moiety
bearing azide and terminal alkyne groups. Chinese Chemical Letters 2011, 22, 785-788.
- Zhao, F.; Chen, Z.; Lei, P.; Kong, L.; Jiang, Y. Facile one-pot synthesis of aryl azides
from nitrobenzenes. Tetrahedron Lett. 2015, 56, 2197-2199.

133

CHAPTER FIVE
5. Experimental
Reaction conditions and yields were not optimized. All reactions were performed using
flame-dried glassware under an inert atmosphere of argon unless otherwise noted. All
solvents and chemicals were purchased from Aldrich Chemical Co. or Fisher Scientific and
used without further purification unless otherwise noted. All known chemical compound
synthesized are referenced with the corresponding literature containing the characterization
data used for comparison. Flash column chromatography was performed according to the
method of Still et al., 1978 using Sorbtech 52500-25 silica gel sorbent (40-75 μm) (200 x
400 mesh) and eluting solvent mixtures as specified. Thin-layer chromatography (TLC)
was performed using Silica XG TLC Plates with UV254 from Sorbtech and compounds
were visualized under UV light and/or I2 stain. Proportions of solvents used for TLC are
by volume. 1 H and 13C NMR spectra were recorded on either a Bruker 400 or 500 MHz
spectrometer. Chemical shifts for 1H and 13 C NMR spectra are reported as parts per million
(δ ppm) relative to tetramethylsilane (0.00 ppm) as an internal standard. Coupling constants
are measured in hertz (Hz). HRMS samples were analyzed at Old Dominion University
(Norfolk, VA) by positive ion electrospray on a Bruker 10 Tesla APEX-Qe FTICR-MS
with an Apollo II ion source. LRMS samples were analyzed by an Advion Expression
Benchtop Mass Spectrometer using Electro Spray Ionization (ESI). Melting point
determinations were conducted using a Thomas-Hoover melting point apparatus and are
uncorrected. Infrared spectra were recorded using a Perkin-Elmer Spectrum RZ I FT-IR
spectrometer.
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Synthesis of (3-ethynyl-5-nitrophenyl)methanol (4.11):
A solution of lithium hydroxide (0.7391 g, 30.86 mmol, 5.50 equiv) in water (151
mL) was added to a stirred solution of the TMS ethyne 4.10 (1.40 g, 5.61 mmol, 1.00 equiv)
in methanol (151 mL). The mixture was stirred for 2 hours. The product mixture was
quenched with aqueous 1M hydrochloric acid solution. The aqueous mixture was
transferred to a separatory funnel and extracted with ethyl acetate (3 × 50 mL). The organic
layer was dried over magnesium sulfate and the dried solution was filtered. The filtrate was
concentrated by rotary evaporation to afford a brown solid. The solid was purified by flash
column chromatography (SiO2, 25% ethyl acetate-hexanes) to afford the ethyne 4.11 as a
white solid (0.9708 g, 98%).
Rf = 0.24 (25% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 8.238.22 (t, 2H, H4, H6), 7.79 (s, 1H), 4.81 (s, 2H), 3.22 (s, 1H), 2.22-2.17 (m, 1H). 13C NMR
(100 MHz, CDCl3): δ 148.22, 143.18, 135.59, 125.84, 123.93, 121.51, 81.06, 79.84, 63.48.
FTICR-MS (m/z): [M+Cl] - calculated for C9H7NO3 Cl-, 212.011994; found 212.011977.
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Synthesis of 3-ethynyl-5-nitrobenzaldehyde (4.12):
Pyridinium chlorochromate (PCC) (0.8191 g, 3.80 mmol, 1.10 equiv) was added to
a stirred solution of the benzyl alcohol 4.11 (0.6104 g, 3.45 mmol, 1.00 equiv) in DCM
(4.42 mL). The mixture was stirred for 19.5 hours. The product mixture was concentrated
by rotary evaporation to afford a brown oil. The oil was purified by flash column
chromatography (SiO2, 25% ethyl acetate-hexanes) to afford the benzaldehyde 4.12 as a
white solid (0.4894 g, 81%).
Rf = 0.63 (25% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3) δ 10.09
(s, 1H), 8.67 (t, J = 1.8 Hz, 1H), 8.55 (t, J = 1.9 Hz, 1H), 8.28 (t, J = 1.5 Hz, 1H), 3.34 (s,
1H).13C NMR (100 MHz, CDCl3) δ 188.86, 148.67, 137.85, 137.43, 131.53, 125.24,
123.87, 81.71, 79.89. ESI-MS (m/z): [M-H] - calculated for C9H5NO3H-, 174.14; found
174.1.
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Synthesis of (3-azido-5-ethynylphenyl)methanol (4.14):
tert-Butyl nitrite (0.43 mL, 3.63 mmol, 1.50 equiv) and azidotrimethylsilane (0.38
mL, 2.90 mmol, 1.20 equiv) was added in sequence to a stirred solution of the aniline 4.13
(0.3560 g, 2.42 mmol, 1.00 equiv) in acetonitrile (4.48 mL) at 0 °C. The temperature was
gradually raised to room temperature. The mixture was stirred for 1 hour. The product
mixture was concentrated by rotary evaporation to afford a red-orange oil. The oil was
purified by flash column chromatography (SiO2 , 15% ethyl acetate-hexanes) to afford the
aryl azide 4.14 as a pale-orange oil (0.40 g, 95%).
Rf = 0.14 (15% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 7.22 (s,
1H), 7.03 (d, J = 11.1 Hz, 2H), 4.64 (s, 2H), 3.11 (s, 1H), 2.08 (t, J = 5.6 Hz, 1H).

13 C

NMR (100 MHz, CDCl3): δ 143.03, 140.54, 126.70, 123.77, 121.43, 117.71, 82.41, 78.20,
64.11. IR (ATR-FTIR), cm-1: 3291 (br), 2926 (w), 2875 (w), 2437 (w), 2232 (w), 2150
(w), 2102 (s), 1599 (s), 1587 (s), 1449 (w), 1435 (s), 1360 (w), 1304 (s), 1228 (s), 1152
(w), 1122 (w), 1053 (w), 1023 (w). FTICR-MS (m/z): [M+H]+ calculated for
2[C9H7N3OH+], 347.125100; found 347.125229.
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OH
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4.14

O

N3

4.15

Synthesis of 3-azido-5-ethynylbenzaldehyde (4.15):
Pyridinium dichromate (PDC) (0.6997 g, 1.86 mmol, 1.50 equiv) and Celite
(0.6997 g) was added to a stirred solution of the benzyl alcohol 4.14 (0.2147 g, 1.24 mmol,
1.00 equiv) in dichloromethane (4.13 mL). The mixture was stirred for 21 hours. The
product mixture was filtered. The filtrate was concentrated by rotary evaporation to afford
a black-brown solid. The solid was purified by flash column chromatography (SiO2, 25%
ethyl acetate-hexanes) to afford the benzaldehyde 4.15 as a white solid (0.1719 g, 81%).
Rf = 0.73 (25% ethyl acetate-hexanes, UV). MP = 103.4 °C. 1H NMR (400 MHz,
CDCl3): δ 9.95 (s, 1H), 7.73 (t, J = 1.4 Hz, 1H), 7.54 – 7.48 (m, 1H), 7.38 – 7.32 (m, 1H),
3.21 (s, 1H), 2.16 (d, J = 0.6 Hz, 1H). 13C NMR (100 MHz, CDCl3 ): δ 190.31, 141.73,
137.77, 130.16, 127.70, 124.89, 119.01, 81.15, 79.83. IR (ATR-FTIR), cm-1 : 3273 (s),
3057 (w), 2860 (w), 2748 (w), 2526 (w), 2454 (w), 2341 (w), 2203 (w), 2155 (w), 2110
(s), 1690 (s), 1598 (s), 1583 (s), 1453 (s), 1431 (s), 1393 (s), 1322 (s), 1305 (s), 1257 (s),
1230 (s), 1152 (s). FTICR-MS (m/z): [M+Na]+ calculated for 2[C 9H5N3ONa+],
365.075745; found 365.075967.
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O
H
NO2
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Triphosgene, NEt3
DCM, 0 °C
20%

O2N

4.16

4.17

Synthesis of 1-ethynyl-3-(isocyanomethyl)-5-nitrobenzene (4.17):
Triethylamine (0.33 mmol, 2.40 mmol, 2.40 equiv) was added to a stirred solution
of the formamide 4.16 (0.2043 g, 1.00 mmol, 1.00 equiv) in dichloromethane (1 mL) at 0
°C. The mixture was stirred for 10 minutes at 0 °C. A solution of triphosgene (0.1187 g,
0.40 mmol, 0.40 equiv) in dichloromethane (1 mL) was added dropwise to the mixture at
0 °C over the course of 30 minutes. The mixture was stirred for 10 minutes at 0 °C. 4Chlorophenylacetic acid (0.2218 g, 1.30 mmol, 1.30 equiv) and isovaleraldehyde (0.14 mL,
1.30 mmol, 1.30 equiv) was added in sequence to the stirred mixture at 0 °C. The
temperature was gradually raised to room temperature. The mixture was stirred for 44
hours. The product mixture was diluted with dichloromethane. The organic solution was
transferred to a separatory funnel and washed sequentially with saturated aqueous sodium
bicarbonate solution, saturated aqueous sodium bisulfite solution, and brine. The organic
layer was dried over magnesium sulfate and the dried solution was filtered. The filtrate was
concentrated by rotary evaporation to afford an orange oil. The oil was purified by flash
column chromatography (SiO 2, 25% ethyl acetate-hexanes) to afford the isocyanide 4.17
as a white solid (0.0893 g, 20%).
Rf = 0.58 (25% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 8.29 (t,
J = 1.9 Hz, 1H), 8.19 (q, J = 1.3 Hz, 1H), 7.80 (s, 1H), 4.77 (s, 2H), 3.29 (s, 1H). 13 C NMR
(100 MHz, CDCl3): δ 160.11, 148.34, 135.54, 134.56, 126.84, 124.85, 121.62, 81.06,
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80.28, 44.48. FTICR-MS (m/z): [M+Na]+ calculated for 2[C 10H6N2O2Na +], 395.075076;
found 395.075582.
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N
H

4.5

H
N

O
O
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(±)-4.22

Synthesis of 1-((2-(1H-indol-3-yl)ethyl)amino)-3-methyl-1-oxobutan-2-yl 3-ethynyl-5nitrobenzoate ((±)-4.22):
Isobutyraldehyde (0.10 mL, 1.10 mmol, 1.10 equiv) and the carboxylic acid 4.5
(0.2103 g, 1.10 mmol, 1.10 equiv) was added in sequence to a stirred solution of 3-(2isocyanoethyl)indole (0.1702 g, 1.00 mmol, 1.00 equiv) in dichloromethane (2 mL). The
mixture was stirred for 23 hours. The product mixture was diluted with dichloromethane.
The organic solution was transferred to a separatory funnel and washed sequentially with
saturated aqueous sodium sulfite solution, saturated aqueous sodium bicarbonate solution,
and brine. The organic layer was dried over magnesium sulfate and the dried solution was
filtered. The filtrate was concentrated by rotary evaporation to afford an orange solid. The
solid was purified by flash column chromatography (SiO2 , 35% ethyl acetate-hexanes) to
afford the adduct (±)-4.22 as an orange solid (0.2474 g, 57%).
Rf = 0.29 (35% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 8.58
(dt, J = 2.5, 1.2 Hz, 1H), 8.49 (dq, J = 2.5, 1.5 Hz, 1H), 8.27 (p, J = 1.5 Hz, 1H), 8.10 (s,
1H), 7.56 – 7.49 (m, 1H), 7.27 – 7.20 (m, 1H), 7.08 (tt, J = 8.1, 1.4 Hz, 1H), 7.02 (tdd, J =
7.0, 2.7, 1.2 Hz, 2H), 5.98 (s, 1H), 5.27 – 5.19 (m, 1H), 3.72 – 3.62 (m, 2H), 3.39 – 3.33
(m, 1H), 3.04 – 2.94 (m, 2H), 2.46 – 2.35 (m, 1H), 1.05 – 0.94 (m, 6H).

13 C

NMR (100

MHz, CDCl3): δ 168.28, 162.63, 148.13, 138.23, 136.24, 131.25, 130.88, 127.03, 124.60,
124.11, 122.22, 122.14, 119.56, 118.41, 112.37, 111.14, 81.45, 80.17, 79.85, 39.13, 30.63,
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25.01, 18.81, 17.10. FTICR-MS (m/z): [M+H]+ calculated for C24H23N3O5H +, 434.171047;
found 434.170867.
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(±)-4.23

(±)-4.22

Synthesis of 1-((2-(1H-indol-3-yl)ethyl)amino)-3-methyl-1-oxobutan-2-yl 3-amino-5ethynylbenzoate ((±)-4.23):
Solid zinc (0.1004 g, 1.5357 g atom, 3.00 equiv) was added to a stirred solution of
the aryl nitro (±)-4.22 (0.2219 g, 0.5119 mmol, 1.00 equiv) in acetic acid (1.5 mL) and
water (0.75 mL). The mixture was stirred for 20 hours. The product mixture was diluted
with ethyl acetate. The organic mixture was transferred to a separatory funnel and washed
with water and brine. The organic layer was dried over magnesium sulfate and the dried
solution was filtered. The filtrate was concentrated by rotary evaporation to afford an
orange solid. The solid was purified by flash column chromatography (SiO2, 50% ethyl
acetate-hexanes) to afford the aniline (±)-4.23 as a pale-yellow solid (0.1033 g, 50%).
Rf = 0.23 (50% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 8.19 (s,
1H), 7.57 (d, J = 8.0 Hz, 1H), 7.44 (d, J = 1.5 Hz, 1H), 7.37 (d, J = 4.2 Hz, 1H), 7.36 –
7.28 (m, 1H), 7.23 – 7.13 (m, 2H), 7.14 – 7.05 (m, 1H), 7.02 (dq, J = 2.3, 1.2 Hz, 1H), 6.90
(q, J = 2.2 Hz, 1H), 6.13 (s, 1H), 5.37 – 5.27 (m, 1H), 3.90 (s, 2H), 3.74 – 3.51 (m, 2H),
3.17 (d, J = 3.9 Hz, 1H), 3.06 – 2.87 (m, 2H), 2.46 – 2.35 (m, 1H), 1.05 – 0.84 (m, 6H).
13C

NMR (100 MHz, CDCl3): δ 169.04, 164.53, 146.72, 136.44, 130.51, 126.84, 123.17,

122.98, 122.63, 122.40, 122.17, 119.43, 118.57, 116.40, 112.20, 111.28, 82.90, 78.53,
77.89, 38.56, 30.70, 25.15, 18.85, 16.84. FTICR-MS (m/z): [M+Na]+ calculated for
C24H25N3O3Na+, 426.178813; found 426.178732.
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Synthesis of 1-((2-(1H-indol-3-yl)ethyl)amino)-3-methyl-1-oxobutan-2-yl 3-acrylamido5-ethynylbenzoate ((±)-4.24):
Diisopropylethylamine (0.37 mL, 2.048 mmol, 8.00 equiv) and acryloyl chloride
(0.04 mL, 0.5120 mmol, 2.00 equiv) was added in sequence to a stirred solution of the
aniline (±)-4.23 (0.1033 g, 0.2560 mmol, 1.00 equiv) in tetrahydrofuran (0.25 mL) at 0 °C.
The mixture was stirred for 5 minutes at 0 °C. The temperature was gradually raised to
room temperature. The mixture was stirred for 1 hour at room temperature. The product
mixture was concentrated by rotary evaporation and the oil residue was dissolved in
dichloromethane. The organic solution was transferred to a separatory funnel and washed
sequentially with saturated aqueous sodium bicarbonate solution and brine. The organic
layer was dried over magnesium sulfate and the dried solution was filtered. The filtrate was
concentrated by rotary evaporation to afford an orange solid. The solid was purified by
flash column chromatography (SiO2 , 50% ethyl acetate-hexanes) to afford the acrylamide
(±)-4.24 as a yellow solid (0.0594 g, 51%).
Rf = 0.25 (50% ethyl acetate-hexanes, UV). 1H NMR (500 MHz, MeOD): δ 8.29 –
8.18 (m, 1H), 8.03 (s, 1H), 7.79 (d, J = 1.3 Hz, 1H), 7.49 (d, J = 7.7 Hz, 1H), 7.22 (t, J =
9.2 Hz, 1H), 7.03 – 6.94 (m, 2H), 6.95 – 6.88 (m, 1H), 6.40 – 6.33 (m, 1H), 5.76 (dd, J =
7.4, 4.4 Hz, 1H), 4.94 (d, J = 5.1 Hz, 1H), 3.59 (s, 1H), 3.57 – 3.40 (m, 2H), 3.27 (d, J =
1.5 Hz, 1H), 2.91 (td, J = 7.3, 5.2 Hz, 2H), 2.27 – 2.14 (m, 1H), 1.04 – 0.93 (m, 6H). 13C
NMR (126 MHz, MeOD): δ 171.77, 166.28, 166.11, 145.01, 140.48, 138.07, 132.07,
144

131.92, 129.46, 128.68, 128.63, 128.40, 124.72, 123.60, 122.27, 119.58, 119.20, 112.89,
112.18, 83.11, 80.48, 80.09, 41.10, 32.02, 26.15, 19.25, 17.80. FTICR-MS (m/z): [M+Na]+
calculated for C27H27N 3O4Na+, 480.189377; found 480.189041.
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4.5

Synthesis of 1-(3-ethynyl-5-nitrobenzoyl)piperidin-4-one (4.26):
4-piperidone monohydrate hydrochloride (0.7681 g, 5.00 mmol, 1.00 equiv),
ethylcarbodiimide hydrochloride (1.1502 g, 6.00 mmol, 1.20 equiv), hydroxybenzotriazole
(0.7432 g, 5.50 mmol, 1.10 equiv), and triethylamine (0.80 mL, 6.00 mmol, 1.20 equiv)
was added in sequence to a stirred solution of the carboxylic acid 4.5 (0.9560 g, 5.00 mmol,
1.00 equiv) in dimethylformamide (18 mL). The mixture was stirred for 41 hours. The
product mixture was diluted with ethyl acetate. The organic mixture was transferred to
separatory funnel and washed with saturated sodium carbonate solution and brine. The
organic layer was dried over magnesium sulfate and the dried solution was filtered. The
filtrate was concentrated by rotary evaporation to afford a brown oil. The oil was purified
by flash column chromatography (SiO2, 50% ethyl acetate-hexanes) to afford the
piperidone 4.26 as a white solid (1.1392 g, 84%).
Rf = 0.28 (50% ethyl acetate-hexanes, UV). 1H NMR (500 MHz, CDCl3): δ 8.37
(dd, J = 2.2, 1.5 Hz, 1H), 8.30 – 8.24 (m, 1H), 7.86 (t, J = 1.5 Hz, 1H), 3.87 (d, J = 145.9
Hz, 4H), 3.31 (s, 1H), 2.53 (d, J = 73.8 Hz, 5H). 13C NMR (126 MHz, CDCl3): δ 205.55,
167.24, 147.96, 136.90, 135.91, 128.10, 124.72, 122.02, 81.43, 80.08, 46.27, 41.65, 40.50,
39.84. FTICR-MS (m/z): [M+Na]+ calculated for C14H12N2O4 +, 295.068928; found
295.068954.

146

NO2

NO2
O
OH
O

NH2
+

O
+

O

O
N

+

CN

OMe

4.26

of

methyl

O

H
N

N
O

O

Synthesis

N

MeOH
55 °C
8%

O
OMe

O
4.30

(1-(3-ethynyl-5-nitrobenzoyl)-4-(N-isobutylbenzofuran-2-

carboxamido)piperidine-4-carbonyl)glycinate (4.30):
Isobutylamine (0.11 mL, 1.15 mmol, 1.00 equiv) was added to a stirred solution of
the ketone 4.26 (0.3126 g, 1.15 mmol, 1.00 equiv) in methanol (5.75 mL). The mixture
was stirred for 2 hours. Benzofuran-2-carboxylic acid (0.1865 g, 1.15 mmol, 1.00 equiv)
and methyl isocyanoacetate (0.10 mL, 1.15 mmol, 1.00 equiv) was added in sequence to
the stirred solution at 55 °C. The mixture was stirred for 17 hours at 55 °C. The product
mixture was concentrated by rotary evaporation and the oil residue was dissolved in
chloroform. The organic solution was transferred to a separatory funnel and washed
sequentially with aqueous 1M hydrochloric acid solution, saturated aqueous sodium
bicarbonate solution, and brine. The organic layer was dried over magnesium sulfate and
the dried solution was filtered. The filtrate was concentrated by rotary evaporation to afford
a brown solid. The solid was purified by flash column chromatography (SiO2, 50% ethyl
acetate-hexanes) to afford the adduct 4.30 as a white solid.
Rf = 0.23 (50% ethyl acetate-hexanes, UV). 1H NMR (500 MHz, CDCl3): δ 8.91
(d, J = 4.7 Hz, 1H), 8.38 – 8.32 (m, 1H), 8.28 – 8.21 (m, 1H), 7.81 (d, J = 1.6 Hz, 1H),
7.73 – 7.65 (m, 1H), 7.59 – 7.52 (m, 1H), 7.51 – 7.43 (m, 1H), 7.38 (s, 1H), 7.36 – 7.28
(m, 1H), 3.92 (s, 2H), 3.76 (s, 3H), 3.71 – 3.41 (m, 4H), 3.28 (s, 1H), 2.63 – 2.19 (m, 4H),
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1.88 (hept, J = 6.5 Hz, 1H), 0.75 (s, 6H). 13C NMR (126 MHz, CDCl3): δ 173.18, 169.92,
166.60, 165.31, 154.66, 149.39, 147.98, 137.51, 135.97, 127.78, 127.25, 126.89, 124.55,
123.93, 122.51, 122.14, 113.59, 112.05, 81.15, 80.27, 63.67, 55.37, 52.32, 44.34, 41.32,
38.74, 32.78, 31.76, 27.93, 19.84. FTICR-MS (m/z): [M+Na]+ calculated for
C31H32N4O8Na+, 611.211235; found 611.210724.
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of

methyl

(2-(4-chlorophenyl)-2-(3-ethynyl-N-isopropyl-5-

nitrobenzamido)acetyl)glycinate ((±)-4.34):
4-Chlorobenzaldehyde (0.2205 g, 1.569 mmol, 1.00 equiv) was added to a stirred
solution of isopropylamine (0.14 mL, 1.569 mmol, 1.00 equiv) in methanol (10 mL). The
mixture was stirred for 2 hours. The carboxylic acid 4.5 (0.3000 g. 1.569 mmol, 1.00 equiv)
and methyl isocyanoacetate (0.14 mL, 1.569 mmol, 1.00 equiv) was added in sequence to
the mixture at 55 °C. The mixture was stirred for 15 hours at 55 °C. The product mixture
was concentrated by rotary evaporation to afford an orange oil. The oil was purified by
flash column chromatography (SiO2 , 35% ethyl acetate-hexanes) to afford the adduct (±)4.34 as a pale-yellow solid (0.3704 g, 50%).
Rf = 0.52 (35% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 8.35
(dd, J = 2.2, 1.4 Hz, 1H), 8.27 – 8.21 (m, 1H), 7.83 (q, J = 1.1 Hz, 1H), 7.45 (s, 2H), 7.39
(d, J = 8.5 Hz, 2H), 6.84 (d, J = 0.4 Hz, 1H), 4.96 (s, 1H), 4.12 – 3.92 (m, 3H), 3.73 (s,
3H), 3.30 (s, 1H), 1.36 (d, J = 6.5 Hz, 3H), 1.12 (d, J = 6.7 Hz, 3H). 13C NMR (100 MHz,
CDCl3): δ 170.00, 169.49, 168.68, 148.03, 138.21, 135.06, 134.48, 134.23, 129.45, 129.27,
127.70, 124.77, 121.15, 81.32, 80.22, 60.33, 52.33, 41.41, 21.50, 20.97, 20.77. FTICR-MS
(m/z): [M+Na]+ calculated for C23 H22ClN3 O6Na+, 494.108934; found 494.108159.
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Synthesis

O

methyl

(2-(3-acrylamido-5-ethynyl-N-isopropylbenzamido)-2-(4-

chlorophenyl)acetyl)glycinate ((±)-4.36):
Acrylic acid (0.03 mL, 0.367 mmol, 1.20 equiv), ethylcarbodiimide hydrochloride
(0.0711 g, 0.458 mmol, 1.50 equiv), hydroxybenzotriazole (0.0619 g, 0.458 mmol, 1.50
equiv), and diisopropylethylamine (0.11 mL, 0.611 mmol, 2.00 equiv) was added in
sequence to a stirred solution of the aniline (±)-4.35 (0.1350 g, 0.305 mmol, 1.00 equiv) in
dimethylformamide (1.22 mL). The solution was stirred for 12 hours. The product mixture
was quenched with water. The aqueous solution was transferred to a separatory funnel,
extracted with ethyl acetate (3 × 15 mL), and washed with aqueous 1M hydrochloric acid
solution. The organic layer was dried over magnesium sulfate and the dried solution was
filtered. The filtrate was concentrated by rotary evaporation to afford an orange oil. The oil
was purified by flash column chromatography (SiO2, 50% ethyl acetate-hexanes) to afford
the aliphatic diazirine (±)-4.36 as a pale-yellow foam (0.0402 g, 27%).
Rf = 0.14 (50% ethyl acetate-hexanes, UV). 1 H NMR (500 MHz, CDCl3) δ 8.60 (s,
1H), 7.72 (d, J = 84.5 Hz, 1H), 7.55 – 7.31 (m, 4H), 7.12 (d, J = 8.9 Hz, 1H), 6.96 – 6.59
(m, 1H), 6.39 (t, J = 12.4 Hz, 1H), 6.26 – 5.98 (m, 1H), 5.71 (s, 1H), 4.95 (s, 1H), 4.23 –
3.85 (m, 4H), 3.73 (s, 3H), 2.94 (d, J = 7.4 Hz, 1H), 1.24 (d, J = 94.6 Hz, 6H). 13C NMR
(100 MHz, CDCl3 ) δ 172.69, 170.62, 170.14, 149.89, 137.65, 134.50, 133.73, 129.20,
124.73, 123.78, 120.19, 119.19, 113.87, 112.77, 81.98, 79.14, 78.62, 77.37, 61.55, 54.72,
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52.40, 41.46, 21.47, 21.00. ESI-MS (m/z): [M-H]- calculated for C26H26 ClN3 O5H-, 494.96;
found 494.6.

151

N N

H 2N

N N

O

H
N

O

O

OH

+
OMe

EDC•HCl, HOBT, DIPEA
DMF
18%

O

O

H
N
O

O

H
N

O

O
OMe

O

(±)-4.39

(±)-4.40

Synthesis of 1-(3-ethynyl-5-(3-(3-methyl-3H-diazirin-3-yl)propanamido)phenyl)-2-((2methoxy-2-oxoethyl)amino)-2-oxoethyl isobutyrate ((±)-4.40):
3-Methyl-3H-diazirine-3-propanoic acid (0.1627 g, 1.27 mmol, 1.20 equiv) (known
via Ahad et al., 2013), ethylcarbodiimide hydrochloride (0.2468 g, 1.59 mmol, 1.50 equiv),
hydroxybenzotriazole (0.2148 g, 1.59 mmol, 1.50 equiv), and diisopropylethylamine (0.37
mL, 2.12 mmol, 2.00 equiv) was added in sequence to a stirred solution of the aniline (±)4.39 (0.3531 g, 1.06 mmol, 1.00 equiv) in dimethylformamide (4.24 mL). The solution was
stirred for 23 hours. The product mixture was quenched with water. The aqueous solution
was transferred to a separatory funnel, extracted with ethyl acetate (3 × 15 mL), and washed
with aqueous 1M hydrochloric acid solution. The organic layer was dried over magnesium
sulfate and the dried solution was filtered. The filtrate was concentrated by rotary
evaporation to afford an orange oil. The oil was purified by flash column chromatography
(SiO2, 50% ethyl acetate-hexanes) to afford the aliphatic diazirine (±)-4.40 as a pale-yellow
oil (0.0729 g, 18%).
Rf = 0.27 (50% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 8.16 (s,
1H), 7.72 (d, J = 1.8 Hz, 1H), 7.42 (t, J = 1.9 Hz, 1H), 7.24 (s, 1H), 7.09 (t, J = 5.2 Hz,
1H), 6.00 (s, 1H), 4.16 – 3.93 (m, 2H), 3.72 (d, J = 4.0 Hz, 3H), 3.06 (s, 1H), 2.77 – 2.59
(m, 1H), 2.09 – 2.00 (m, 2H), 1.83 – 1.63 (m, 2H), 1.21 (dd, J = 18.7, 7.0 Hz, 6H), 1.00 (s,
3H).

13C

NMR (100 MHz, CDCl3): δ 175.16, 170.15, 169.80, 168.65, 138.51, 136.03,
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125.81, 123.56, 123.21, 119.07, 82.62, 78.07, 74.19, 52.52, 41.09, 33.79, 31.18, 29.52,
25.33, 19.75, 18.74, 18.65. FTICR-MS (m/z): [M+Na] + calculated for C22 H26N4O6Na+,
465.174456; found 465.174257.
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2-(5-((3,4-dihydroisoquinolin-2(1H)-yl)(3-ethynyl-5-

nitrophenyl)methyl)-1H-tetrazol-1-yl)acetate ((±)-4.42):
Tetrahydroisoquinoline (0.14 mL, 1.10 mmol, 1.10 equiv) was added to a stirred
solution of the benzaldehyde 4.12 (0.1751 g, 1.00 mmol, 1.00 equiv) in methanol (2 mL).
The mixture was stirred for 10 minutes. Azidotrimethylsilane (0.15 mL, 1.10 mmol, 1.10
equiv) and methyl isocyanoacetate (0.10 mL, 1.10 mmol, 1.10 equiv) was added in
sequence to the mixture. The mixture was stirred for 72 hours. The product mixture was
concentrated by rotary evaporation. The oil residue was dissolved in ethyl acetate. The
organic solution was transferred to a separatory funnel and washed sequentially with
aqueous 1M hydrochloric acid solution, saturated aqueous sodium bicarbonate solution,
and brine. The organic layer was dried over magnesium sulfate and the dried solution was
filtered. The filtrate was concentrated by rotary evaporation to afford a brown solid. The
solid was purified by flash column chromatography (SiO2 , 30% ethyl acetate-hexanes) to
afford the tetrazole (±)-4.42 as a yellow solid (0.1300 g, 30%).
Rf = 0.40 (30% ethyl acetate-hexanes, UV). MP = 140-143 °C. 1H NMR (400 MHz,
CDCl3): δ 8.36 (t, J = 1.9 Hz, 1H), 8.31 (t, J = 1.8 Hz, 1H), 7.99 (t, J = 1.6 Hz, 1H), 7.10
(tdd, J = 12.0, 7.0, 1.7 Hz, 3H), 6.93 (dd, J = 7.4, 1.7 Hz, 1H), 5.48 – 5.28 (m, 3H), 3.57
(s, 2H), 3.50 (s, 3H), 3.28 (s, 1H), 2.88 (q, J = 5.3, 4.6 Hz, 2H), 2.73 (tdd, J = 11.6, 9.0, 5.4
Hz, 2H). 13 C NMR (100 MHz, CDCl3): δ 165.71, 153.37, 147.90, 138.73, 134.39, 132.93,
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132.75, 128.59, 127.07, 126.62, 126.53, 125.90, 124.59, 124.05, 80.80, 80.65, 63.45,
52.94, 51.90, 48.96, 47.73, 28.62. FTICR-MS (m/z): [M]+ calculated for C22H21N6O4 ,
433.161880; found 433.161994.
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Synthesis of methyl 2-(5-((3-amino-5-ethynylphenyl)(3,4-dihydroisoquinolin-2(1H)yl)methyl)-1H-tetrazol-1-yl)acetate ((±)-4.43):
Solid zinc (0.7255 g, 11.10 g atom, 3.00 equiv) was added to a stirred solution of
the aryl nitro (±)-4.42 (1.6026 g, 3.70 mmol, 1.00 equiv) in acetic acid (10.88 mL) and
water (5.44 mL). The mixture was stirred for 18 hours. The product mixture was diluted
with ethyl acetate. The organic mixture was transferred to a separatory funnel and washed
with water and brine. The organic layer was dried over magnesium sulfate and the dried
solution was filtered. The filtrate was concentrated by rotary evaporation to afford a yellow
solid. The solid was purified by flash column chromatography (SiO 2, 50% ethyl acetatehexanes) to afford the aniline (±)-4.43 as a yellow-orange solid (1.0723 g, 72%).
Rf = 0.36 (50% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 7.09
(dddd, J = 15.2, 8.1, 6.7, 2.1 Hz, 1H), 6.99 – 6.85 (m, 2H), 6.75 (dt, J = 3.6, 1.9 Hz, 2H),
5.33 (d, J = 1.5 Hz, 2H), 5.09 (s, 1H), 3.69 (d, J = 14.8 Hz, 1H), 3.52 (s, 3H), 3.03 (s, 1H),
2.92 – 2.81 (m, 3H), 2.65 (dd, J = 7.3, 4.1 Hz, 1H). 13 C NMR (100 MHz, CDCl3): δ 165.63,
154.67, 147.01, 135.04, 133.50, 128.57, 126.68, 126.47, 125.78, 123.26, 121.86, 118.52,
115.91, 83.22, 77.20, 64.56, 53.56, 52.98, 48.68, 48.53, 28.74. FTICR-MS (m/z): [M] +
calculated for C22H23N 6O2, 403.187700; found 403.187740.
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methyl 2-(5-((3-acrylamido-5-ethynylphenyl)(3,4-dihydroisoquinolin-

2(1H)-yl)methyl)-1H-tetrazol-1-yl)acetate ((±)-4.44):
Acrylic acid (0.03 mL, 0.38 mmol, 1.20 equiv), ethylcarbodiimide hydrochloride
(0.0745 g, 0.48 mmol, 1.50 equiv), hydroxybenzotriazole (0.0649 g, 0.48 mmol, 1.50
equiv), and diisopropylethylamine (0.11 mL, 0.64 mmol, 2.00 equiv) was added in
sequence to a solution of the aniline (±)-4.43 (0.1305 g, 0.32 mmol, 1.00 equiv) in
dimethylformamide (1.28 mL). The mixture was stirred for 22 hours. The product mixture
was quenched with water. The aqueous mixture was transferred to a separatory funnel,
extracted with ethyl acetate (3 × 10 mL), and washed with saturated aqueous sodium
bicarbonate solution and brine. The organic layer was dried over magnesium sulfate and
the dried solution was filtered. The filtrate was concentrated by rotary evaporation to afford
a colorless solid. The solid was purified by flash column chromatography (SiO2, 50% ethyl
acetate-hexanes) to afford the arcylamide (±)-4.44 as a white oil (0.0355 g, 24%).
Rf = 0.33 (50% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 8.48 (s,
1H), 7.78 (s, 1H), 7.68 (d, J = 1.7 Hz, 1H), 7.28 (s, 1H), 7.15 – 7.01 (m, 3H), 6.91 (dd, J =
7.5, 1.6 Hz, 1H), 6.39 (dd, J = 16.8, 1.6 Hz, 1H), 6.27 (dd, J = 16.9, 10.0 Hz, 1H), 5.72
(dd, J = 10.0, 1.6 Hz, 1H), 5.40 (s, 2H), 5.23 (s, 1H), 3.62 – 3.50 (m, 2H), 3.49 (s, 3H),
3.06 (s, 1H), 2.91 – 2.82 (m, 2H), 2.80 – 2.66 (m, 2H). 13C NMR (100 MHz, CDCl3): δ
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165.89, 154.74, 138.63, 133.40, 133.36, 130.85, 129.30, 128.57, 128.27, 128.18, 126.67,
126.48, 125.79, 123.12, 82.59, 78.29, 64.54, 52.95, 52.72, 49.06, 48.22, 28.75. FTICR-MS
(m/z): [M]+ calculated for C25H25N6O3 , 457.198265; found 457.198383.
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Synthesis of methyl N-(2-(tert-butylamino)-1-(3-ethynyl-5-nitrophenyl)-2-oxoethyl)-Nmethylglycinate ((±)-4.47):
The benzaldehyde 4.12 (0.1751 g, 1.00 mmol, 1.00 equiv), methyl isocyanoacetate
(0.12 mL, 1.10 mmol, 1.10 equiv), and methanol (2 mL) was added in sequence to a stirred
solution of sarcosine (0.0980 g, 1.10 mmol, 1.10 equiv) in dichloromethane (1 mL). The
mixture was stirred for 49 hours. The product mixture was concentrated by rotary
evaporation to afford an orange oil. The oil was purified by flash column chromatography
(SiO2, 25% ethyl acetate-hexanes) to afford the adduct (±)-4.47 as a white oil (0.1384 g,
38%).
Rf = 0.20 (25% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 8.23
(d, J = 0.9 Hz, 1H), 8.12 (s, 1H), 7.71 (s, 1H), 7.30 (s, 1H), 4.30 (s, 1H), 3.69 (s, 3H), 3.33
– 3.10 (m, 3H), 2.32 (s, 3H), 1.34 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 171.01, 168.49,
148.02, 138.43, 138.34, 126.48, 123.97, 123.95, 80.84, 80.22, 77.32, 77.00, 76.68, 72.64,
55.32, 51.66, 51.12, 40.60, 28.49. FTICR-MS (m/z): [M+Na]+ calculated for
C18H23N3O5Na+, 384.152992; found 384.153036.
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Synthesis of methyl N-(1-(3-amino-5-ethynylphenyl)-2-(tert-butylamino)-2-oxoethyl)-Nmethylglycinate ((±)-4.48):
Solid zinc (0.1667 g, 1.11 g atom, 3.00 equiv) was added to a stirred solution of the
aryl nitro (±)-4.47 (0.1340 g, 0.37 mmol, 1.00 equiv) in acetic acid (1.10 mL) and water
(0.55 mL). The mixture was stirred for 19 hours. The product mixture was diluted with
ethyl acetate. The organic solution was transferred to a separatory funnel and washed with
water and brine. The organic layer was dried over magnesium sulfate and the solution was
filtered. The filtrate was concentrated by rotary evaporation to afford a yellow foam. The
foam was purified by flash column chromatography (SiO2, 65% ethyl acetate-hexanes) to
afford the aniline (±)-4.48 as a colorless oil (0.0263 g, 21%).
Rf = 0.25 (65% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 7.45 (s,
1H), 6.99 (d, J = 1.8 Hz, 1H), 6.93 (d, J = 1.7 Hz, 1H), 6.81 (d, J = 1.8 Hz, 1H), 4.03 (d, J
= 1.3 Hz, 1H), 3.67 (s, 3H), 3.27 – 3.05 (m, 2H), 3.02 (d, J = 1.3 Hz, 1H), 2.28 (s, 3H),
1.34 (s, 9H).

13 C

NMR (100 MHz, CDCl3): δ 171.63, 170.57, 150.78, 136.78, 124.94,

122.61, 117.07, 115.49, 83.61, 77.32, 77.20, 77.00, 76.68, 73.90, 55.66, 51.75, 51.00,
41.11, 28.56. FTICR-MS (m/z): [M+Na]+ calculated for C18H25 N3O3Na+, 354.178813;
found 354.179114.
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Synthesis of methyl (2-(3-ethynyl-5-nitrophenyl)-2-(2-oxoazetidin-1-yl)acetyl)glycinate
((±)-4.52):
ß-Alanine (0.3207 g, 3.60 mmol, 1.20 equiv) was added to a stirred solution of the
aldehyde 4.12 (0.5254 g, 3.00 mmol, 1.00 equiv) in methanol (15 mL). The mixture was
stirred for 30 minutes. Methyl isocyanoacetate (0.27 mL, 3.00 mmol, 1.00 equiv) was
added to the mixture. The mixture was stirred for 68 hours. The product mixture was
concentrated by rotary evaporation to afford an orange oil. The oil was purified by flash
column chromatography (SiO2 , 65% ethyl acetate-hexanes) to afford the ß-lactam (±)-4.52
as a white oil (0.3375 g, 33%).
Rf = 0.33 (65% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 8.25 –
8.22 (m, 1H), 8.21 (s, 1H), 7.81 (d, J = 1.5 Hz, 1H), 7.68 (s, 1H), 5.76 (d, J = 2.7 Hz, 1H),
4.13 – 3.92 (m, 2H), 3.70 (s, 3H), 3.68 – 3.28 (m, 2H), 3.29 – 3.23 (m, 1H), 2.98 (qdd, J =
14.9, 5.5, 2.8 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 169.63, 168.33, 167.56, 148.15,
137.15, 137.08, 126.74, 124.41, 123.18, 80.72, 80.55, 57.46, 52.35, 41.22, 39.35, 36.50.
FTICR-MS (m/z): [M+Na]+ calculated for C16H15 N3O6Na+, 368.085306; found
368.085272.

161

O2N

H 2N
H
N

N
O

O

O
OMe

Zn(s)
AcOH/H2O
23%

(±)-4.52

H
N

N
O

O
OMe

O

(±)-4.53

Synthesis of methyl (2-(3-amino-5-ethynylphenyl)-2-(2-oxoazetidin-1-yl)acetyl)glycinate
((±)-4.53):
Solid zinc (0.1667 g, 1.11 g atom, 3.00 equiv) was added to a stirred solution of the
aryl nitro (±)-4.52 (0.2945 g, 0.85 mmol, 1.00 equiv) in acetic acid (2.50 mL) and water
(1.25 mL). The mixture was stirred for 19 hours. The product mixture was diluted with
ethyl acetate. The organic solution was transferred to a separatory funnel and washed with
water and brine. The organic layer was dried over magnesium sulfate and the solution was
filtered. The filtrate was concentrated by rotary evaporation to afford an orange foam. The
foam was purified by flash column chromatography (SiO2 , 100% ethyl acetate) to afford
the aniline (±)-4.53 as a colorless oil (0.0617 g, 23%).
Rf = 0.11 (100% ethyl acetate, UV). 1H NMR (400 MHz, CDCl3): δ 7.18 – 7.11 (m,
1H), 6.81 (d, J = 1.6 Hz, 1H), 6.78 – 6.69 (m, 1H), 6.65 (d, J = 2.0 Hz, 1H), 5.36 (s, 1H),
3.97 (d, J = 5.7 Hz, 4H), 3.69 (s, 3H), 3.37 (dd, J = 166.0, 2.8 Hz, 2H), 3.02 (s, 1H), 2.99
– 2.76 (m, 2H). 13C NMR (100 MHz, CDCl3 ): δ 169.88, 168.78, 167.05, 147.25, 135.61,
123.45, 121.44, 118.27, 115.43, 83.28, 77.26, 58.70, 52.29, 41.23, 38.97, 36.25. FTICRMS (m/z): [M+Na] + calculated for C16H17N3 O4Na+, 338.111127; found 338.111156.
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Synthesis of methyl (2-(3-(4-benzoylbenzamido)-5-ethynylphenyl)-2-(2-oxoazetidin-1yl)acetyl)glycinate ((±)-4.55):
4-Benzoylbenzoic acid (0.0452 g, 0.20 mmol, 1.00 equiv), ethylcarbodiimide
hydrochloride (0.0373 g, 0.24 mmol, 1.20 equiv), hydroxybenzotriazole (0.0068 g, 0.05
mmol, 0.25 equiv), and diisopropylethylamine (0.04 mL, 0.24 mmol, 1.20 equiv) was
added in sequence to a stirred solution of the aniline (±)-4.53 (0.0632 g, 0.20 mmol, 1.00
equiv) in tetrahydrofuran (0.80 mL). The mixture was stirred for 19 hours. The product
mixture was concentrated by rotary evaporation. The oil residue was dissolved in
dichloromethane. The organic solution was transferred to a separatory funnel and washed
with saturated aqueous sodium bicarbonate solution, water, and brine. The organic layer
was dried over magnesium sulfate and the dried solution was filtered. The filtrate was
concentrated by rotary evaporation to afford a colorless oil. The oil was purified by flash
column chromatography (SiO2, 100% ethyl acetate) to afford the benzoylbenzamide (±)4.55 as a colorless oil (0.0368 g, 35%).
Rf = 0.28 (100% ethyl acetate, UV). 1H NMR (400 MHz, CDCl3): δ 9.13 (s, 1H),
8.03 (s, 1H), 7.99 (d, J = 8.4 Hz, 2H), 7.82 (d, J = 8.4 Hz, 2H), 7.79 (d, J = 6.9 Hz, 2H),
7.70 – 7.59 (m, 2H), 7.55 (s, 1H), 7.50 (dd, J = 8.3, 7.0 Hz, 2H), 7.28 (s, 1H), 5.53 (s, 1H),
4.00 (d, J = 5.7 Hz, 2H), 3.68 (s, 3H), 3.45 (dd, J = 151.3, 2.8 Hz, 2H), 3.08 (s, 1H), 2.97
– 2.76 (m, 2H).

13C

NMR (100 MHz, CDCl3): δ 196.07, 169.89, 168.68, 168.37, 165.33,
163

140.33, 138.91, 137.61, 136.77, 135.37, 133.02, 130.11, 130.01, 128.48, 127.41, 127.32,
124.09, 123.58, 120.86, 82.59, 78.42, 77.32, 77.20, 77.00, 76.68, 58.63, 52.36, 41.29,
39.29, 36.25. FTICR-MS (m/z): [M+Na]+ calculated for C30H25 N3O6Na+, 546.163557;
found 546.163070.

164

O
OH

+

O

HO

PPh2

EDC•HCl, DMAP, DIPEA
O

DCM
6%

O
PPh2
O
4.61

Synthesis of 2-(diphenylphosphaneyl)phenyl 4-benzoylbenzoate (4.61):
Benzoylbenzoic acid (0.2716 g, 1.20 mmol, 1.20 equiv), ethylcarbodiimide
hydrochloride (0.2876 g, 1.50 mmol, 1.50 equiv), 4-dimethylaminopyridine (0.0122 g,
0.10 mmol, 0.10 equiv), and diisopropylethylamine (0.35 mL, 2.00 mmol, 2.00 equiv) was
added to a stirred solution of (2-hydroxyphenyl)diphenylphosphine (0.2783 g, 1.00 mmol,
1.00 equiv) in dichloromethane (4 mL). The mixture was stirred for 23 hours. The product
mixture was diluted with dichloromethane. The organic solution was transferred to
separatory funnel and washed sequentially with aqueous 1M hydrochloric acid solution,
aqueous 1M sodium hydroxide solution, water, and brine. The organic layer was dried over
magnesium sulfate and the dried solution was filtered. The filtrate was concentrated by
rotary evaporation to afford a white foam. The solid was purified by flash column
chromatography (SiO2 , 15% ethyl acetate-hexanes) to afford the ester 4.61 as a white oil
(0.0284 g, 6%).
Rf = 0.46 (15% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 7.97 –
7.90 (m, 2H), 7.84 – 7.77 (m, 2H), 7.75 (dd, J = 8.4, 1.4 Hz, 2H), 7.68 – 7.59 (m, 1H), 7.56
– 7.47 (m, 2H), 7.45 (td, J = 7.7, 1.6 Hz, 1H), 7.37 – 7.32 (m, 10H), 7.21 (t, J = 7.5 Hz,
1H), 6.87 (ddd, J = 7.5, 4.3, 1.5 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 196.03, 163.51,
152.61, 152.44, 141.61, 136.87, 135.25, 135.16, 134.18, 133.97, 133.60, 133.00, 132.17,
130.68, 130.53, 130.11, 129.99, 129.94, 129.58, 129.11, 128.62, 128.55, 128.46, 126.40,
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122.43. FTICR-MS (m/z): [M+Na] + calculated for C32H23O 3PNa+, 509.127702; found
509.127590.
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Synthesis of 2-(diphenylphosphaneyl)phenyl 2-chloro-5-nitrobenzoate (4.62):
5-Nitro-3-chlorobenzoic acid (0.2419 g, 1.20 mmol, 1.20 equiv), ethylcarbodiimide
hydrochloride (0.2876 g, 1.50 mmol, 1.50 equiv), 4-dimethylaminopyridine (0.0122 g,
0.10 mmol, 0.10 equiv), and diisopropylethylamine (0.35 mL, 2.00 mmol, 2.00 equiv) was
added to a stirred solution of (2-hydroxyphenyl)diphenylphosphine (0.2783 g, 1.00 mmol,
1.00 equiv) in dichloromethane (4 mL). The mixture was stirred for 20 hours. The product
mixture was diluted with dichloromethane. The organic solution was transferred to
separatory funnel and washed sequentially with aqueous 1M hydrochloric acid solution,
saturated aqueous sodium bicarbonate solution, water, and brine. The organic layer was
dried over magnesium sulfate and the dried solution was filtered. The filtrate was
concentrated by rotary evaporation to afford a white solid. The solid was purified by flash
column chromatography (SiO2 , 25% ethyl acetate-hexanes) to afford the ester 4.62 as a
yellow solid (0.2884 g, 62%).
Rf = 0.56 (25% ethyl acetate-hexanes, UV). MP = 118.2 °C. 1H NMR (400 MHz,
CDCl3): δ 8.52 (d, J = 3.0 Hz, 1H), 8.24 (dd, J = 8.8, 2.7 Hz, 1H), 7.61 (d, J = 8.8 Hz, 1H),
7.50 – 7.41 (m, 1H), 7.36 – 7.30 (m, 11H), 7.23 (td, J = 7.7, 1.5 Hz, 1H), 6.90 (ddd, J =
7.7, 4.2, 1.7 Hz, 1H).

C NMR (100 MHz, CDCl3): δ 161.12, 152.27, 145.96, 141.20,

13

134.89, 134.79, 134.06, 133.85, 132.19, 130.10, 129.90, 129.26, 128.72, 128.65, 127.11,
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126.85, 122.40.

31P

NMR (162 MHz, CDCl3 ): δ -16.55. FTICR-MS (m/z): [M+Na]+

calculated for C25H17 ClNO4 PNa+, 484.047593; found 484.048218.
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Synthesis of 1-(3-azido-5-ethynylphenyl)-2-((2-methoxy-2-oxoethyl)amino)-2-oxoethyl
isobutyrate ((±)-4.63):
Isobutyric acid (0.10 mL, 1.10 mmol, 1.10 equiv) and methyl isocyanoacetate (0.10
mL, 1.10 mmol, 1.10 equiv) was added in sequence to a stirred solution of the
benzaldehyde 4.15 (0.1712 g, 1.00 mmol, 1.00 equiv) in dichloromethane (5 mL). The
mixture was stirred at reflux for 21 hours at 55 °C. The product mixture was diluted with
dichloromethane. The organic solution was transferred to a separatory funnel and washed
sequentially with saturated aqueous sodium bicarbonate solution, saturated aqueous
sodium bisulfite solution, and brine. The organic layer was dried over magnesium sulfate
and the dried solution was filtered. The filtrate was concentrated by rotary evaporation to
afford an orange oil. The oil was purified by flash column chromatography (SiO2, 25%
ethyl acetate-hexanes) to afford the adduct (±)-4.63 as a colorless oil (0.2326 g, 65%).
Rf = 0.14 (25% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 7.33
(d, J = 1.6 Hz, 1H), 7.10 (s, 2H), 6.83 (d, J = 5.2 Hz, 1H), 6.06 (s, 1H), 4.11 – 4.03 (m,
2H), 3.77 (s, 3H), 3.12 (s, 1H), 2.79 – 2.66 (m, 1H), 1.25 (dd, J = 17.7, 7.0 Hz, 6H). 13C
NMR (100 MHz, CDCl3): δ 174.76, 169.83, 167.72, 140.81, 137.62, 127.11, 124.17,
122.76, 118.46, 81.99, 78.77, 73.85, 52.57, 41.04, 33.87, 18.79, 18.70. IR (ATR-FTIR),
cm-1: 3291 (br), 2977 (w), 2879 (w), 2110 (s), 1744 (s), 1672 (s), 1599 (w), 1588 (s), 1530
(s), 1437 (s), 1371 (w), 1323 (w), 1307 (w), 1210 (s), 1185 (s), 1143 (s), 1043 (w), 1011
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(w), 920 (w), 865 (s), 799 (w), 682 (br). FTICR-MS (m/z): [M+Na]+ calculated for
C17H18N4O5Na+, 381.116941; found 381.116918.
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1-(3-(2-chloro-5-nitrobenzamido)-5-ethynylphenyl)-2-((2-methoxy-2-

oxoethyl)amino)-2-oxoethyl isobutyrate ((±)-4.64):
The aryl azide (±)-4.63 (0.1306 g, 0.36 mmol, 1.00 equiv) was added to a stirred
solution of the ester 4.62 (0.1663 g, 0.36 mmol, 1.00 equiv) in tetrahydrofuran (3.24 mL)
and water (0.36 mL). The product mixture was concentrated by rotary evaporation. The oil
residue was dissolved in ethyl acetate. The organic solution was transferred to a separatory
funnel and washed with aqueous 1M sodium hydroxide solution and brine. The organic
layer was dried over magnesium sulfate and the solution was filtered. The filtrate was
concentrated by rotary evaporation to afford a yellow oil. The oil was purified by flash
column chromatography (SiO2, 50% ethyl acetate-hexanes) to afford the adduct (±)-4.64
as a white solid (0.1128 g, 60%).
Rf = 0.33 (50% ethyl acetate-hexanes, UV). MP = 165-170 °C. 1H NMR (400 MHz,
CDCl3): δ 9.07 (s, 1H), 8.40 (s, 1H), 8.18 – 8.08 (m, 1H), 7.75 (d, J = 2.0 Hz, 1H), 7.62 (d,
J = 2.0 Hz, 1H), 7.55 (d, J = 8.8 Hz, 1H), 7.27 (d, J = 2.1 Hz, 1H), 7.08 (t, J = 5.3 Hz, 1H),
5.97 (s, 1H), 4.04 – 3.85 (m, 2H), 3.70 (s, 3H), 3.09 (s, 1H), 2.66 (p, J = 7.0 Hz, 1H), 1.19
(dd, J = 13.9, 7.2 Hz, 6H). 13 C NMR (100 MHz, CDCl3): δ 175.09, 169.72, 168.35, 162.89,
146.11, 138.00, 137.75, 136.36, 131.35, 126.91, 125.72, 124.53, 123.97, 123.35, 119.52,
82.29, 78.51, 74.00, 52.48, 40.95, 33.76, 18.66. FTICR-MS (m/z): [M+Na] + calculated for
C24H22ClN3O 8Na+, 538.098763; found 538.098782.
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Synthesis of methyl 2-(5-((3-azido-5-ethynylphenyl)(3,4-dihydroisoquinolin-2(1H)yl)methyl)-1H-tetrazol-1-yl)acetate ((±)-4.65):
Tetrahydroisoquinoline (0.14 mL, 1.10 mmol, 1.10 equiv) was added to a stirred
solution of the benzaldehyde 4.15 (0.1716 g, 1.00 mmol, 1.00 equiv) in methanol (2 mL).
The mixture was stirred for 10 minutes. Azidotrimethylsilane (0.14 mL, 1.10 mmol, 1.10
equiv) and methyl isocyanoacetate (0.10 mL, 1.10 mmol, 1.10 equiv) was added in
sequence to the mixture. The mixture was stirred for 72 hours.The product mixture was
concentrated by rotary evaporation. The oil residue was dissolved in ethyl acetate. The
organic solution was transferred to a separatory funnel and washed sequentially with
aqueous 1M hydrochloric acid solution, saturated aqueous sodium bicarbonate solution,
and brine. The organic layer was dried over magnesium sulfate and the dried solution was
filtered. The filtrate was concentrated by rotary evaporation to afford a brown oil. The oil
was purified by flash column chromatography (SiO2, 40% ethyl acetate-hexanes) to afford
the tetrazole (±)-4.65 as a colorless oil (0.1617 g, 38%).
Rf = 0.45 (40% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 7.69 (s,
1H), 7.58 (s, 1H), 7.51 – 7.40 (m, 9H), 5.68 (s, 2H), 5.56 (s, 1H), 3.93 (s, 2H), 3.86 (s, 4H),
3.47 (s, 1H), 3.21 (s, 8H), 3.10 (s, 2H), 3.01 (dt, J = 11.8, 6.0 Hz, 2H).

13 C

NMR (126

MHz, CDCl3 ) δ 165.73, 154.11, 141.21, 135.48, 133.40, 133.31, 129.05, 128.78, 126.79,
126.09, 124.37, 122.77, 120.57, 82.10, 79.28, 64.39, 53.18, 53.13, 48.89, 48.51, 28.91.
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FTICR-MS (m/z): [M+Na]+ calculated for C22H20 N8O2Na+, 451.160143; found
451.160301.
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(±)-4.66

(1-(3-azido-5-ethynylphenyl)-2-(tert-butylamino)-2-

oxoethyl)glycinate ((±)-4.66):
Glycine (0.0826 g, 1.10 mmol, 1.10 equiv), tert-butyl isocyanide (0.12 mL, 1.10
mmol, 1.10 equiv), and methanol (2 mL) was added in sequence to a stirred solution of the
benzaldehyde 4.15 (0.1716 g, 1.00 mmol, 1.00 equiv) in dichloromethane (1 mL). The
mixture was stirred for 48 hours. The product mixture was concentrated by rotary
evaporation. The oil residue was dissolved in ethyl acetate. The organic solution was
transferred to a separatory funnel and washed with saturated aqueous sodium bicarbonate
solution, saturated aqueous sodium bisulfite solution, water, and brine. The organic layer
was dried over magnesium sulfate and the dried solution was filtered. The filtrate was
concentrated by rotary evaporation to afford an orange-brown solid. The solid was purified
by flash column chromatography (SiO2, 25% ethyl acetate-hexanes) to afford the adduct
(±)-4.66 as a colorless oil (0.0766 g, 22%).
Rf = 0.21 (25% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 7.05
(dd, J = 2.3, 1.3 Hz, 1H), 7.01 (t, J = 1.9 Hz, 1H), 6.98 (s, 1H), 4.04 (s, 1H), 3.72 (s, 3H),
3.46 – 3.29 (m, 2H), 3.10 (s, 1H), 1.33 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 171.95,
169.52, 141.13, 140.71, 127.45, 124.12, 122.12, 118.53, 82.19, 78.49, 77.32, 77.00, 76.68,
66.87, 52.04, 50.95, 48.85, 28.59. FTICR-MS (m/z): [M+Na]+ calculated for
C17H21N5O3Na+, 366.153661; found 366.153694.
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Synthesis of methyl (2-(3-azido-5-ethynylphenyl)-2-(2-((tert-butoxycarbonyl)amino)-N(4-methoxybenzyl)acetamido)acetyl)glycinate ((±)-4.69):
4-Methoxybenzylamine (0.12 mL, 0.95 mmol, 1.00 equiv) was added to a stirred
suspension of the benzaldehyde 4.15 (0.1623 g, 0.95 mmol, 1.00 equiv) in methanol (1.90
mL). The mixture was stirred for 2 hours. N-(tert-butoxycarbonyl)glycine (0.1664 g, 0.95
mmol, 1.00 equiv) and methyl isocyanoacetate (0.09 mL, 0.95 mmol, 1.00 equiv) was
added in sequence to the mixture. The mixture was stirred for 16 hours. The product
mixture was concentrated by rotary evaporation and the oil residue was dissolved in ethyl
acetate. The organic solution was transferred to a separatory funnel and washed
sequentially with saturated aqueous sodium bicarbonate solution, aqueous 1M
hydrochloric acid solution, saturated aqueous sodium bisulfite solution, and brine. The
organic layer was dried over magnesium sulfate and the dried solution was filtered. The
filtrate was concentrated by rotary evaporation to afford a brown solid. The solid was
purified by flash column chromatography (SiO2 , 50% ethyl acetate-hexanes) to afford the
adduct (±)-4.69 a yellow oil (0.3217 g, 60%).
Rf = 0.25 (50% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 7.19 (s,
1H), 6.92 (dd, J = 17.6, 8.6 Hz, 5H), 6.71 (d, J = 9.0 Hz, 2H), 5.85 (s, 1H), 5.50 (s, 1H),
4.67 – 4.39 (m, 2H), 3.95 (s, 3H), 3.89 – 3.81 (m, 1H), 3.71 (d, J = 9.8 Hz, 6H), 3.09 (s,
1H), 1.37 (s, 9H). 13 C NMR (100 MHz, CDCl3): δ 170.93, 169.88, 168.75, 158.81, 155.75,
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140.53, 136.35, 129.65, 127.72, 127.50, 123.86, 122.28, 120.99, 113.97, 81.83, 79.61,
78.80, 62.28, 55.11, 52.24, 49.18, 42.87, 41.19, 28.16. IR (ATR-FTIR), cm-1 : 3304 (w),
29.71 (w), 2838 (w), 2253 (w), 2111 (s), 1749 (w), 1650 (s), 1513 (s), 1456 (w), 1438 (w),
1418 (w), 1367 (w), 1222 (w), 1246 (s), 1167 (s), 1034 (w), 906 (s), 726 (s), 647 (s).
FTICR-MS (m/z): [M+Na]+ calculated for C28H32 N6O7Na+, 587.222469; found
587.222252.

176

O
BocHN

H
N

N

N N

H
N

N3
PPh2

O
OMe +

N N

O

THF/H2O
64%

O

O
MeO

O
BocHN

H
N

N

O

O
OMe

O
MeO

(±)-4.69

Synthesis

(±)-4.70

of

methyl

(2-(2-((tert-butoxycarbonyl)amino)-N-(4-

methoxybenzyl)acetamido)-2-(3-ethynyl-5-(3-(3-methyl-3H-diazirin-3yl)propanamido)phenyl)acetyl)glycinate ((±)-4.70):
The aryl azide (±)-4.69 (0.1920 g, 0.34 mmol, 1.00 equiv) was added to a stirred
solution of 2-(diphenylphosphaneyl)phenyl 3-(3-methyl-3H-diazirin-3-yl)propanoate
(0.1318 g, 0.34 mmol, 1.00 equiv) in tetrahydrofuran (3.06 mL) and water (0.34 mL). The
mixture was stirred 24 hours. The product mixture was concentrated by rotary evaporation
to afford a pale-yellow solid. The solid was purified by flash column chromatography
(SiO2, 65% ethyl acetate-hexanes) to afford the adduct (±)-4.70 as a white solid (0.1420 g,
64%).
Rf = 0.27 (65% ethyl acetate-hexanes, UV). MP = 147-160 °C. 1H NMR (400 MHz,
CDCl3): δ 8.37 (s, 1H), 7.90 (s, 1H), 7.20 (s, 1H), 7.07 (s, 1H), 6.95 (s, 3H), 6.72 (d, J =
7.9 Hz, 2H), 5.63 (d, J = 19.1 Hz, 2H), 4.48 (dd, J = 91.6, 17.2 Hz, 2H), 3.92 (t, J = 14.7
Hz, 4H), 3.68 (d, J = 25.7 Hz, 6H), 3.02 (s, 1H), 2.09 (d, J = 8.0 Hz, 2H), 1.74 (d, J = 7.7
Hz, 2H), 1.36 (s, 9H), 1.02 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 170.93, 170.23, 170.02,
169.23, 158.86, 156.03, 138.74, 134.98, 131.41, 128.62, 128.25, 127.72, 123.06, 121.19,
114.06, 82.68, 79.79, 78.02, 77.20, 69.27, 63.05, 55.13, 52.25, 49.37, 42.94, 41.26, 31.13,
29.49, 28.20, 19.77. FTICR-MS (m/z): [M+Na]+ calculated for C33 H40N6O8Na+,
671.279983; found 671.279610.
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Synthesis of methyl (2-(3-azido-5-ethynylphenyl)-2-(2-oxoazetidin-1-yl)acetyl)glycinate
((±)-4.71):
ß-Alanine (0.1069 g, 1.20 mmol, 1.20 equiv) was added to a stirred solution of the
benzaldehyde 4.15 (0.1717 g, 1.00 mmol, 1.00 equiv) in methanol (5 mL). The mixture
was stirred for 30 minutes. Methyl isocyanoacetate (0.09 mL, 1.00 mmol, 1.00 equiv) was
added to the mixture. The mixture was stirred for 70 hours. The product mixture was
concentrated by rotary evaporation. The oil residue was dissolved in ethyl acetate. The
organic solution was transferred to a separatory funnel and washed sequentially with
saturate aqueous sodium bicarbonate solution, aqueous 1M hydrochloric acid solution, and
brine. The organic layer was dried over magnesium sulfate and the dried solution was
filtered. The filtrate was concentrated by rotary evaporation to afford a brown foam. The
foam was purified by flash column chromatography (SiO2, 65% ethyl acetate-hexanes) to
afford the ß-lactam (±)-4.71 as a pale-yellow oil (0.1352 g, 40%).
Rf = 0.20 (65% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 7.49 (t,
J = 5.6 Hz, 1H), 7.23 (s, 1H), 7.07 (d, J = 1.0 Hz, 1H), 7.02 (s, 1H), 5.56 (s, 1H), 3.98 (d,
J = 5.6 Hz, 2H), 3.69 (s, 3H), 3.65 – 3.17 (m, 2H), 3.14 (s, 1H), 3.01 – 2.81 (m, 2H). 13 C
NMR (100 MHz, CDCl3): δ 169.72, 168.16, 168.13, 140.99, 136.57, 128.04, 124.27,
122.26, 119.41, 81.84, 79.04, 77.32, 77.00, 76.68, 58.11, 52.31, 41.18, 39.09, 36.30.
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FTICR-MS (m/z): [M+Na]+ calculated for C16H15 N5O4Na+, 364.101625; found
364.101715.
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H
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(±)-4.74

1-((3-ethynyl-5-nitrobenzyl)amino)-4-methyl-1-oxopentan-2-yl

2-(4-

chlorophenyl)acetate ((±)-4.74):
Triethylamine (0.33 mmol, 2.40 mmol, 2.40 equiv) was added to a stirred solution
of the formamide 4.16 (0.2043 g, 1.00 mmol, 1.00 equiv) in dichloromethane (1 mL) at 0
°C. The mixture was stirred for 10 minutes at 0 °C. A solution of triphosgene (0.1187 g,
0.40 mmol, 0.40 equiv) in dichloromethane (1 mL) was added dropwise to the mixture at
0 °C over the course of 30 minutes. The mixture was stirred for 10 minutes at 0 °C. 4Chlorophenylacetic acid (0.2218 g, 1.30 mmol, 1.30 equiv) and isovaleraldehyde (0.14 mL,
1.30 mmol, 1.30 equiv) was added in sequence to the stirred mixture at 0 °C. The
temperature was gradually raised to room temperature. The mixture was stirred for 44
hours. The product mixture was diluted with dichloromethane. The organic solution was
transferred to a separatory funnel and washed sequentially with saturated aqueous sodium
bicarbonate solution, saturated aqueous sodium bisulfite solution, and brine. The organic
layer was dried over magnesium sulfate and the dried solution was filtered. The filtrate was
concentrated by rotary evaporation to afford an orange oil. The oil was purified by flash
column chromatography (SiO2, 25% ethyl acetate-hexanes) to afford the adduct (±)-4.74
as a colorless oil (0.1858 g, 42%).
Rf = 0.29 (25% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 8.15 (t,
J = 1.9 Hz, 1H), 7.94 – 7.89 (m, 1H), 7.53 (t, J = 1.6 Hz, 1H), 7.24 – 7.13 (m, 4H), 6.35 –
6.27 (m, 1H), 5.21 (dd, J = 8.8, 4.5 Hz, 1H), 4.41 – 4.26 (m, 2H), 3.65 (s, 1H), 3.23 (s, 1H),
1.80 – 1.54 (m, 3H), 0.88 (dd, J = 9.8, 6.4 Hz, 6H). 13 C NMR (100 MHz, CDCl3): δ 170.47,
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169.87, 148.05, 140.30, 136.41, 133.39, 131.75, 130.45, 128.83, 125.82, 124.10, 122.04,
80.75, 80.23, 73.01, 41.75, 40.55, 40.45, 24.41, 22.91, 21.55. FTICR-MS (m/z): [M+Na]+
calculated for C23H23 ClN2O5Na +, 465.118771; found 465.118792.
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Synthesis of N-(3-bromo-5-nitrobenzyl)formamide (5.2):
Formic acid (1.51 mL, 40.00 mmol, 8.00 equiv) was added to a stirred suspension
of the benzaldehyde 5.1 (1.1501 g, 5.00 mmol, 1.00 equiv) (known via Hartley, Elliott, and
Moore, 2007) in formamide (2.38 mL, 60.00 mmol, 12.00 equiv). The mixture was stirred
at reflux for 3 hours at 180 °C. The product mixture was diluted with ethyl acetate. The
organic solution was transferred to a separatory funnel and washed sequentially with water
and brine. The organic layer was dried over magnesium sulfate and the dried solution was
filtered. The filtrate was concentrated by rotary evaporation to afford a brown-orange oil.
The oil was purified by flash column chromatography (SiO 2, 75% ethyl acetate-hexanes)
to afford the formamide 5.2 as a yellow solid (0.7920 g, 61%).
Rf = 0.35 (75% ethyl acetate-hexanes, UV). 1H NMR (500 MHz, CDCl3): δ 8.35
(d, J = 1.8 Hz, 1H), 8.27 (d, J = 1.8 Hz, 1H), 8.08 (d, J = 1.9 Hz, 1H), 7.78 (d, J = 1.7 Hz,
1H), 6.23 (s, 1H), 4.57 (d, J = 6.5 Hz, 2H).13C NMR (126 MHz, CDCl3): δ 161.25, 148.88,
141.70, 136.52, 125.81, 123.17, 120.99, 40.89. FTICR-MS (m/z): [M+Na]+ calculated for
C8H7BrN2O3Na +, 280.953226; found 280.953218.
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Synthesis of ((3-(bromomethyl)-5-nitrophenyl)ethynyl)trimethylsilane (5.3):
Triphenylphospine (1.10 g, 4.21 mmol, 1.50 equiv) and carbon tetrabromide (3.07
g, 9.26 mmol, 3.30 equiv) was added in sequence to a stirred solution of the benzyl alcohol
4.10 (0.70 g, 2.81 mmol, 1.00 equiv) in dichloromethane (16 mL) at 0 °C. The mixture was
stirred for 20 hours at 0 °C. The product mixture was concentrated by rotary evaporation
and the oil residue was purified by flash column chromatography (SiO2, 10% ethyl acetatehexanes) to afford the benzyl bromide 5.3 as a white solid (0.8333 g, 95%).
Rf = 0.75 (10% ethyl acetate-hexanes, UV). 1H NMR (400 MHz, CDCl3): δ 8.22
(dd, J = 2.1, 1.4 Hz, 1H), 8.21 – 8.15 (m, 1H), 7.80 – 7.76 (m, 1H), 4.48 (s, 2H), 0.27 (s,
9H).13C NMR (100 MHz, CDCl3): δ 148.21, 139.79, 137.84, 126.43, 125.55, 123.50,
101.55,

98.40,

30.47,

-0.34.

FTICR-MS

(m/z):

C12H14BrNO2 SiNa+, 333.986939; found 333.986970.
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